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Initial antibiotic treatment of hemodialysis catheter-related sepsis
without catheter removal. J.K Kwon, TH. Lee, YK Seong, J. Suk, S.B.
Park, and H. C. Kim, Department of Internal Medicine, Keimyung University,
School of Medicine, Taegu, Korea. The use of dual-lumen, silicone central
venous catheter has become commonplace for prolonged temporary
hemodialysis vascular access. However, catheter-related sepsis remains a
major problem limiting their long-term use. Standard therapy of catheter-
related sepsis is catheter removal and systemic antibiotics followed by
replacement a new catheter at a new venous site after eradication of
bacteremia. However, the catheter removal is undesirable in patients who
have limited vascular access or, are waiting for full maturation of an
already created arteriovenous fistula. We tried systemic antibiotic treat-
ment initially in 23 patients of suspected catheter-related sepsis in an effort
to preserve the vascular access in patient who has a serious vascular access
problem. Catheters were removed only when the continuing sign of
scpticemia was associated with shock or there was no response after 48 to
72 hours of antibiotic therapy. Staphylococcus was the predominant
organism (13 cases). This maneuver was successful in 7 patients (30%),
and remaining 16 patients had to remove the catheter for various reasons.
All patients who had catheter removal had a prompt resolution of
catheter-related sepsis. There was no serious complication or death due to
delayed removal of catheter. The risk factors for catheter-related sepsis
were catheterization period, mean age, and other immunocompromized
states. We conclude that the initial systemic antibiotic treatment is
advisable in a limited number of patients who have a serious vascular
access problem before considering catheter removal.
Effect of recombinant human erythropoietin on anemia in 5/6 nephrec-
tomized rat. M.K Chung, J.H. Oh, K!. Song, MS. Park, H.B. Lee, Hyonam
Kidney Laboratory, Soon Chun Hyang University, Seoul, Korea. Recombi-
nant human erythropoietin (rhEPO) is widely used to correct anemia in
uremic patients. Only imported products have been available for clinical
use in Korea. LG Chemical recently succeeded in producing rhEPO. To
evaluate the effect of rhEPO from LG Chemical on anemia in uremia, 5/6
nephrectomy (NPX) was done in 10 normal Sprague-Dawley rats. Body
weight, BUN, and hematocrit level were monitored before and weekly
after NPX for 8 weeks. rhEPO was intraperitoncally injccted every day for
1 week and then every other day for 2 weeks beginning 8 weeks after NPX.
Tiematocrit was monitored every other day and BUN weekly during
injection. Body weight and BUN increased (250 17 g vs. 380 33 g,
41.8 9.6 mg/dl vs. 60.8 3.9 mg/dl, respectively, 1' < 0.01 each), and
hematocrit decreased (48.2 4,1% vs. 44.3 6.5%, p < 0.01) at 8 weeks
after NPX compared with baseline values. rhEPO 250 lU/kg was injected
in 5 rats and 500 lU in the other 5 rats. Hematoerit level increased after
injection of rhEPO and became significantly higher after 8 days (63.4
3.2% at 8 day and 64.2 2.7% at 10 days, P < 0.01 each) compared with
the baseline value. BUN remained stable while body weight increased
gradually. Hematoerit, body weight, and BUN levels did not differ
between the two groups with rhEPO 250 lU/kg and rhEPO 500 lU/kg. In
conclusion, the rhEPO from LG Chemical was effective in correcting
anemia in animal model of chronic renal failure. More studies to evaluate
the long-term effects of domestically produced rhEPO are required.
Hypokalemia and hypertension due to unilateral adrenal tumor pre-
sented with dissecting aneurysm. S.H. Lee, YS. Park, J.H. Sohn, I.H. Lee,
and H.J. Kim, Department of internal medicine, Hanyang University Kuri
Hospital, Kuri, Korea. Simultaneous presentation of hypokalemia and
hypertension narrows the differential diagnosis among diverse etiologies
of hypokalemia in general, and their treatments require the correction of
hypokalemia by medical and surgical methods, if necessary. We experi-
enced a patient who presented with hypokalemia and hypertension, which
required emergent surgical intervention due to an acute dissecting aneu-
rysm for the complication of hypertension, but not for hypokalemia.
Biochemical work-ups were as follows.
Serum Urine
K K
mEqiliter pH PRA ng/mllhr Aldosterone pg/mi
1.9 30 7.46 0.26 (supine: 0.68—1.36) 307 (supine: 40—194)
1.9 16 7.54 0.20 (standing: 0.24—4.7) 642 (standing: 94-338)
24-hr Urine
aldosterone
rg/day
VMA . .Metanephrine Epinephrine Norepinephrrne
mg/day pg/day
—
59 1.06 0.55 7.1 10.0
(nl:2.3—21.4) (nl:2—10) (nI: up to 1.2) (nl:0—40) (nl:0—80)
These data of the imaging studies were consistent with primary aldoste-
ronism due to unilateral adrenal tumor. Our experience suggested that
secondary hypertension with adrenal tumor (Conn's tumor) would be
initially presented with dissecting aortic aneurysm besides hypokalemic
symptoms, which might mask its classic symptoms.
Hypertension as a sign of renal involvement in polyarteritis nodosa
(Case report and review). Vi. Cho, S.M. Kim, S.f. fang, C.K. Park, and H.J.
Kim, Departments of Internal Medicine, Patholo, and Radioloi, 1-lanyang
University Kuri Hospital, Kuri, Korea. We report a 46-year-old man
diagnosed with the classic polyarteritis nodosa (PAN), who initially
presented with acute abdomen due to acute acaleulous cholecystitis.
histological examination of gall bladder after cholecystectomy showed
necrotizing arteritis. Despite the lack of multisystem involvements except
severe hypertension (230/130mm Hg), angiographic studies, known as the
gold standard of radiologie diagnosis of PAN, showed the typical findings
of PAN: multifocal vascular irregularities and mieroaneurysms in medium
and small arteries of kidney and celiac axis with decreased opacifleation of
renal cortex. Routine urinalysis with microscopic examination did not
show active urinary sediments or proteinuria, and other renal function
profiles were with in normal limit. Furthermore, no evidence of lung
involvement was shown in high resonance CT scanning. Therefore, this
patient presented with necrotizing arteritis in gall bladder, and the
presence of severe hypertension as the "only" sign of renal involvement
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was diagnosed as classic PAN. This experience prompts us to review the
reported cases of PAN in the world literature with clinical manifestations
of renal involvement as hypertension.
A case of overlap type Polyarteritis nodosa associated with papillary
carcinoma of thyroid. M.H. Park, C.H. Lee, C.H. Park, Department of
Internal Medicine and Pathology, College of Medicine, Hanyang University,
Seoul, Korea. Polyarteritis nodosa(PAN) is traditionally divided into two
basic forms including microscopic type; however, the pathologic and
clinical validities of this separation have been challenged as greater
number of cases with overlapping feature are recognized. The cause of
PAN remains unknown. It has been suggested in some reports that PAN
might be associated with tumors. Classic polyarteritis nodosa is often
manifested by organ ischemia or necrotizing vasculitis: but, microscopic
polyarteritis nodosa always includes necrotizing and crescentic glomeru-
lonephritis. A 74-year-old woman with a 2 year history of thyroid mass was
admitted because of nausea, vomiting since I month ago. Physical
examinations included BP of 110/70mm 1-1g. Laboratory findings were: Hb
9.4 g/dl, WBC 14,400/mm3, PLT 43 1,000/mm3, serum creatinine 0.8 mg/dl
and urine RBC2O/HPF, urine albumin 3+, antimicrosomal antibody(+),
antithyroglobulin antibody(+), C3 98.2 mg/dl, C4 16.8 mg/dl, p-ANCA
1:160, ANA 1:80, and HBsAg(—). Needle aspiration of the thyroid mass
revealed cytological patterns compatible with papillary carcinoma. The
operation was delayed due to poor general condition. Pulmonary hemor-
rage, congestive heart failure with arrhythmia, GI bleeding, and ARF
developed during the hospital course. The renal biopsy showed typical
features of microscopic PAN. Most glomeruli displayed segmental fibrin-
oid necrosis associated with segmental destruction of GBM, polymorpho-
nuclear infiltration, and small or circumferential cellular crescents in 6 out
of 9 glomeruli. The arteries of arcuate and interlobular arteries displayed
acute neerotizing arteritis. Tubulointerstitial inflammation resembling
interstitial nephritis was marked. Immunofluorescence findings revealed
totally negative findings, except for trace mesangeal C3 staining. Electron
microscopic findings showed no glomerular electron-dense deposits and a
segmental collapse of glomerular capillary tuft with crescent formation.
Vasculitis of other organs was not determined by biopsy. Because she
could not undergo thyroideetomy, after treatment of papillary carcinoma
of thyroid, we could not confirm whether there could be any improvement
of the PAN, and could not clinically determine any relation between the
two diseases. In spite of hemodialysis and steroid pulse therapy, she
expired at 2 months of her hospital stay due to intracranial hemorrhage.
We report a case with focal segmental necrotizing GN with crescents
associated with acute necrotizing arteritis involving in arcuate and inter-
lobular arteries with papillary carcinoma of the thyroid.
Isolated C3 mesangial proliferative glomerulonephritis: A case of rapid
progression to chronic renal failure. J.K Kwon, TH. Lee, YK Seong, J.
Suk, SB. Park, and H.C. Kim, Department of Internal Medicine, Keimyung
University, School of Medicine, Taegu, Korea. Isolated mesangial C3
proliferative glomerulonephritis is a nephropathy that is poorly defined
among glomerular diseases. The clinical picture is characterized by
episodes of gross hematuria and/or persistent or recurrent microhematu-
na and/or proteinuria. Nephrotic syndrome may also be present. Early
reports regarding this entity suggested that this disease is both clinically
and pathologically benign. However, a recent report by Ginesta et al has
indicated that there were 4 of 5 patients with this entity who developed
terminal renal failure in a long-term follow-up. We report a case of
isolated C3 mesangial proliferative glomerulonephritis, which rapidly
progressed to chronic renal failure. A 26-year-old female patient was
admitted to our department because of generalized edema. 11cr urinalysis
showed proteinuria (3+), RBC 4/HPF, WBC 2/HPF. Proteinuria was 12.1
g/24 hr. Laboratory findings included BUN 31 mg/dl, serum creatinine 1.3
mg/dl, serum albumin 1.6 g/dl, and serum cholesterol 618 nig/dI, Percuta-
neous renal biopsy showed only mild mesangial proliferation and mild
focal interstitial fibrosis. Immunofloorescenee study revealed an isolated
C3 mesangial deposition. Prednisolone was given under the initial diag-
nosis of minimal change nephrotie syndrome, without response. Eight
weeks of cyclosporine A was tried, without good results. Subsequently her
renal function deteriorated rapidly to a serum creatinine level of 3.8 mg/dl
at 3 months after diagnosis. At last follow-up, 6 months after diagnosis,
her serum creatininc rose up to 5.9 mg/dl. She began to feel anorexia,
weakness, and mild nausea.
Cyclosporine (Cs) induced remission of relapsing minimal change
nephrotic syndrome (MCNS) in adults. E.J. Choi, S.Y. Kim, YS. Chang,
BK. Bang, Department of Internal Medicine, YJ. Choi, Department of
Clinical Pathology, Catholic University Medical College, Seoul, Korea. To
evaluate the efficacy and safety of a 6 month course of Cs therapy in
refractory cases of MCNS, Cs (Implanta®, Hanmi Pharm. Co., Seoul,
Korea) was given to 11 adult MCNS (male 7, female 4, age 16—48), 2 of
whom were steroid-dependent (SD), 7 frequent relapsers (FR), and 2
were steroid resistant (SR), with starting dose of S mg/kg/day and tried to
maintain Cs RIA levels of —150 ng/ml. After 3 months, 8 patients had a
complete remission (CR, Upr,,t* <0.5 g/day, 5A15 g/dl), 1 a partial
remission (PR, Upr,,t <3.Sg/day, SAIb >3.5 g/dl), and 2 failed (CR rate
73%). Remissions were achieved after 2—5 weeks of starting and trough
levels of Cs were 256 111 ng/ml. Also, remission occurred in all eases of
SD and FR, but none in SR. After another 3 months of Cs maintaining
(2.5 mg/kg/day) in remitted 9 patients, 7 had a CR, 2 a PR. After 6 months
therapy, we are maintaining Cs for another 4—8 months in 7 patients who
were CR and they are remitting completely, but 3 patients who withdrew
Cs relapsed 2—6 weeks after cessation of Cs. At 3 and 6 month after Cs
therapy, in 7 CR patients, the mean serum albumin rose from 2.1 0.6
g/dl to 3.7 1.0 g/dl, 3.9 1.1 g/dl, and proteinuria decreased from 7.9
3.4 g/day to 0.2 0.4 g/day, 0.3 0.7 g/day, and serum cholesterol
decreased from 378 114 mg/dl to 219 54 mg/dl, 223 47 mg/dl at 3
and 6 months after Cs therapy, respectively, and the differences were
significant (P < 0.05). The mean serum creatinine, BUN, and blood
pressures were not significantly different after Cs therapy. The side effects
were hypertrichosis 5, tremor 2, gastrointestinal discomfort 1, gingival
hypertrophy 1, and in I patient renal function was decreased and
recovered after cessation of Cs. In conclusion, Cs can be used to induce a
remission in troublesome MCNS adults and side effects will be eliminated
after cessation. Relapsing after cessation of Cs is one of problems to be
solved.
The angiotensin.converting enzyme gene polymorphism in non.insulin
dependent diabetic nephropathy. J.K Seo, 5.1-I. Park, CII. Park, 5K. Ha,
S. W. Kang, K.H. Choi, H. Y Lee, and D. S. Han, Department of Internal
Medicine, Yonsei University, Seoul, Korea. Approximately 10—20% of
non-insulin dependent (NTDDM) diabetic patients develop diabetic nc-
phropathy. The pathogenesis of diabetic nephropathy is not fully under-
stood, but present evidence suggests a multifactorial origin with contribu-
tions from hemodynamic alterations, metabolic abnormalities, and various
growth factors and genetic factors. The angiotensin converting enzyme, its
gene is located in intron 16, plays a key role in the production of
angiotensin II and in the catabolism of bradykinin, two peptides involved
in the modulation of vascular tone and in the proliferation of smooth
muscle cells. Good evidence exists that genetic predisposition plays a
major role in the development of diabetic nephropathy. Recently it was
reported that the insertion/deletion(1/D) polymorphism in the gene for
angiotensin I converting enzyme was related to the occurrence of ne-
phropathy. We examined 106 patients with NJDDM: 47 without nephrop-
athy and 59 with nephropathy, and 67 normal controls. Duration of
diabetes in both groups was at least 10 years and nephropathy was defined
by excretion of albumin > 300 mg/day. The age, sex, blood pressure,
HbA1C, body mass index and serum cholesterol level were not different in
either diabetic group. The 1/D polymorphism was analyzed with a PCR
technique.
NIDDM with
Control NIDDM nephropathy(N = 67) (N = 47) (N = 59) P
ACE genotypes
DD 9 6 11
ID 36 28 33 0.81
11 22 13 15
ACE alleles (l/D) 80/54 54/40 63/55 0.60
No significant difference in genotype distribution and allele frequencies
were found among the NIDDM with or without nephropathy and control
groups. We conclude that ACE gene polymorphism is not associated with
the pathogenesis of diabetic ncphropathy in NIDDM patients.
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Pathogenic role of advanced glycosylation end-products in experimen-
tal diabetic nephropathy. MK C/ia, K!. Song, J.H. Kim, E. V. Lee, D.C.
Han and H.B. Lee, Hyonam Kidney Laboratory, Soon Chun Hyang Univer-
sity, Seoul, Korea. Advanced glycosylation end products (AGE) have been
implicated in the pathogenesis of diabetic renal and vascular injury. Most
of the evidcnces have been obtained, however, from in vitro studies or in
vivo studies independent of diabetes mellitus. In order to evaluate the in
viva evidence of pathogenic role of AGE in diabetic glomerular injury we
observed streptozotocin-induced diabetic rats without (D) and with ami-
noguanidine (DA), inhibitor of glucose-induced protein cross-link, from 4
days to 24 weeks after induction of diabetes. Age-matched control rats
without (C) and with aminoguanidine (CA) served as controls. HbA1C
was measured by HPLC and whole kidney tissue AGE by ELISA method.
Glomerular volume (Gv) was calculated by Weibel and Gomez equation
from glomerular surface area measured by Image-pro (Media Cybernet-
ics) software program on PAS-stained tissue section. Blood glucose levels
were significantly higher in both D and DA than in C and CA at all times.
Progressive increase in kidney weight, urinary albumin excretion (UAIhE),
serum creatinine, HbA1C, and whole kidney tissue AGE was observed in
D. Tissue AGE level was significantly higher in D as compared to C and
CA in 12 weeks, and kidney weight, Gv, UAE, and HbAJC were
significantly higher in D in 24 weeks. With significant reduction in HbA1C
(at 4 weeks) and tissue AGE (at 12 weeks) in DA, there was significant
decrease in Gv and UAIbE in DA at 24 weeks. In conclusion, this study
provides further in vivo evidence of pathogenic role of AGE in diabetic
nephropathy. The mechanisms by which AGE induces glomerular injury
in diabetes need further study.
Effects of glucose control on the progression of diabetic nephropathy.
YJ. Kim, D.C. Han, M.K Cha, KJ. Song, J.H. Kim, E.Y Lee, H.J. Ha, and
H.B. Lee, Hyonam Kidney Lab., Soon Chun Hyang University and Depart-
ment of Pharmacology, Yonsei University Medical School, Seoul, Korea.
Intensive insulin therapy effectively delays the Onset and slows the
progression of nephropathy in patients with IDDM. TGF-13 has recently
been implicated in the pathogenesis of diabetic nephropathy. We evalu-
ated the effects of glucose control with insulin therapy on the progression
of diabetic nephropathy and the glomerular expression of TGF-f31 tran-
script and its protein and type IV collagen protein in age-matched control
rats (C) and 3 groups of streptozotocin-diabetic rats; high blood glucose
without insulin therapy (HG), moderate glucose with insulin (MG), and
normal glucose with insulin (NG). Glomerular volume (Gv) was measured
using Image-Pro morphometric software, TGF-f31 mRNA by Northern
analysis and in situ hybridization, and TGF-13 and type IV collagen
proteins by immunohistochemical staining. Gv was significantly higher in
HG than in other groups at 3 months (mos) after induction of diabetes.
Kidney weight (KW) was the highest while the body weight was the lowest
in HG of all groups in 3 mos. Daily urine albumin excretion (UAIhE)
increased with time in all groups but was significantly larger in HG than in
all other groups at 3 mos. MG also had significantly larger UAIhE than C
at 3 mos. There was no difference in Gv, KW, and UbE between NG and
C. Glomerular TGF-131 mRNA expression increased twofold in HG in one
month after the induction of diabetes, while the expression was not
different among C, MG, and NG. Glomerular expression of TGF-f3 and
type IV collagen proteins was proportional to the level of blood glucose,
being the highest in JIG and low or no expression in NG in 3 mos. The
results support the view that high blood glucose is a prerequisite for
glomerular injury in diabetes mellitus, and that the glomcrul-ar injury in
diabetes is mediated by TGF- and suppressed by glucose control.
The clinical characteristics of biopsy-proved lupus nephritis. .1. V
Chung, WS. An, S.]. Bae, S.E. Kim, K.H. Kim, Department of Internal
Medicine, College of Medicine, Dong-A University, Pusan, Korea. We
analyzed 37 biopsy-proven lupus nephritis retrospectively for clinical and
pathologic characteristics and clinical course. (1) The mean age was
30.9 10.3 (15—60) years old, of whom 40.5% were in their third decade,
32.4% in fourth decade, and 8.1% in fifth decade at initial presentation.
Male to female ratio was 1:8.3 (4:33), (2) By the time of first admission,
serum albumin was 2.4 0.7 g/dl, 24 hr urine protein was 4295 3120mg.
ANA was found in 89.2% of patients and anti-DNA in 63.9%. Serum C3
and C4 were below normal in 33 cases (89.2%) and 34 cases (91.9%),
respectively. (3) Hypertension was found in 11 cases (29.7%) and ne-
phrotic syndrome in 18 cases (48.7%). (4) By WHO classification, 18 cases
(48.6%) were diagnosed as class IV (diffuse proliferative nephritis) lupus
nephritis, 11 cases (29.7%) as class V (membranous nephritis), and 8 eases
as class III (focal proliferative nephritis). Patients with class IV lesion had
higher rates for the presence of hypertension, increased serum ereatinine,
and nephrotic syndrome. (5) We treated 25 cases with only prednisolone,
3 cases with steroid pulse and prednisolone maintenance, 5 cases with
prednisolone maintenance after p.o. cyclophosphamide therapy, 2 cases
with prednisolone maintenance after iv. eyelophsphamide therapy, and 1
case with pulse steroid and p.o. cyclophosphamide followed by pred-
nisolone maintenance. Among them, the group given prednisolone ther-
apy have shown relatively stable course, whereas iv. cyclophosphamide
treatment resulted in severe leukocytopenia in the majority of patients. (6)
During the follow-up period (mean duration of 36.5 32.7, range of
1—135 months), 3 eases (class III 1, class IV 2) went into end-stage renal
failure, 4 cases (class IV 3, class V 1) showed chronic progressive renal
insufficiency wirh persistent proteinuria, and 23 cases (class III 7, class IV
7, class V 9) also continued proteinuria hut preserved normal renal
function. Four cases (class IV) reached to complete remission and 3 cases
(class IV 2, class V 1) died. In summary, nephrotic syndrome occurred in
about 50% out of 37 patients with lupus nephritis. WHO class IV was the
most prevalent and the patients belongs to this class had the worst
prognosis during follow-up.
Prognosis in lupus nephritis: Patient chracteristics associated with
poor outcome. H.J. Chin, S.f Lee, W.S. Huh, H.J. Yoon, C. Ahn, J.S. Han,
S. Kim, iS. Lee, Department of Internal Medicine, College of Medicine,
Seoul National University, Seoul, Korea. To assess the impact of demo-
graphic and clinical factors on death and renal survival in patients with
lupus nephritis (LN) who were referred to a tertiary health care hospital,
Seoul National University Hospital, we retrospectively analyzed medical
records from 1973 through 1995. We defined renal death as the ratio of
initial to the last creatinine over 2.0 and analyzed the impact of azotemia
as creatinine over 1.5, 1.7, 2.0, and 2.5 mg/dl on prognosis. We examined
for the contents of The American Rheumatism Association Criteria, sex,
age, blood pressure, activity of serum complement, severity of nephritis,
renal pathlolgic type, method of treatment, and diagnosed period as risk
factors influencing the prognosis. In 323 systemic lupus erythematosus
(SLE) patients whose clinical findings fulfilled The American Rheumatism
Association Criteria for SLE, LN occurred in 198 patients (63.7%). In the
combined therapeutic group with steroid and cyclophophamide pulse, rate
of remission of proteinuria was 50%, with steroid and oral immunosup-
pressive drug, 36.2%, and with only steroid, 50.6%. The estimated renal
survival rate from diagnosis was 96.6% in 1 year, 92.1% inS years, 92.1%
in 10 years, and the estimated survival rate from diagnosis was 96.1% in I
year, 90.1% in 5 years, 90.1% in 10 years. There was no statistical
difference in the rate of survival and renal death with regard to the
presence of nephritis and renal histologic type. But there was a significant
difference between therapeutic groups with combined steroid and cyclo-
phamide pulse and with steroid only (P < 0.05). In total patients with SLE,
the estimated renal survival rate from diagnosis was 95.8% in 1 year,
89.0% in 5 years, 87.2% in 10 years, and the estimated survival rate from
diagnosis was 96.0% in 1 year, 89.7% in 5 years, 89.7% in 10 years. We
found that involvement of central nervous system, anemia, pleurisy, and
therapy with steroid only worsened the probability of renal survival and
male, severe nephritis (serum creatinine 2.0 mgldl and amount of
proteinuria), hypertension, thrombo-cytopenia, increased anti-ds DNA
antibody titer, and therapy with steroid only emerged as the risk factors for
a worse prognosis in total SLE patients. There was no fatality in .LN
patients diagnosed in the 1970s, 10 fatalities (9.7%) in the 1980s, and 3
fatalities (3.3%) in the 1990s. This shows a significant improvement in the
survival rate during last 22 years (P < 0.05).
Clinical manifestations of lupus nephritis. J.E. Oh, S.C. Lee, I-if. Chin,
W.S. Huh, II.J. Yoon, C. Ahn, J.S. Han, S. Kim, J.S. Lee, Department of
Internal Medicine, College of Medicine, Seoul National University, Seoul,
Korea. Renal involvement in systemic lupus erythematosus (SLE) is one of
the most serious complications of the disorder. Here we described the
clinical manifestations, renal pathology, methods of treatment, and end
results of patients with lupus nephritis (LN) who were referred to a
tertiary health care hospital, Seoul National University Hospital, from
1973 through 1995. We reviewed medical records of 198 patients (63.7%)
with LN in 323 SLE patients whose clinical findings fulfilled The American
Rheumatism Association (ARA) Criteria for SLE. We defined deteriora-
tion of renal function as the ratio of initial to the last creatinine over 2.0.
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Of 198 cases, seventeen (8.6%) were males. Mean age at diagnosis was
27.1 years (standard deviation 10.5 years, range 8 to 63 years) and those in
the age group of 20 to 30 were 38.4%. The mean interval between the
appearance of the first symptom subseqently related to SLE and diagnosis
was 15.5 months (SD 19.5 months) and the mean follow-up period was
44.1 months (SD 41.7 months). The mean frequency of ARA criteria was
5 (SD 1.4). The most common initial clinical manifestation was malar rash
(56.9%), followed by Raynaud phenomenon (54.1%), fever (39.3%),
arthritis (38.9%), and hypertension (36.0%). Hematologic laboratory
findings were lymphopenia (<1000 cells/mm3) 44.3%, leukopenia (<4000
cells/mm3) 42.8%, thrombocytopenia (<100,000 cells/mm3) 28.9%, hemo-
lytic anemia 21.7% and in immunologic laboratory findings, there were
antinucler antibody 92.6%, anti-ds DNA antibody 79.4%, LE cell prepa-
ration 56.3%, decreased C3 titer 74.1%, and decreased CH5O titer 76.4%.
Mild to moderate azotemia (serum creatinine 1.5—3.0 mg/dl) was observed
in 25 patients (12.6%) and severe azotemia (serum creatinine 3.0 mg/dl)
was seen in 12(6.3%). Ncphrotie syndrome (daily proteinuria 3500 mg)
was documented in 57 of 173 patients (32.9%). The prevelance of different
WHO classifications of the total renal 139 biopsied cases were: class I
2.2%, 11 6.5%, III 7.2%, IV 72.7%, V 11.5%. Relative higher frequencies
of fever, hypertension, azotemia (serum creatinine 1.5 mg/dl), hypo-
complementemia, high anti-ds DNA titer were shown in LN and hyper-
tension, proteinuria, and high erythrocyte sedimentation rate in WHO
class IV of LN. During the clinical course of LN, deterioration of renal
function in 9.3%, end-stage renal disease in 1%, and death occurred in 13
(6.6%). Lupus related organ system involvement (7 cases) and infection (4
cases) were the most frequent primary causes of death.
Reversible multiorgan failure due to high dose treatment of cisplatin
based chemotherapy. YS. Park and J.B. Yoon, Department of Urology,
College of Medicine, Pusan University, Pusan, Korea. Cisplatin (CDDP) is
an important antineoplastic chemotherapeutic agent. The administration
of intensified chemotherapy of CDDP produces significant renal toxicity
and causes multiorgan failure, which may be lethal. The patient was a
46-year-old man who was performed partial cystectomy of urachal adeno-
carcinoma with a combination of chemotherapeutic regimens (high dose
CDDP, Mitomycin and 5-Flurouracil). Cisplatin was given intravenously
70 mg/m2/day for 5 days. The patient underwent multiorgan failure and
then recovered after intensive care for one month. After one year of
follow-up, the patient was alive and there was no evidence of tumor
recurrence.
Apparent bicarbonate space dependent on muscle mass in patients with
metabolic acidosis. J.H. Shin, SM. Kim, YS. Park, D.S. Han, J.H. Sohn,
Mi. Ahn, H.J. Kim, Department of Internal Medicine, Hanyang University
Kuri Hospital, Kuri, Korea. This study was aimed to test the hypothesis that
the apparent bicarbonate space, i.e., the volume of distribution of
bicarbonate, will depend largely on the amount of bicarbonate entering
the cell to be buffered by cellular buffers, and the cellular buffering will in
turn depend on the muscle mass. This hypothesis was tested with
intravenous bicarbonate administration of 3 mEq/kg for ito 2 hours in 15
patients of body weights between 50 and 70 kg (including 7 wasted ones,
and 8 well-built men) with stable mild to moderate metabolic acidosis, and
determined the extent of rise in serum bicarbonate. We also measured
urine creatinine excretion rates as a measure of muscle cell mass. Plasma
bicarbonate rose from 16.3 (range 13—2t) niEq/liter at baseline to 23.5, 22.0
and 24.1 mEq/litcr, and blood p1-1 from 7.27 (range 7.21 to 7.34) to 7.39,
7.38 and 7.40 after, and one and two hours alter the infusion, respectively.
Compared to the well-built patient (8 pts), 7 wasted patients had low
creatinine excretion rate (9.3 vs. 15.6 mg/kg/day, P < 0.001), and,
immediately after and ooe and two hours of bicarbonate infusion, these
wasted patients showed a substantially greater increase in plasma bicar-
bonate from basal value (9.6 1.8 vs. 7.3 2.1 mEq/liter, P < 0.01; 9.5
1.4 vs. 7.0 1.9 mEq/liter, P < 0.01; 10.! 1.5 vs. 7.2 1.7 mEq/liter, P
0.01, respectively). Blood pH rose in parallel with the significant difference
in both groups (P 0.05). Furthermore, there was a significant negative
correlation between the urine creatinine excretion rate and the increase of
plasma bicarbonate after bicarbonate infusion (r = 0.7, P < 0.05). These
observations suggest that, in the treatment of metabolic acidosis with
bicarbonate, patients with low urine creatinine excretion (therefore with
low cell mass) would have a much greater rise in serum bicarbonate, and,
therefore, the measurement of urine creatinine excretion rate could be
considered as a simple tool to assess the required amount of bicarbonate
as well as the apparent volume of distribution of bicarbonate in patients
with metabolic acidosis and muscle wasting.
Renal potassium wasting ameriolated with magnesium repletion in
Gitelman's syndrome. H.S. Moon, SM. Kim, S.C. Yang, D.S. Han, M.J.
Ahn, S.K. Kim, J.H. Lee, H.J. Kim, Department of Internal Medicine,
Hanyang University Kuri Hospital, Kuri, Korea. A case of Gitelman's
syndrome (GS) characterized by hypokalemic metabolic alkalosis, hypo-
magnesemia, marked hypocalciuria and renal potasium wasting was
evaluated for the responses following the three therapeutic regimens: KCI
repletion alone, MgO alone, and combined therapy of KC1 with MgO.
Each regimen was given for 10 days, and these three different experiments
were separated each other by at least 30 days.
Serum mEq/liter
K Mg HCO3
Baseline 2.6 1.1 33
KCI alone 3.6 1.1 31
MgO alone 3.2 2.0 34
KCI + MgO 3.9 1.9 30
Urine
UK mEq/liter UM5 mg/day U mg/day
Baseline 72 124 18
KCI alone 148 112 28
MgO alone 13 153 20
KCI + MgO 112 145 32
In contrast to the effect of serum potassium and urinary K wasting to Mg
supplementation, MgO did not affect the mildly increased basal values of
plasma renin activity and aldosterone. These observations suggest that
hypokalemia and renal potassium wasting in Gitelman's syndrome may be
related to abnormal Mg metabolism, and Mg supplementation in addition
to KCI would be necessary for the optimal therapeutic regimen of this
disorder.
Absence of H-ATPase in the intercalated cells of renal biopsy tissues
in two patients with distal renal tubular acidosis (dRTA). YS. Cho, YY.
Jung, U.S. Jeon, G-H. Kim, C. Ahn, J.S. Han, S. Kim, iS. Lee, YH. Kim, J.
Kim, Department of Internal Medicine, Seoul National Unviersity Medical
College; Department of Internal Medicine, Hallym Unviersity Medical Col-
lege; and Department of Anatomy, Catholic University Medical College,
Seoul, Korea. Proton-secretory defect is thought to be a major pathophys-
iologic mechanism leading to dRTA. However, there have been only two
case reports demonstrating the absence of proton pump in renal tissues of
patients with dRTA. We examined the renal biopsy tissues from two
patients with dRTA due to the proton-secretory defect by immunohisto-
chemistry using a rabbit polyclonal antibody against the 70-kDa catalytic
subunit of H -ATPase from bovine brain clatbrin-coated vesicles (provid-
ed by Dr. Dennis Stone). Normal human kidncy(NC) and the renal biopsy
tissue from a patient with chronic tubulointerstitial nephritis whose proton
secretory capacity was intact(DC) were compared as controls. The first
dRTA patient was a 26-year-old woman presenting with myalgia and lower
extremity weakness, and the second who initially presented with a
pathologic fracture of both femoral necks was a 43-year-old woman
retrred for the evaluatioo of hypokalemia from the department of
orthopedic surgery. Their laboratory abnormalities consisted of severe
hypokalemia and metabolic acidosis, and proton secretory defects were
demonstrated by a failure to lower the urine pH during marked acidemia
induced by NII4CI loading and an abnormally low urine-blood PCO7
difference during bicarbonate administration. Stainings with the anti-H-
ATPase antibody in NC and DC were strongly positive in intercalated cells
in the connecting tubules and collecting ducts. The tissues from both of the
patients with dRTA were devoid of any anti-FU-ATPase staining io the
intercalated cells. This result suggests that the pathophysiologic basis of
impaired 1I secretion in our two patients with dRTA was secondary to
the absence of intact H -ATPasc pumps.
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The role of vasopressin and oxytocin as antidiuretic hormones in
edematous patients. US. Jean, J.H. Kim, W.S. Huh, YS. Cho, G.H. Kim, C.
Ahn, J.S. Han, S. Kim, J.S. Lee. Department of Internal medicine, College of
Medicine, Seoul National University, Department of Internal Medicine,
College of Medicine, Hanilym University, Seoul, Korea. Vasopressin(VP) is
known as the only antidiuretic hormone in humans. However, the plasma
levels of VP during severe dehydration increase only high enough to
increase water permeability in collecting duct to a half-maximal level.
Therefore, VP alone cannot produce maximal urinary concentration.
Recently, oxytocin(OT) was documented as an antidiuretic hormone in an
in vitro study of animal, but an antidiuretic action of oxytocin in human has
not been documented. In this study, we examined the role of vasopressin
and oxytocin in humans who have edema and water disturbance. In 12
adult patients who were admitted in Seoul National University Hospital
due to general edema with 10% weight gain or more over, the levels of VP
and UT measured at edematous state and after edema had subsided. With
them, VP and UT levels measured in 7 normal adult males as controls and
were compared with those of patients. The results were: (1) underlying
diseases of 12 patients (8 males and 4 females, mean 44-years-old: range
22—65) were nephrotic syndrome (N = 7), liver cirrhosis (N 3) and acute
reanl failure (N = 3). (2) At an edematous condition, plasma VP and UT
levels were 7.0 0.7 pg/mI (normal controls 4.1 0.2) and 12.8 1.6
pg/mi (normal controls 3.8 0.2). Both VP and UT levels of patients were
higher than those of normal controls, respectively (P < 0.01). (3) Plasma
VP levels did not show significant changes between edematous and
edema-subsided conditions (from 7.0 0.7 to 8.8 1.2 pg/mI), but plasma
UT leves decreased significantly from 12.8 1.6 to 10.5 1.2 pglml (P <
0.05). (4) There were correlations between plasma or urine VP and UT
levels, respectively (P < 0.01). (5) After edema had subsided, 12 patients
showed 13 2% reduction of body weight (P < 0.01). Plasma and urine
Na levels, osmolality and urine volume did'nt correlate with urine Na,
osmolality level or FEN4 in patients. We concluded that oxytocin may
function in water or sodium balances and role as an antidiuretic hormone
like VP in human. To confirm that, we would observe the changes of water
balance in normal humans treated with VP and UT.
Correlation of modified urine osmolal gap(UOG) with urine ammoni-
um(NH4') in high anion gap metabolic acidosis (AGMA): Comparison to
urine anion gap(UAG). YY. Jung, M.S. Park, US. Jeon, G.H. Kim, J.S.
Han, S. Kim, J. S. Lee, Department of Internal Medicine, Hallym Unviersity
and Seoul National Unviersily Medical College, Seoul, Korea. UAG and
UUG were proposed as indirect measures of urine NH4. While the
former is known to have its usefulness limited to hyperchloremie meta-
bolic acidosis, the latter is reported to have its correlation with urine
NH4 in ketoacidosis. However, it is not clear whether the UUG can be
used in any other cases of AGMA. To evaluate the correlation of UUG
with urine NH4 in AGMA and to compare it with that of UAG, we
measured urine NH4 (by enzymatic determination), UUG(= 0.5 )<
[urine osmolality {2 X (Na + K) + urea + glucose}), and UAG(=Na — K — Cl) in 18 patients(serum AG = 24.4 1.6 mM) with
AGMA. When they were grouped into those with acute disorders (N =
11) including diabetic ketoacidosis and lactic acidosis and those with
chronic renal failure (N = 7), urine NH4 concentration was higher (P <
0.05) in the acute(35.6 7.7 mM) than in the chronic group (3.8 0.9
mM). The UOG was higher (P < 0.05) in the acute (73.2 18.9 mM) than
in the chronic group (6.3 8.7 mM), hut the UAG had no difference
between the two groups. When both groups of the patients were consid-
ered together, urine NH4 concentration correlated with the UUG(r =
0.90, P < 0.01), but not with the UAG. While the patients with lower urine
NH44 excretion (<30 ininol/day) had the UUG < 40 mu, those with
higher urine NH4 excretion (>40 mmol/day) had a UOG > 40 mat. We
conclude that, in contrast to the UAG, the UOG has a significant
correlation with urine NH4' in AGMA.
A molecular genetic study on the WTI gene mutation in patients with
Denys-Drash syndrome. P.S. Oh, S.f. Kim, lIZ. Whang, 11W Roh, M.L.
Oh, N.S. Beck, D.K fin, 1-1.1. Cheong, H.S. Ahn, Y Choi, Department of
Pediatrics, Department of Nephrology, Samsung Medical Center, Center for
Clinical Research, Samsung Biomedical Research Institute, Seoul, Korea.
The Denys-Drash syndrome is known to be an important model in the
study of renal failure and tumor genesis and is characterized by nephrotic
syndrome, external genitalia abnormality and Wilms tumor at an early age.
Recently, this syndrome has been intensively studied at the molecular level
and mutation of the WT1 gene, which belongs to nuclear binding protein
and functions as tumor suppressor gene, has been found in patients with
this syndrome. In the current study, we investigated the mutation of the
WTI gene in 2 patients with Wilms tumor and nephrotic syndrome/
proteinuria. There was a substitution of 355 Ser for cys(TGT—TCT) in
exon 8 of one patient and a substitution of 387 Thr to Ala (GCT—ACT)
in the other patients. From these results, it is conceivable that the critical
mutation in the zinc finger domain may play a role in the pathogenesis of
the syndrome. However, in order to prove a direct correlation, we need a
evidence that the mutation of WT1 gene dictate the nephrotic syndrome
or renal failure. We are now studying on the effects of abnormal WTI on
the expression of PDGF-A or TGF-fl that adversely influence the kidney
cells.
Chronic hypokalemia enhances expression of the H-K-ATPase a2
subunit gene in renal medulla. KY. Ahn, K W. Park, B. C. Kone, Depart-
ment of Anatomy, Chonnam University Medical School, Kwangju, Korea,
and Departments of Internal Medicine and Integrative Biology, The University
of Texas Medical School at Houston, Houston, Texas, USA. Recent
molecular and physiological studies suggested that at least two H-K-
ATPase isoenzymes are expressed in the rat kidney, and that these ion
pumps respond to changes in dietary potassium balance. We used
Northern analysis and in Situ hybridization to analyze the expression of
mRNA encoding the "colonic" isoform of the H' -K-ATPase a subunit
(HKa2) in normal and potassium-deprived (2-week-old) rats. Control rats
exhibited low levels of HKa2 mRNA in the cortical and medullary thick
ascending limb, distal convoluted tubule, connecting segment, and the
entire collecting duct. The potassium-deprived rats expressed --5-fold
higher levels of HKa2 mRNA in the outer and inner medulla compared to
controls, and hypertrophy and increased in situ hybridization signal in the
intercalated cells of the outer medullaty collecting duct,,r ..tripe and the
proximal inner medullary collecting duct. In contrast, renal cortical
expression of HKa2 mRNA was low and comparable in the two groups.
Uur results suggest that enhanced expression of the HKa2 subunit gene in
the renal medulla contributes to potassium conservation during chronic
hypokalemia.
Efl'ect of cadmium on Na-Pi transport kinetics in rabbit renal brush-
border membrane vesicles. J.Y. Kim, KR. Kim, K. Park, YS. Park,
Department of Physiology, Kosin Medical College, Pusan, Korea. Chronic
exposure to cadmium impairs various renal tubular functions, including
inorganic phosphate transport. To investigate the mechanism of cadmium-
induced alterations in the inorganic phosphate transport system, kinetics
of phosphate uptake was studied in renal cortical brush border membrane
vesicles (BBMV) directly exposed to CdCI2 in vitro. The BBMVs were
prepared from rabbit renal cortex by Percoll gradient centrifugation and
preincubated in 50 fLat CdCl2 for 1 hour. The vesicular uptake of Pi was
determined by rapid filtration technique using 32P-labeled phosphate.
Cadmium treatment resulted in a marked attenuation of Nat-dependent
phosphate uptake with no changes in Na-independent transport compo-
nent. Kinetic analysis indicated that two Na ions and one phosphate ion
interact with a carrier and this stoichiometry is not altered by cadmium
treatment. Cadmium treatment did not affect the Km for Na' and that for
phosphate, hut it markedly reduced the Vm. of the Natdependent Pi
transport. These results suggest that the exposure of proximal tubular
brush border membranes to free cadmium results in an impairment of the
active transport capacity for inorganic phosphate probably by reducing
effective number of Na-Pi cotransporter Units without altering the bio-
chemical properties of the carrier.
Expression of cell adhesion molecules in generalized Shwartzman
reaction of the rabbit. KH. Lee, SO. Choi, H.Y Kim, B. G. Han, D.S. Yoon,
Division of J'/ephrology, Department of Internal Medicine, Wonju College of
Medicine, Yonsei University, Seoul, Korea. To investigate the role of cell
adhesion molecules in generalized Shwarzman reaction (gSr), the authors
examined the expression of cell adhesion molecules, ICAM- I and CD 18,
in gSr of the rabbit. Group A (N 5) received two intravenous injections
of 200 jrg/kg of bacterial Iipopolysaccharide (LPS) from E. coli (055:135)
24 hours apart. Group B (N = 5) received one dose of LPS after 3 days of
glucocorticoid treatment (methylprednisolone, 25 mg/kg/day). Group C(N = 5) received a single dose of LPS. The control group (N 3) received
two injections of saline instead of LPS. Animals were sacrificed four hours
after the last dose of LPS or saline and then the kidney, spleen, liver and
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lungs were removed. The histologic findings in various organs was
observed with a light microscope. The degree of microvascular fibrin
deposition was graded from 0 to 3 by the indirect immunofluorescence
(IF) method. Expression of ICAM-1 and CD18 in the tissues was observed
by immunohistochemical stain and was graded from 0 to 3. The results
were as follows: (1.) Group A and B showed numerous fibrin micro-
thrombi, inflammatory cell infiltration and some hemorrhagic change in
all of the the observed organs, but group C and the control group did not
show any lesions. The degree of fibrin deposition by IF was significantly
increased in the kidney and spleen in groups A and B when compared to
group C (P < 0.05). (2.) In the control group, vascular endothelium of all
observed organs expressed ICAM-1. In groups A and B that showed
typical Shwartzman lesion significant decrease in ICAM-1 expression was
observed, especially in kidney of group A and B when compared with
group C and the control group (P < 0.05). (3.) Groups A and B were
significantly increased in CD18 expressing cells in glomerulus when
compared with the control group (P < 0.05). (4.) The number of CDI8
expressing cells in glomerulus correlated significantly with a degree of
fibrin deposition. In conclusion, these results suggest that the development
of gSr requires the adhesion of activated inflammatory cells especially
neutrophils to vascular endothelium and these are achieved by the
interaction of adhesion molecules like ICAM-1 and CD 18.
Effects of changes in body fluid balance on the brain natriuretic peptide
release in normotensive and hypertensive rats. S. W. Kim, S.H. Moon, N.H.
Kim, J. Lee, KC. Choi and YJ. Kang. Departments of Internal Medicine and
Physiology, Chonnam University Medical School, Kwangju, Korea. Plasma
levels of brain natriuretic peptide (BNP) are, along with atrial natriuretic
peptide (ANP), elevated in disease states associated with fluid overload.
Although the endothelium-derived nitric oxides (NO) have been sug-
gested to modulate the release of other hormones affecting body fluid
balance and blood pressre regulation, no information has been available
about the interaction between NO and BNP in response to an altered fluid
balance. Furthermore, hypertension may also modify the responsiveness
of BNP to an altered body fluid balance in hypertension. The present study
was aimed to investigate the effects of acute and chronic changes in body
fluid balance on the plasma BNP in normotensive and hypertensive states.
Male Sprague-Dawley rats were either supplied with normal or high-salt
diet during one week. On the experimental day, under thiopental anes-
thesia (50 mg/kg, i.p.), the left femoral artery was cannulated to measure
arterial pressure and the vein to serve as an infusion route. Two-kidney,
one-clip (2K1C) hypertension was made and used 4 weeks after clipping
the artery. The control group was sham-clipped. Either extracellular
volume expansion (VE) induced by intravenous infusion of saline up to
5% of the body weight or inhibition of endogenous cyclooxygenase
pathway by treatment with indomethacin (10 mg/kg) was without signifi-
cant effects on plasma BNP. High salt intake significantly increased the
plasma BNP. L-NAME (200 g kg' per mm) significantly increased
plasma BNP in rats with normal sodium intake, whereas it did not further
affect the plasma BNP in rats with high-salt intake. Although L-arginine
(20mg• kg' per mm) per Se did not significantly affect the plasma BNP,
it abolished the L-NAME-stimulated BNP increase. The plasma BNP
level was severalfold increased following intravenous injection of endo-
thelin (0.3 sg kg'), the magnitude of which was not altered by high-salt
intake. Plasma BNP levels were higher in 2KIC rats, which were not
affected by VE but was significantly decreased by indomethacin-treatment.
It is concluded that BNP is regulated by chronic, not acute, changes in
body fluid balance and blood pressure. Endothelin and NO systems may
directly regulate the secretion of BNP in vivo. It is also suggested that
prostaglandin synthesis is involved in the stimulated release of BNP in
2KIC rats.
Role of the insertion/deletion polymorphism of the angiotensin H
converting enzyme (ACE) gene in the progression of childhood reflux
nephropathy. H.!. Cheong, H. W. Park and Y Choi, Department of Pediat-
des, Seoul National University Children s Hospital and Seoul City Boramae
Hospital, Seoul, Korea. The renin-angiotensin system may play a role in the
progression of renal disease. Recently, the deletion polymorphism of the
ACE gene, whieh is associated with elevated concentration of serum ACE,
is known to be a significant prognostic indicator in the progression of
several chronic renal diseases. We examined the relationship between
ACE genotype and progression of reflux nephropathy in children.
Genomic DNAs were extracted from peripheral blood cells of 20 children
with reflux nephropathy and decreased renal function (RNP group), 10
children with vesicoureteral reflux and normal renal function (VUR
group), and 100 normal controls (NC group). The ACE genotype based on
presence (I) or absence (D) of 287 bp DNA fragment in intron 16 was
determined using the polymerase chain reaction method. The allele
frequency in the RNP group (I:D = 69:31) was not significantly different
from that of VUR group (I:D = 56:44) or that of the NC group (I:D =
62:38). In conclusion, the deletion polymorphism of the ACE gene (and
probably elevated serum ACE) does not play a major role in the
progression of reflux nephropathy.
Medullary nephrocalcinosis associated with long-term furosemide
abuse in adults. YH Lee, YG. Kim, KB. Lee, H.Y. Oh, B.H. Kim, M.K
Kim, and YS. Cho, Department of Internal Medicine, Diagnostic Radiology
and Diagnostic Pathology, Samsung Seoul Hospital, Department of Internal
Medicine, Kang Nam General Hospital Public Corporations, Seoul, Korea.
Although furosemide therapy is an important risk factor for medullary
nephrocalcinosis in neonates, it is not certain in adults. We examined
nephroealcinosis in six successive patients with long-term furosemide
abuse (male:female = 1:5, age range 28 to 39 years) by renal ultrasonog-
raphy (US) and computed tomography (CT) between July 1992 and
February 1996. All six patients were normotensive and showed hypokale-
mia (range 2.3 —3.1 mEq/liter) and metabolic alkalosis at the time of
presentation. The serum creatinine and creatinine clearance ranged from
0.7 to 1.5 mg/dl and from 39.2 to 99.0 mI/mm, respectively, and hyperu-
ricemia (range 8.5 — 12.9 mg/dl) was observed in five patients. Furosemide
abuse was confirmed by history in five patients and by urine assay for
diuretics in one patient who denied diuretic abuse. The daily dose and
duration of continuous intake of furosemide ranged from 40 mg to 1600
mg and from 4 to 20 years, respectively. Renal US showed diffuse increase
in echogenicity in the medullaiy pyramids and/or echogenic rims in the
periphery of renal pyramids in all six patients. Medullary calcifications,
which were concentrated mainly at the outer medulla, were demonstrated
by CT in four patients. The calcification was not detectable on plain
abdominal radiography except in one patient. In one out of two patients,
in whom the calcification was not demonstrated by CT, kidney biopsy
findings showed tubulointerstitial fibrosis and atrophy with fine calcifica-
tions in the interstitiums and tubules particularly at the outer medulla. We
conclude that long-term furosemide abuse may cause medullaty nephro-
calcinosis in adults and medullary nephrocalcinosis detected by US and/or
CT in adult patients with otherwise unexplained hypokalemia may be a
clue in the diagnosis of long-term furosemide abuse.
Interaction of nitric oxide and endothelin systems in adaptation to
increased dietary salt intake in the rat. H.S. Oh, S. W. Kim, N.H. Kim, J.
Lee, K C. Choi, and YJ. Kong, Departments of Physiology and Internal
Medicine, Chonnam University Medical School, Kwang/u, Korea. It has
become known that endothelium-derived nitric oxide (NO) plays a role in
regulating renal hemodynamics and excretory functions. In addition, NO
is considered as an inhibitor of the stimulated production of endothelin,
and an endothelial activation leading to increases of NO production could
therefore exert a feedback control on endothelin release. Little informa-
tion, however, has been available about the interaction between NO and
endothelin in mediating the urinary response to an altered fluid balance.
The present study was aimed at investigating a role for NO and endothelin
systems in mediating urinary responses to acute cxtraccllular volume
expansion (VE) in normal and salt-loaded conditions. Male Sprague-
Dawley rats were supplied with either normal or high salt diet for a week.
On the experimental day, under thiopental anesthesia (50mg/kg, i.p.), VE
was achieved by intravenous infusion of saline (0.9% NaCI) over 60
minutes with the total volume infused amounting to 5% of the body
weight. M-'-nitro-L-arginine methyl ester (L-NAME), a competitive inhib-
itor of NO synthesis, was infused. L-NAME (10—200 p.g - kg' per mm)
caused diuretic and natriuretic responses, the magnitude of which was
attenuated in high salt-fed rats compared with the control. The magnitude
of the pressor effect caused by L-NAME did not significantly differ
between the control and high salt-fed rats. VE significantly decreased and
L-NAME increased the plasma endothelin. When VE was superimposed
on the ongoing infusion of L-NAME, the magnitude of increase due to
L-NAME alone was attenuated. However, VE could not attenuate the
L-NAME-induccd increase of endothelin level in high salt-fed group. The
L-NAME-induced increase of plasma endothelin was not further accen-
tuated in high salt-fed group. These results suggest that an increased
Abstracts 951
activity of NO system stimulates sodium excretion and a decreased activity
results in sodium retention. Although an interaction between NO and
endothelin is suggested, its physiological significance in response to
perturbations in body fluid homeostasis remains to be further determined.
Role of reactive oxygen species in hypoxia/reoxygenation renal cell
injury. YK Kim and YH. Kim, Department of Physiology, College of
Medicine, Pusan National University, Pusan, Korea. Several in vivo and in
vitro studies have demonstrated an increase in generation of reactive
oxygen species (ROS) during reperfusion following ischemia in the kidney.
However, whether ROS play a critical role in the pathogenesis of
isehemia/reperfusion renal injury is not clearly defined. The purpose of
this study was to determine: (1) if agents that decrease tissue ROS
attenuate ischemia/reperfusion renal injury, and (2) lipid peroxidation
increases during ischemia/reperfusion period. We employed two in vitro
models using renal cortical slices: hypoxia/reoxygenation (H/R) injury and
tubular damage induced by exogenous oxidant. Oxidant injury was in-
duced by exposing slices to H2O2 at 37°C for 60 mm, and cell injury was
evaluated by measuring lactate dehydrogenase (LDH) release. Hypoxia
and H202 induced time-dependent and dose-dependent increases in LDH
release, respectively. When slices were reoxygenated for 10—50 mm after
20 mm of hypoxia, LDH release did not exceed that of slices subjected to
only 20-mm hypoxia without reoxygenation. H/R injury was significantly
prevented by extracellular acidosis, dithiothreitol and glycine, whereas the
cell injury by H,02 was not affected. Glutathione attenuated cell injuries
induced by H/R and H2O2. Oxidant injury was prevented by ROS
scavengers (catalase, dimethylurea and thiourea), iron chelators (deferox-
amine and phenanthroline), and an antioxidant DPPD, but H/R injury was
not significantly altered. H/R and oxidant-induced cell injuries were
attenuated by phospholipase A2 inhibitors, dibucaine and butacaine. Lipid
peroxidation was markedly increased by treatment of 100 mM H202, but it
was not affected by 30 mm of reperfusion following 20 mm of hypoxia in
which the increase of LDH release was similar to the H2O2 treatment.
When kidneys were subjected to reperfused for 3 or 72 hr following 60 mm
isehemia in vivo, lipid peroxidation of renal cortical tissues was not
different from that of the control kidney. These results indicate that
underlying mechanisms of H/R injury are different from those of oxidant-
induced cell injury in rabbit renal tubular cells, suggesting that ROS may
not be a critical mediator of isehemia/reperfusion renal injury.
Outcome of antenatal hydronephrosis due to obstruction of the uret-
eropelvic junction. J.M. Heo and J.B. Yoon, Department of Urology, College
of Medicine, Pusan University, Pusan, Korea. Obstruction of the uretero-
pelvic junction (UPJO) is the most common congenital condition that is
detected by prenatal ultrasonography (US). In many cases, UPJO is
transient and ceases in utero but when it persists into infantile period, its
clinical course must be evaluated. Thus we evaluated the seven infants
with prenatally detected UPJO and established the guidelines for postna-
tal evaluation and management of this abnormality. All patients were
diagnosed by US and did not have any abnormal pregnancy. Postnatal
diagnosis was made by US, excretory urography, DTPA renography,
diuretic renography and voiding cystourethrography, if needed. Seven
infants had ten hydronephrosis (3 infants had bilateral hydronephrosis).
Five infants (6 kidneys) who had 40% or greater to the overall function on
glomerular filtration rate (GFR) using DTPA renography showed clinical
and radiological improvement on follow-up. Among them, one kidney
showed marked hydronephrosis, two kidneys showed moderate hydrone-
phrosis and three kidneys showed mild hydronephrosis. Pyeloplasty fol-
lowing percutaneous nephrostomy was done in two infants (2 kidneys),
and they were less than 20% to the overall function on GFR using DTPA
renography. Among them, one kidney showed marked hydronephrosis
and the other kidney showed moderate hydronephrosis. Two infants (2
kidneys) who were 20—39% GFR using DlPA renography and marked
hydronephrosis were performed pyeloplasty at postnatal 2—4 months.
Antenatal hydronephrosis due to UPJO is transient in many cases, so
unnecessary surgery can be avoided by careful repeated examinations
without any renal deterioration. In our experiences, assessment of each
GFR using DTPA renography and change of hydronephrosis by US are
useful and noninvasive evaluation modalities for neonatal UPJO.
Ultrasound-guided cannulation of the femoral vein for acute hemodi-
alysis access. Si. Kim, CD. Kim, M. V. Back, J.H. Kim, S. Cho, TH. Kwon,
YL. Kim, and D.K C'ho, Department of Internal Medicine, Kyungpook
University Hospital, Taegu, Korea. Central venous access is a mandatory
part, of patient management in many clinical settings and is usually
achieved with a blinded, external landmark-guided technique. The pur-
pose of this study is to evaluate whether an ultrasound technique can
improve on the external landmark method. We prospectively evaluated an
ultrasound-guided method in 28 patients undergoing femoral vein eannu-
lation and compared the results with 38 patients in whom an external
landmark-guided technique was used. The external landmark-guided
technique was done by manual localization of the femoral artery in the
femoral triangle inferior to the inguinal ligament with needle insertion
medial to the artery. Ultrasound-guided cannulation was performed in the
same location with the aid of an ultrasound device (Site-Rite, Dymax
Corp.) with a 7.5 MHz transducer covered by a sterile sheath. Cannulation
of the femoral vein was achieved in all patients (100%) using ultrasound
and in 34 patients (89.5%) using the landmark-guided technique. The vein
was entered on the first attempt in 92.8% of patients using ultrasound and
in 55.3% using the landmark technique (P < 0.05). The average access
times (skin to vein) were similar, but the total procedure time was 45.1
seconds by the ultrasound approach and 79.4 seconds by the landmark
approach (P < 0.05). Using ultrasound, puncture of the femoral artery
occurred in 7.7% of patients, and hematoma in 0%. Using external
landmark technique, puncture of the femoral artery occurred in 15.8% of
patients, and hematoma in 2.6%.
Table 1. Results of ultrasound-guided versus landmark-guided
technique
Access
N
time Total time
seconds
Ultrasound 28 11.4 5.5 45.1 18W'
Landmark 38 15.0 13.3 79.4 61.7
Success
rate %
Artery
puncture Hematoma
Access with
one attempt
Ultrasound 100.0 2 (7.7%) 0 (0%) 26° (92.8%)
Landmark 89.5 6 (15.8% 1(2.6%) 21 (55.3%)
ap <005
Ultrasound-guided eannulation of the femoral vein reduces the time
required for the procedure, reduces the number of passes needed to
puncture the vein, and minimizes complications such as arterial puncture
or hematoma.
Morphometric study of renal sizes and weight in Korean adults. C.K
Lee, S.J. Yoo, J. C. An, and H. Y Rhew, Department of Urology, College of
Medicine, Kosin University, Pusan, Korea. This study determined the
standard surgical measurement of kidney size in the normal Korean
population that might be basic data-base of renal size in comparison with
radiographic and ultrasonographic measurement. The 235 donors for
renal transplantation were measured by the length, width, thickness,
weight and the outer diameter of renal vessels as well as identification of
branches of renal vein at the time of donor nephrectomy. These data were
tested to be statistically significant by f-test, ANOVA, Pearson correlation
analysis and multivariate analysis. 1he mean values of renal size were:
11.6 0.87 (9.2—15.4) cm x 6.1 (1.81 (4.4—10.0) cm X 4.9 0.75
(2.2—7.1) cm; for males it was 1.7 0.77 (9.8—14.0) cm X 6.2 0.85
(4.5—10.0) em X 5.0 0.77 (2.8—7.1) cm, and for females, 11.4 0.96
(9.2—15.4) cm X 6.0 (1.75 (4.4—8.2) cm X 4.8 0.71 (2.2—7.0) cm. The
mean value of renal weights was 183.1 36.92 (115.0—370.0)g; for males
it was 188.2 40.10 (120.0—370.0) g, and for females, 177.6 32.41
(115.0—300.0) g. The width, thickness and weight of kidneys were larger in
males than in females (P < 0.05). The donor's age did not affect the renal
length, width, thickness or weight (P> 0.05). The renal length, width, and
weight increased proportionally to the body weight P < 0.05). The rerLal
thickness and weight were different in each range of the body height (P <
0.05). The body weight had correlation with renal length (R 0.26),
thickness (R 0.32), weight (r = 0.36, P < 0.001) and width (r = 0.16, P <
0.05). The body height was correlated well with renal length (r = 0.20),
thickness (r = 0.18) and weight (r 0.25, P < 0.05). The body weight was
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the most reliable factor affecting renal size and weight in multivariate
analysis (P < 0.05). The mean number of branches of renal vein was
0.36 0.63 (0.0—2.0) in right kidney and 3.12 0.76 (1.0—6.0) in left one.
The mean diameter of the renal artery was 0.61 0.132 (0.3—1.0) cm and
the mean diameter of the renal vein 1.46 0.132 (0.50—2.20) cm. The
radiographic measurement of renal size was larger than our surgical
measurement. The mean renal length and width in radiographic measure-
ment (IVP) were 12.1 0.70cm in right kidney, 12.1 0.66cm in left one
and 6.4 0.54cm in right kidney, 6.8 0.45 cm in left one versus 11.6
0.87 cm, 11.6 0.89 cm and 6.1 0.81 cm, 6.1 0.84 cm in surgical
measurements. Surgical measurements of renal size of donors at the time
of renal transplantation were real renal size despite radiographic and
ultrasonographic measurements, and provided basic standard data for the
Korean population that might be utilized in approaching renal disease.
A study of PerwCath® catheterization as vascular access for childhood
hemodialysis. M.D. Shin, HI. ('heong, Y Choi, Department of Pediatrics,
Seoul National University Children's Hospital, Seoul, Korea. Hemodialysis is
a major mode of renal replacement therapy in children as well as CAPD.
PermCath®, a dual lumen silicone atrial catheter with dacron cuff, has
been used as vascular access for hemodialysis. During the period from
Aug. 1, 1994 to Mar. 31, 1996, 29 hemodialyzed children received
PermCath® implantation in our hospital. Their medical records were
analyzed retrospectively. The mean age and weight of the patients were 9.8
years (6 months—17 years) and 25.7 kg (6.2 kg—40 kg), respectively.
Fourteen catheters were implanted for short-term use. Two catheters were
removed due to thrombosis of acute onset (<2 weeks). In additional 12
patients, the catheter was removed within 60 days because of the patients'
death (2 patients), recovery of renal function (3 patients), renal transplan-
tation (3 patients) or switch to arteriovenous fistula (1 patient) or CAPD
(3 patients). In 16 long-term (>60 days) users, the mean life span of the
catheter was 230.8 days (61—591 days). The mean recirculation rate
checked in 5 patients was 9.6%. The rate of thrombotic occlusion was
1.5/1,000 catheter days. Most of the clots except one could be lysed with
local urokinase therapy. The rate of catheter associated fever was 0.6/1,000
catheter days. One catheter needed revision due to malposition and local
bleeding developed during the procedure. In conclusion, the PermCath®
catheter can be used as an immediate, durable and relatively safe vascular
access in childhood hemodialysis.
Clinical evaluation of use of Permcath® (double-lumen silicone rubber
catheter) in 16 cases. C.H. Mi J.H. Park, E. T. Kang, S.H. Yu, Department
of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea. Perma-
nent vascular access is a prerequisite for successful treatment of patients
with chronic hemodialysis. Although a number of strategies including
native and synthetic arteriovenous fistulae are performed to create
vascular access, they are often not available due to increase of peripheral
vascular disease in patient with diabetic renal failure and elderly patients.
Recently, the Permcath® (double-lumen silicone rubber catheter) has
been introduced as a permanent vascular access. We studied the availabil-
ity of Permeath® in Chung-Ang University Hospital between April 1993 to
Mar. 1996. Sixteen catheters were placed in 14 patients. The mean age of
patients was 56 9 years (39—67), male to female ratio was 6 to 10.
Underlying causes of chronic renal failure were diabetes in 10 patients
(71%), malignant hypertension in 2 patients, SLE in one and polycystic
kidney disease in one. The indications were exhausted peripheral access,
contraindication of conventional vascular access, and limited life expect-
ancy. The median survival of the catheters was 80 weeks with a range of
one week to 113 weeks. The one-year actuarial catheter survival rate was
71% and two-year actuarial catheter survival rate 47%. The complications
during use of catheters were infection inS patients (31.2%), thrombosis in
one patient and malfunction due to malposition in one patient. Twelve
catheters (75%) required removal because of infection in 3 patients and
malfunction in one patient. Five catheters were removed due to patient's
death and three after successful creation of arteriovenous fistulac. In
summary, we suggest that the Permcath® is a safe and durable access for
patients with vascular diseases and poor venous vascular system anticipat-
ing a long duration for arteriovenous fistula maturation.
Prevalence of heparin-induced thrombocytopenia (HIT) and of hepa-
nfl-dependent anti-platelet antibodies using platelet factor 4(PF4)/hepa-
rin ELISA in hemodialysis patients—A multicenter study. Y L. Kim, D.C.
Park, SR. Kim, J.H. Hsvang, .I.H. Bang, TH. Kwon, D.K. Cho, iS. Suh,
Department of Internal Medicine, Kyungpook University, Donggang Hospital,
Mason Samsung Hospital, Fatima Hospital, Andong Hospital, Department of
Clinical Pathology, Kyungpook University, Taegu, Korea. Heparin remains
the standard anticoagulant worldwide for hemodialysis (HD). Heparin-
induced thrombocytopenia (HIT) is a serious clinical disorder character-
ized by the thrombocytopenia and is often associated with paradoxic
thrombosis in patients receiving heparin. But in HD patients, the preva-
lence of HIT and of heparin-dependent anti-platelet antibodies that
activate platelets through their Fe receptors is unknown. We performed
the current study to evaluate the prevalence of HIT and of heparin-
dependent anti-platelet antibodies in HD patients using unfractionated
heparin. All the patients (195 patients) in five HD centers received
unfractionated heparin for HD. We measured antibodies to PF4/heparin
complexes using an ELISA assay regardless of their platelet counts. HIT
was defined as at least two consecutive platelet counts below 100,000 per
cubic millimeter, and a positive test for antibodies to PF4/heparin
complexes. HIT occurred in 4 of 195 patients (2.1%) who received
unfractionated heparin for HD and heparin-dependent anti-platelet anti-
bodies in 11 for 195 patients (5.6%). The prevalence of heparin antibody
was higher among patients with thrombocytopenia (P = 0.031). Throm-
botic events were not more common in patients with heparin antibody
(P = 0.214). The prevalence of heparin antibody was not correlated to the
duration of HD (P = 0.142), underlying renal disease (P = 0.814) and
frequency of HD (P = 0.098). We conclude that HIT is an important cause
of thrombocytopenia in HD patients using unfractionated heparin, but
further prospective studies of heparin antibody in HD patients are needed
to confirm its value as a clinical significance and the true incidence of
antibodies induced by heparin in either the unfractionated or the low-
molecular-weight form.
Anticardiolipin antibody (ACA) and lupus anticoagulant (LA) in
hemodialysis (HD) patients: Association with vascular access occlusion.
S.K Ryu, D.H. Kang, KB. Choi, KI. Yoon, Department of Internal Medicine,
College of Medicine, Ewha Women 'a University, Seoul, Korea. Vascular
access occlusion by thrombosis (VAT) is one of the most important
complications in HD patients, accounting for 15—50% of all hospital
admissions in these patients. Anticardiolipin antibody (ACA) and lupus
anticoagulant (LA) acquire antiphospholipid antibodies (APAs), which
are regarded as risk factors for vascular thrombosis and recurrent fetal
loss. However, the exact prevalence and the clinical significance of APAs
in HD patients are still uncertain. We performed a cross-sectional study of
ACA and LA in 50 stable HD patients and 68 vascular accesses (52 native
arteriovenous fistulae and 16 synthetic arteriovenous grafts), with an
analysis of factors associated with the presence of APAs and the retro-
spective evaluation of the possible relationship between APAs and
vascular access thrombosis (VAT). LA was assessed by tissue thrombo-
plastin inhibition assay whereas IgG-ACA was measured by a solid phase
ELISA. Values higher than 23 GPLU/ml (IgG phospholipid units) were
considered to be positive for IgG-ACA. Survival curves were calculated
for each access using the Kaplan-Meier method. The mean age of the
subjects (M:F 21:29) was 48.2 13.2 and the mean duration of HD was
46.6 37.7 months. Six out of 50 patients (12%) had an increased titer of
lgG-ACA (29.2 8.5 GPLU/ml) with a distribution from 24.5 to 46.1
GPLU/ml, and LA was found in 11 patients (22%). No patients were
positive for ACA and LA simultaneously. There was no significant
difference in sex, etiology of ESRD, diabetic status, the dosage of heparin
during HD, or the amount of erythropoietin administered according to the
presence of APAs. In the patients with positive ACA, the frequency of
VAT was 1.05 0.12 episodes/patient/year, which was significantly higher
than the patients without ACA (0.33 0.17 episodes/patient/year, p <
0.05). This relationship was also evident with the presence of LA (1.25
0.50 vs. 0.12 0.25 episodes/patient/year, P < 0.01). Fourteen patients
(28%) were found to have a history of VAT occurring more than once.
IgG-ACA was found 28.6% in the patients with VAT which was signifi-
cantly higher than in the patients group without the history of VAT (5.6%,
P < 0.05). The mean titer of IgG-AGA was also significantly higher in the
VAT group (20.3 8.5 vs. 13.6 7.7 (JIPLU-ml, P < 0.01). The median
vascular access survival time was 27 months for the IgG-ACA positive
patients and 42 months fur the IgG-ACA negative group. In conclusion,,
our data suggest that the presence of APAs (ACA and/or LA) affects the
event-free vascular access survival in HD patients. Therefore, the evalu-
ations of APAs status have to be included in the diagnostic strategies for
the patients with recurrent VAT. Further studies arc necessary to explore
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the pharmacologic intervention method to decrease APAs and prevent
VAT in HD patients.
Comparison of hemodialysis with heparin pre-rinsed hemophan mem-
brane and hemodialysis with routine heparinization. KB. Lee, YH. Lee,
Y G. Kim, and H. Y Oh, Division of Nephrology, Samsung Seoul Hospital,
Seoul, Korea Objectives: Positively charged DEAE groups on Hemophan
membrane enable negatively charged heparin to be attached to the
membrane. We thought that the usc of heparin pre-rinsed Hemophan
membrane in renal failure patients with high bleeding risk would minimize
the bleeding risk. We made the heparin pre-rinsed Hemophan membrane
by the method that involved 20,000 units of heparin being added to 1,000
ml of saline and recirculated through the Hemophan dialyzers for 1 hour.
To evaluate the clotting of dialyzer and adequacy of this hemodialysis we
hemodializcd the patients with high risk for bleeding complication with
heparin pre-rinsed Hemophan membrane (HPH hemodialysis) and an-
other session with systemic anticogulation (RH hemodialysis). We com-
pared the adequacy and dialyzer clotting between HPH hemodialysis and
RH hemodialysis. Patients and Methods: Five maintenance hemodialysis
patients with high risk for bleeding complication in Samsung Seoul
Hospital were considered for the study. They were dialyzed with GFS + 11
(Gambro) membrane for 4 hours at a blood flow rate of 200 —250 mI/mm.
They were dialyzed with HPH hemodialysis in ease of increased risk of
bleeding complication and with RH hemodialysis in the other session. We
compared dialyzer urea clearances (K), Kt/V and fiber volume losses
(FVL). Results: 1. In HPH hemodialysis aPTI was slightly increased after
the first 15 minutes (15% increase from predialysis level) and not
increased at subsequent times (1 hour, 2 hour, 4 hour), but in RH
hemodialysis aPTI was increased during hcmodialysis (15 mm = 127%, 1
hour = 94%, 2 hour = 86%, 4 hour = 26% increase from predialysis
level). Total heparin doses in RH hemodialysis were 3276 495 (mean
SE) units. 2. Factors that influenced clotting of dialyzer (pump flow,
ultrafiltration, mean arterial pressure, hematoerit, platelet and PT) were
not significantly different between HPH hemodialysis and RH hemodial-
ysis. 3. The dialyzer urea clearances Kt/V between HPH hemodialysis
(KuPII = 142 5 mI/mm, Kt/VHPH = 1.13 0.11, P > 0.05) and RH
hemodialysis (KRH = 136 2 mI/mm, Kt/VRH = 1.20 0.06, P < 0.05)
were not significantly different. The fiber volume losses were greater in
HPH hemodialysis (FVLI-IPH = 19 6%) than RH hemodialysis (FVLRH
= 3 1%, P < 0.05). Conclusions: HPH hemodialysis is effective
hemodialysis in patients with high risk of bleeding complication, but the
clotting of dialyzer is observed carefully.
A comparison of low molecular weight heparin with unfractionated
heparin for anticoagulation during hemodialysis. T.H. Kwon, YL. Kim,
and D.K Cho, Department of Internal Medicine, Kyungpook University
Hospital, Taegu, Korea. Hemodialysis requires antieoagulants to prevent
fibrin deposition and thrombus formation in the extracorporeal circuit.
Unfraetionated heparin (UFH) has been used as a conventional antico-
agulant for a long time, but recently many side effects of heparin have
been documented: hemorrhage, thrombocytopenia with or without throm-
bosis, osteoporosis, skin necrosis, alopecia, and hypersensitivity reactions.
In the past decade, low molecular weight heparins (LMWH) have been
developed. Compared with UFH, these compounds have a longer plasma
half-life, less variability in the anticoagulant response to fixed doses, and
a more favorable antithrombotic to hemorrhagic ratio. Thus, rationales for
using LMWH as an alternative to IJFH would be a reduced risk for
bleeding complications and simplified routines for heparinization due to a
longer half-life of the anticoagulant activity. To evaluate the efficacy and
safety of a single bolus injection of LMWH (Fragmin®) as an anticoagu-
lant in hemodialysis treatment; we conducted a prospective crossover
study with paired comparison of two different heparins in 18 end-stage
renal disease patients undergoing hemodialysis. During the first two
months of observation, patients received at single bolus of LMWH
2,552 221 TU aXa/one dialysis session. Then patients were switched to
UFH dose regimen comprised of a saline prime, no initial bolus and a
continuous infusion of 3,174 420 lU/one dialysis session for a further
two months. All hemodialysis sessions were completed uneventfully. The
coagulation values of an anti-factor Xa-specific clotting method (Hep-
test®) from eitrated whole blood samples taken 15 minutes after starting
hemodialysis were 0.47 0.21 U/mI with LMWH and 0.12 0.03 U/mi
with UFH (P < 0.05) The values taken 4 hours after starting hemodialysis
were 0.24 0.10 U/mI with LMWH and 0.22 0.04 U/mI with UFH (P>
0.05). The prolongation of the Heptest clotting times with LMWH and
UFH was 2.86 for LMWH and 2.55 for UFH using the whole blood assay.
The mean frequency of clot deposition in dialyzer was similar (1.1 vs. 0.87)
as well as mean venous compression time at the end of dialysis (5.96 vs.
6.23 minutes). The hematologic and biochemical parameters such as
hemoglobin, platelet count, triglyceride level, total cholesterol and HDL-
cholesterol level did not show any differences between the two heparins.
We conclude that a single dose of LMWH is effective and safe in repeated
use for hemodialysis and prevents clot formation to a similar degree as
UFH.
A study of acid-base imbalance in maintenance hemodialysis patients.
J.K Ahn, C.H. Lee, K W Kahng, SM. Kim, C.H. Park G.M. Kang, and TIC.
Park. Department of Internal Medicine, College of Medicine, Hanyang
University, Seoul, Korea. Blood gas analysis of 426 blood samples were
performed using arteriovenous fistula blood from 146 patients with
maintenance hemodialysis, and the results were related with data from
clinical parameters over 18 months of observation. The mean values were
pH 7.282 0.061, Po2 90.01 6.5 mm Hg, PCO2 33.4 5.9 mm Hg, and
base excess —9.7 3.6 mEq/Iiter. The sera electrolytes were Na 139.7
3.3 mEq/liter, K 5.3 0.9 mEq/liter, Cl 103.9 3.6 mEq/liter, CO2 17.0
2.7 mEq/liter and anion gap {(Na + K)-(Cl + C02)} 24.1 4.2 mEq/liter.
Although the distributions approximated normal curves, the deviations
were generally wider, meaning that marginal situations on blood gas data
were not infrequent on silent patients. The studies also showed that low
blood pH was present not only with low PCO2 and normal Po2, but also
with high PCO2 and low P02, suggesting that mixed metabolic and
respiratory mechanisms were present. Over 18 months observation, 8 out
of 146 patients died due to medical reasons and the incidences were
statistically related with low serum albumin, old age, or low dialysis
frequencies per week, but not with abnormal blood pH, P02, PCO2, or
high anion gap. The relationships were also loose with appetite, nutritional
status, mental depression, BUN, or serum ereatinine. The performance of
Status of Karnofsky was also poorly related with blood pH, P02, PCO2,
serum CO2 content, or anion gap but was related significantly with age,
appetite, and the degree of mental depression.. Blood gas data suggest
need of these analyses in clinical medicine. The validity of using arterio-
venous fistula blood was pair-tested with 28 femoral artery blood samples.
Although there were minimal differences, the pair variables were closely
related.
Changes of blood acetate level during hemodialysis. C.Y. Moon, H,S.
Ahn, SI. Choi, H.S. Kim, B.C. Lee, S.K Park, and S.K Kang, Department
of Internal Medicine, Chonbuk National University Medical School, Chonju,
Korea. Patients undergoing hemodialysis with an acetate containing
solution (37 mEq/liter) regularly manifest hypoxemia by acetate metabo-
lism. The reduction in Pa02 is modest, but the clinical importance of the
hypoxemia is suggested by the fact that a number of symptoms that occur
during dialysis can be ameliorated by supply of oxygen. This study was
evaluated ABG and blood lactate level (Nova Biomedical) by during
hemodialysis in 23 chronic stable dialysis patients. The result are shown
below.
Mean .s Baseline
7.33 0.01
18.41 0.47
34.37 0.96
104.70 4.40
14.39 1.19
1 hour
7.36 0.21
18.56 0.51
32.71 0.87
93.40 3.30
13.09 0.09
pH(N:23)
11CC)3 mEq/liter
PCO2 mm fIg
P02 men Hg
Lactate mg/dl
Mean se 4 hour P value
PI1(N:23)
HCO mEq/liter
PCO2 mm Hg
P02 mm Hg
Lactate mg/dl
7.41 0.26
20.21 0.60
31.88 0.83
101.30 3.40
14.30 1.39
P < 0.01
P < 0.05
P < (1.05
Immature reticulocyte count as an indicator of erythropoiesis in CRF.
J. G. Lee and S.C. Yun. Department of Internal Medicine, College of
954 Abstracts
Medicine, Dankook University; Chunan, Korea. Transfusion amounts or
hemoglobin levels have been the major indicators of the erythropoiesis of
CRF patients who have been treated with erythropoietin therapy. How-
ever, more objective and earlier detectable parameters to monitor eryth-
ropoiesis are required. Therefore, we tried to investigate the significance
of immature reticulocyte count (IRC) in CRF patients as a convenient
index of erythropoietin (EPO) therapy. We have measured with flow
cytometry in venous blood samples by using TOA SYSMAX R/3000 based
on the flurorescence intensity of auramin 0 staining to RNA. IRC was
determined as the summation of MFR and HFR (middle fluorescence
ratio and high fluorescence ratio). We evaluated CRF patients undergoing
hemodialysis (N = 30) and a normal control group (N 14). The 21
patients of the CRF group have been under EPO therapy, the others (N =
9) have not been under therapy. (1) To determine the response of IRC to
EPO therapy, preliminaty study was done (N = 4). After EPO adminis-
tration (50 j.L/kg), IRC was increased within 2 days (mean 0.2% increased)
and decreased since 3 days later (mean 3.7% decreased) (2) In all CRF
patients, mean time interval of reticulocyte measurement after EPO
injection was 3.07 0.6 days. there was no significant difference between
CRF patients with EPO therapy and CRF patients without EPO therapy.
(P > 0.05) (Mean Hemoglobin: 8.31 0.98 g/dl vs. 8.32 1.53 g/dl, Mean
total reticulocyte count: 0.86 0.39% vs. 0.68 0.45%, Mean IRC: 8.9
4.22% vs. 7.96 5.87%) (3) At the different dose of EPO therapy (2000
U vs. 4000 U), no significant difference was observed (P > 0.05; mean
hemoglobin: 8.54 0.75 g/dl vs. 8.06 1.178 g/dl; mean total reticulocyte
count: 0.70 0.24% vs. 1.04 0.45%; mean IRC: 8.45 3.54% vs.
10.24 4.71%). Taken together, these results suggest that the response of
IRC to EPO therapy was most sensitive 3 days after EPO administration
and the maintenance of IRC level, up to about 10%, was necessary to
obtain 8 g/dl of hemoglobin level, independent of the dose of EPO as well
as whether the EPO was administered or not. In conclusion, the measure-
ment of IRC in CRF patients undergoing hemodialysis is a clinically more
useful indicator for estimating erythropoiesis than hemoglobin and total
reticulocyte count.
An attenuated central pressor response to nitric oxide synthesis
inhibition in chronic renal failure rats. K C. Cho4 J. Lee, J.J. Lee, S. W.
Kim, N.H. Kim, and Yf. Kang, Departments of Internal Medicine and
Physiology, Chonnam University Medical School, Kwangju, Korea. Central
and peripheral roles of NO in blood pressure regulation have been
suggested. The present study was aimed to determine if the role of
endogenous L-arginine-NO pathway in blood pressure regulation is
altered in chronic renal failure (CRF). Arterial blood pressure responses
to acute inhibition of L-arginine-NO pathway were examined in 5/6
nephrectomized rats (Sprague-Dawley males weighing 200—250 g). They
were used three weeks following the ablation. Under thiopental (50 mg/kg,
i.p.) anesthesia, an intracerebroventricular (ICV) cannuta was placed in
the left lateral ventricle. The right femoral artery was cannulated to
measure arterial blood pressure and the vein to serve as an infusion route.
N°-nitro-L-arginine methyl ester (L-NAME) was infused either intracere-
brovcntricularly or intravenously. Basal mean arterial pressure was 122
13mm Hg in control and 147 14mm Hg in CRF rats. ICV infusion (1.25
j.d/min) of L-NAME (20 or 100 pg/kg per minute for 60 mm) increased the
mean arterial pressure in normal rats (22 3 mm Hg from the basal).
However, it did not significantly affect the mean arterial pressure (0.5 4
mm Jig from the basal) in CRF rats. Intravenous infusion of L-NAME (40
1.d/niin, 10—100 pg/kg per minute for 60 mm) increased blood pressure;
however, the magnitude of which did not significantly differ between
normal and CRF rats (24 3 vs. 16 3 mm Hg from the basal). These
results indicate that the central role nf L-arginine-NO pathway in the
regulation nf blood pressure is altered in CRF rats.
Comparison of the plasma amino acid concentrations in the patients
with end-stage renal disease between Koreans and Americans. S. Y Hong,
D.H. Kim, DII. Yang, H.K. Kwon, and KS. Ha, Department of Internal
Medicine, Soonchunhyang Hospital, Chunan, and Korean Basic Science
C'enter, Taejeon, Korea. This study was designed to compare the plasma
amino acid concentrations between Korean and American end-stage renal
disease (ESRD) patients. Comparing the two control groups, the concen-
trations of seven amino acids (serine, glycine, histidine, argine, threonine,
alanine, and proline) were found to be higher in the American group,
while the concentrations of seven other amino acids (asparate, glutamate,
tyresine, valine, isoleucine, tiyptophan, and lysine) were higher in the
Korean group. The sum of the branched chain amino acids concentrations
(BCAA) were higher while the total amino acids (total AA) and nones-
sential amino acids (NEAA) were lower in the Korean control group than
in the American control group. No difference in the sum of essential
amino acid concentrations (EAA) between the two control groups was
noted. In the two ESRD groups, four amino acids (glutamate, serine,
proline, and lysine) were higher in the American group while four other
amino acids (asparate, histidine, alanine, and tryptophan) were higher in
the Korean group. There was no difference in the concentration of nine
amino acids (glycine, argine, threonine, tyrosine, valine, methionine,
isoleucine, leucine, and phenylalanine) between Korean and American
ESRD groups. The valine/glycine ratio was lower in the Korean ESRD
group than in the control group but not in the American ESRD group.
The tyrosine/phenylalanine ratio was lower in both the Korean and
American ESRD groups than in their control groups. In the Korean
group, the BCAA (447 210 vs. 315 146 mmol/liter) and EAA (1046
421 vs. 897 369 mmol/liter) were lower in the ESRD group than in the
control group. But there was no difference in NEAA (1120 445 vs.
1003 371 mmol/liter) and total AA (2072 807 vs. 2060 778
mmol/liter) between the two groups. In the American group, the EAA
(980 260 vs. 836 204 mmol/liter), NEAA (1654 481 vs. 1099 430
mmol/liter), and total AA (2632 705 vs. 1936 649 mmol/liter) were
lower in the ESRD group than in the control group. There was no
difference in BCAA (355 115 vs. 340 83 mmol/titer) between the two
groups. Further studies are necessary to define the cause of these
discrepancies in amino acid metabolism seen between Korean and Amer-
ican control and ESRD groups and whether these discrepancies might
influence the differences in clinical outcome between the two ESRD
groups.
Tumor markers in patients with chronic renal failure. YJ. Chung, J.H.
Ha, KY Kim, LW Kim, N.H. Kim, KC. Choi, and YJ. Kang, Department
of Internal Medicine, Chonnam University Medical School, Kwangju, Korea.
The following 9 kinds of serum tumor markers, such as a-fetoprotein
(AFP), careinoembryonic antigen (CEA), squamous cell carcinoma-re-
lated antigen (SCC), prostate specific antigen (PSA), human ehorionic
gonadotropin (hCG), CYFRA 21-1, CA (carbohydrate antigen) 19-9, CA
125 and CA 72-4 were measured in 51 persons without chronic renal
failure (CRF) as controls, in 117 patients with chronic renal failure (49
patients on conservative management, 35 patients on chronic hemodialy-
sis, and 33 patients on CAPD) who did not present any evidences of
neoplasia. The results were as follows: (1) The mean level of CEA in CRF
patients was significantly higher than that of controls (P < 0.001), and that
of CRF patients on hemodialysis was significantly higher than that of
patients on conservative management (P < 0.05). (2) The mean level of
SCC in CRF patients was significantly higher than that of controls (P <
0.001), and the mean levels of SCC did not differ significantly among three
groups of CRF patients. (3) The mean level of CYFRA in CRF patients
was significantly higher than that of controls (P < 0.001), and that of CRF
patients on hemodialysis was significantly higher than those of patients on
conservative management and on CAPD respectively (P < 0.05). (4) The
mean level of CA 125 in CRF patients was significantly higher than that of
controls (P < 0.001), and that of CRF patients on CAPD was significantly
lower than that of controls (P < 0.05). (5) Positive percent for CYFRA
21-1 in all CRF patients was 88.3%, and SCC 76.7%, CEA 56.2%, CA 125
50.0%, CA 19-9 24.5%, CA 72-4 6.8%, PSA 6.7%, hCG 4.8% and AFP
3.7% respectively. The present study shows that tumor markers such as
CEA, SCC, CYFRA 21-t, CA 19-9 and CA 125 are elevated above
reference values in a substantial number of patients, making them
unreliable for monitoring malignancies in uremic patients, while the other
tumor markers such as AFP, PSA, hCG and CA 72-4 are reliable for the
same purpose. These results must be taken into account when serum levels
of tumor markers are measured in CRF patients.
Comparison of urea kinetic modeling, standardized creatinine clear-
ance and indices of nutrition in hemodialysis (HD) patients. J.K. Kim,
u.K Kam, KD. Suh, f.M Lee, D. Hu, YS. Jeong, ID. fang, MS. Kim, and
S. R. Lee, Department of Internal Medicine, Bong Saeng Hospital, Pusan,
Korea. Objective: Protein-calorie malnutrition has been shown to he
prevalent among patients on chronic dialysis. Assessment of nutritional
Status of hemodialysis (HD) patients has assumed greater importance
because of the association of protein-calorie malnutrition with increasing
morbidity and mortality. So we observed the incidence and clinical effect
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of protein-calorie malnutrition, and we compared the indices of nutrition
with dialysis adequacy utilizing urea kinetic modeling and creatinine
clearance in HD patients. Method: We performed a cross-sectional study
in which eight parameters, based on anthropometry, blood chemistry and
subjective symptoms, were scored according to the degree of abnormali-
ties in 47 HD patients. A malnutrition index was derived from these
scores. We also performed a comparative analysis to identify significant
correlations of the indices of urea kinetic modeling and creatinine
clearance with the other parameters of nutritional Status. Result: The
malnutrition index classified 12 patients (25%) as normal, 27 (58%)
intermediately malnourished, and 8 (17%) as severely malnourished. The
malnutrition index showed a significant correlation with the body mass
index (BMI), mid-arm circumference (MAC), mid-arm muscle area
(MAMA), duration of HD, transferrin, RRF (residual renal function),
and alkaline phosphatase. The TWR-Kt/V (total Kt/Vurea including
residual renal urea clearance) and BUN were not significantly different in
all groups. The RRF was significantly lower in the groups of severely and
intermediately malnourished than in the normal group. Conclusion: In
assessing the nutritional status of HD patients, body weight, MAC,
MAMA, transferrin and alkaline phosphatase were considered as useful
nutritional parameters. There was a significant decrease of RRF in
severely and intermediately malnourished groups than in the normal
group. However, no meaningful relationships between TWR-Kt/V and
malnutrition index or between NPCR (normalized protein catabolic
rate) including the value of serum albumin and malnutrition index were
found in the cross-sectional study. The malnourished patients had
longer duration of HD and almost no RRF as compared with the
normal group.
Relationship between lean body mass (LBM) derived from bioelectrical
impedance (BIA) and other common nutritional parameters in end-stage
renal disease patients undergoing hemodialysis (HD). SB. Hong, S. W.
Lee, and M.J. Kim, Division of Nephrology, Department of Internal Medicine,
Inha University, Incheon, Korea. To investigate the significance of LBM as
a nutritional parameter in HD patients, we performed body composition
analysis including LBM with BIA in clinically stable patients (N = 25).
Other commonly used methods of nutritional assessment were also
performed: dietary assessment with 24-hour usual food recall method,
biochemical assessment with serum albumin (SA), cholesterol (CHOL),
triglyceride (TG), and creatinine (CR). Mean age was 43.2 12.7 years,
male-to-female ratio 1:13, HD duration 56.3 38.9 months, diabetics 3
(12.0%), delivered Kt/V,rea 1.5 0.2 day, SA 4.1 0.4 gIdl, and %LBM
76.5 10.4%. The patients were divided into two groups according to the
mean % LBM (LMB/BW): group 1 (N = 12, % LMB <75) and group 2
(P 13, % LBM 75). Group I was significantly older than group 2
(49.3 4.0vs. 37.7 8.8 years, P < 0.05). CHOL was significantly higher
(175.3 35.3 vs. 142.5 24.8 mg/dl, P < 0.05), and CR (12.5 2.7 vs.
16.2 4.4 mgldl, P < 0.05) and LBM (37.3 4.8 vs. 47.2 7.0 kg, P <
0.05) were significantly lower in group 1. But there were no differences in
sex, diabetics, HD duration, SA, TG, total calorie intake, dietary protein
intake (DPI), Kt/Vurca, and dry body weight between the two groups.
Percent LBM was positively correlated with CR (r = 0.41) and DPI (r =
0.51) and was negatively correlated with age (r = 0.59) and CHOL (r =
0.52). By multiple regression analysis, age, DPI, and CHOL were inde-
pendently correlated with % LBM. By stepwise multiple logistic regression
analysis, CHOL was an independent predictor for % LBM. In conclusion,
LBM seems to be a more sensitive predictor of malnutrition in lID
patients.
Relationship between diet and metabolic acidosis in chronic dialysis
patients. YK Lee, N.!!. Kim, J. W. Yoon, 5K. c/to, KS. Wee, YJ. Kwon,
iii. P'o, and H. K. Kim, Department of Internal Medicine, College of
Medicine, Korea University, Seoul, Korea. It has been known that the
incidence of protein malnutrition is high in patients with CRF, and even
though the effects of CRF on protein metabolism have not been revealed
clearly, some reports suggest that metabolic acidosis increases protein
catabolism. In order to investigate the relationship between metabolic
acidosis and diet in patients with CRF, we selected 10 patients with
acidosis who have been receiving hemodialysis at Korea University
Hospital as an acidosis group (mean total CO, = 12.01 mEq/dl) and 10
CRF patients with acid-base balance as a control group (mean total CO2
= 18.41 mEq/dl). We compared the two groups by analyzing underlying
diseases, residual renal function, efficacy of dialysis, biochemical studies,
diet (3 day recall method); and nutritional state. (1) The mean ages of the
acidosis group and control group were 44 and 36, respectively. The male
to female ratios were 1:1.5 and 1:1, respectively. The investigation of
underlying diseases showed that 50% of patients in the acidosis group had
CGN and the other 50% had non-CGN, while 90% of patients in the
control group had CGN and the other 10% had non-CGN. The duration
of dialysis and Kru (residual renal urea clearance) showed no significant
difference between the two groups. (2) While the hemodialysis time and
RT/V showed no significant difference between the two groups, the
frequency of dialysis was less in the acidosis group; 2.2 vs. 2.7 times per
week.(P = 0.024) Moreover, the concentration of pre-dialysis Cr was
similar in two groups; 13.90 vs. 12.04 mgldl. The concentration of
pre-dialysis BUN, however, was higher in the acidosis group: 89.74 vs.
71.25 mg/dl (P = 0.020). (3) nPCR of the acidosis group was higher than
the control group: 1.289 vs. 1.035 g/kg/day (P = 0.013). (4) The dietary
protein content analysis showed no significant difference between the
two groups: 66.45 vs. 59.46 g/day. The calories were also similar between the
two groups: 1763 vs. 1859 kcal. (5) Serum albumin, cholesterol, calcium,
phosphorus and body mass index showed no significant difference between
the two groups. The above results showed that pre-dialysis BUN and
nPCR were higher in the acidosis group, while there was no significant
difference in serum albumin, cholesterol and body mass index between
between the two groups. These results seem to be influenced by the high
dietary protein content in the acidosis group. A longitudinal study may be
necessary in the future.
The effect of intravenous calcitriol on secondary hyperparathyroidism
and bone mineral density in chronic hemodialysis patients. SN. Yoon,
C.W. Yang, S.Y Kim, E.J. Choi, YS. Chang, andB.K Bang, Department of
Internal Medicine, Catholic University Medical College, Seoul, Korea. We
evaluated the effect of six months of treatment with intravenous calcitriol
on PTH levels and bone mineral density (BMD) in CRF patients with
secondary hyperparathyroidism. Eleven hemodialysis patients with ele-
vated 1,84-intact PTH (>150 pg/mI) were randomly allocated to thrice
weekly administration of 2 g ealcitriol (6 patients) or once weekly
administration of 3 j.tg (5 patients). 1,84-intact PTH (iPTH) and alkaline
phosphatase were measured monthly and bone mineral density by dual
energy X-ray absorptiometry (DEXA) was measured before and after the
study. After 3 and 6 months, iPTH decreased to 32.6 20.4% and 9.7
3.2% of baseline value in the thrice weekly group versus 50.2 24.7% and
57.7 26.8% in the once weekly group, respectively. Alkaline phospha-
tase decreased to 85.3 35.4% and 54.1 18.5% of baseline value in the
thrice weekly group versus 90.7 13.8% and 80.2 15.7% in the once
weekly group, respectively. The iPTH and alkaline phosphatase of the
thrice weekly group showed the decreasing tendency with time (P = 0.034,
P = 0.0001), but those of the once weekly group did not (P> 0.1). Lumbar
spine (P = 0.036), femoral neck (P 0.015) and trochanter BMD (P =
0.028) were significantly increased in the thrice weekly group. The once
weekly group did not show the significant changes in BMD. Serum
calcium and phosphorus were increased in both groups with time. After
6 months, serum calcium was more increased in the thrice weekly group
(1.81 0.37 mg/dl/6 months) than in the once weekly group (0.98
0.52 mg/dl/6 months) (P = 0.012). In conclusion, iPTH suppression
with thrice weekly intravenous administration of 2 rg calcitriol is more
effective than that seen with once weekly administration of 3 sg.
Effective 6 month therapy of calcitriol results in increased bone mineral
density in chronic hemodialysis patients with secondary hyperparathy-
roidism.
Correction of chronic metabolic acidosis did not improve muscle energy
metabolism measured by MP.NMR spectroscopy in patients with chronic
renal failure (CRF). SB. Kim, W.S. Yang, D.K. Lee, T.W. Lim, CD. hong,
.J.S. Park, University of Ulsan and Asan Life Science Institute, Seoul, Korea.
Correction of metabolic acidosis in CRF was shown to decrease muscle
protein catabolism. The effect of correction of metabolic acidosis with
sodium bicarbonate (SB) on muscle energy metabolism was investigated in
8 patients (6 M, 2 F) with CRF (creatininc clearance <20 ml/min/1.73 m)
who were clinically stable and had serum bicarbonate level less than 18
mEq/liter. The median age was 48 years (range; 29 to 56 years). The
patients were treated with daily doses of 3 gram sodium bicarbonate for
3 months. Phosphocreatinine to inorganic phosphate ratio (Pr/Pi) and
intracellular pH were measured with 31P-NMR spectroscopy, at resting,
nadir and maximum recovery state after all-out exercise, before and
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after correction of acidosis. Serum bicarbonate level increased from
16.2 0.9 (so) to 21.9 1.1 mEq/liter (135%, P < 0.05). Creatinine
clearance and hematocrit did not change during the study period. The
exercise capacity, as measured by the time holding the weight, did not
change with SB treatment [5.0 1.4 vs. 5.6 2.9 mm (103%)I.
Intracellular pH, PCr/Pi at rest, nadir and the maximum recovery points
did not change either.
Pcr/P
Pre-SB Post-SB
Resting state
Nadir state
Max. recovery
7.0 1.9
1.5 0.3
8.2 1.2
6.2 0.8 (91%)
1.4 0.6 (92%)
8.1 0.7(99%)
pH
Pre-SB Post-SB
Resting state
Nadir state
Max. recovery
7.0 0.3
6.8 0.1
7.0 0.1
7.0 0.2 (100%)
6.7 0.1 (99%)
7.0 0.4 (100%)
These results show that the correction of acidosis does not improve energy
reservoir in resting state and maximum energy reservoir during post-
exercise recovery phase in CRF patients.
Renal osteodystrophy (ROD) in predialysis patients in Korea. S.K.
Shin, S.H. Ku, H.S. Kim, YS. Kwac, S.G. Ha, D.F. Sherrard, and D.H. Kim,
Department of Nephrology and Clinical Pathology, School of Medicine, Ajou
University Suwon, Korea, Department of Internal Medicine, School of
Medicine, Younsei University, Seoul, Korea, Department of Nephrology,
Washington University, Seattle, Washington, USA. ROD is one of the major
long-term complications in patients with ESRD. It can also be seen in
predialysis. Most patients with ROD are asymptomatic and therefore a
number of biochemical markers and non-invasive imaging techniques has
been used for a diagnosis of different types of ROD. However, the
quantitative bone histomorphometry is the gold standard method We have
studied 10 prcdialysis patients with ESRD from Nov. 1995 to Jan. 1996 at
Ajou University Medical Center. All patients underwent bone biopsies,
i-PTH, osteocalcin, alkaline phosphatase and serum aluminum pre- and
post-low dose desferrioxamine were measured. There were 7 male and 3
female patients and their mean age was 41.1 12.5 years. On the basis of
bone histonsorphometry, there were 4 patients with mild lesion, 4 aplastic,
and 2 normal pts (Table 1). Osteitis fibrosa (OF), mixed and osteomalacia
(OM) have not been observed so far.
Table 1. Classification of ROD by bone histomorphometry
Area of fibrosis Area of osteoid
Lesion %
Mild 0.42 0.16 6.27 1.45
Aplastic 0.16 0.17 4.86 1.61
Normal 0.14 0.06 1.74 0.93
Bone formation rate Surfacc aluminum
Lcsion 111n2/Pnm2
Mild 321.0 140.89 9.80 8,88
Aplastic 51.09 16.24 5.47 6.51
Normal 164.1 0.00 2.08 2.94
Serum i-PTH (pg/mi) werc 273.5 101.26, 261.0 266.33, and 156.0
155.56, osteocalcin (nglml) 57.20 24.21, 27.63 13.41 and 78.0 0.0,
serum aluminum (pg/liter) 33.05 22.83, 25.45 6.74, 25.75 10.25,
aluminum (tg/liter) —3.57 9.29, 7.42 9.51, 8.25 5.73 in mild,
aplastic and normal, respectively. This study shows that the pattern of
ROD among predialysis patients in Korea may be different. A further
study with a much larger patient population is nccded to draw any
significant conclusion.
Acute effects of recombinant human erythropoietin (rHuEPO) on
plasma concentration of proendothelin.1 (proET.1) and endothelin.!
(ET.!) in hemodialysis (HD) patients. D.H. Kang, KB. Choi, K.!. Yoon,
Department of internal Medicine, College of Medicine, Ewha Women s
University, Seoul, Korea. The exact mechanism of rHuEpo-induced hyper-
tension in HD patients still remains uncertain. We have previously
reported that the plasma ET-i level during rHuEpo administration
revealed the absence of a significant correlation between the development
of rHuEpo-induced hypertension and plasma ET-1 level. However, recent
studies about the endothelial cell response of ET-1 and vascular smooth
cell proliferation to direct rHuEpo stimulation necessitate a more system-
atic clinical study on this vasoactive substance related mechanism of
rHuEpo-induced hypertension. The present study was undertaken to
evaluate the acute effects of rHuEpo (1,000 U/kg) on plasma proET-1 and
ET-1 levels with the 24-hour ambulatory blood pressure monitoring (BP3,
Mediana, USA) according to the administration route (19 intravenous
group, 10 subcutaneous group) compared with the placebo-injected
control group (10 patients). The plasma erythropoietin level reached its
maximal value at 5 minutes after rHuEpo in the i.v. group (13.1 2.4 vs.
278.9 29.1 pg/mI, P < 0.01), whereas it was at 6 hours after rHuEpo in
SQ group (14.7 3.8 vs. 38.9 17.7 pg/mI P < 0.05). Mean blood
pressure (MBP) was significantly increased 30 minutes after rHuEpo in
the i.v. group. However, there were no significant changes of MBP in SQ
and control group after rHuEpo administration. Plasma proET-1 and
ET-1 concentrations started to increase 10 minutes after rHuEpo, and
reached a peak at 30 minutes after rHuEpo in proET-1 (13.5 7.4 vs.
21.6 3.8 pg/mI, P < 0.05), and at 1 hour after rHuEpo in the ET-1 group
(4.2 2.6 vs. 9.9 4.8 pg/mI P < 0.05). In the patients group whose
interdialytic MBP risc above 10 mm Hg (10 patients, 52.6%), the changes
in ET-1 (ET) was significantly increased than the patients without a
significant interdialytic hypertension (7.4 2.4 vs. 3.2 2.8, P < 0.05)
whereas there was no significant difference in proET-1. In conclusion,
not only the administration route, but also the activity of endothelin
converting enzyme (ECE) may play an important role in the development
of rHuEpo-induced hypertension, Further studies are necessary to explore
pharmacologic interventions, such as the use of ECE inhibitor, to treat
rHuEpo-induced hypertension in hemodialysis patients.
Intradialytic biologic effects of rHuEPO administration and lipid
peroxidation: Changes in plasma levels of vasoactive substances during
hemodialysis. GB. Choi, E. Y. Lee, D.H. Kang, K.!. Yoon, Department of
Internal Medicine, College of Medicine, EWI-L4 Women's University, Seoul,
Korea. We have studied the intradiatytic biologic effects of rHuEPO
administration and lipid peroxidation that occurred during hemodialysis.
The plasma levels of vasoactive substances were investigated before and
after hemodialysis in 15 nondiabetic patients with chronic renal failure.
The hemodialysis were performed for 210 to 300 mm by using bicarbonate
dialysate. A hemophan dialyzer was used. Blood pressure were measured
every 30 mm by using CentrysystemR3 BP monitor. Patients were grouped
by two ways: one was according to whether or not patients were treated
with rHuEPO, and the other was according to the mode of changes of
plasma lipid peroxide (LPO) concentration after hemodialysis. -endor-
phin, motilin and mean blood pressure (MBP) were unchanged in the
EPO group (N = 7, treated with rHuEPO; 4000-6000 U/week for more
than 3 months) and LPO-Plus Group (N = 9, increased plasma LPO after
hemodialysis). In contrast, in the Non-EPO group (N ' 8, treated without
rHuEPO) and I.PO-Minus Group (N = 6, decreased plasma LPO after
hemodialysis), an increase in .endorphin (154.37 46.33 to 208.29
68.05 pg/mI, 121.28 22.29 to 153.38 38.38 pg/mI, P < 0.05, respec-
tively) and a decrease in motiOn (221.10 43.07 to 70.59 7.06 pg/mI,
195.45 26.79 to 6.62 7.90 pg/mI, P < 0.05, respectively) occurred.
MBP at 3 hours after hemodialysis decreased in these groups. Arginin
vasopressin decreased in all groups. But angiotensin TI, endothelin-1 and
atrial natriuretic peptide were unchanged. The riluEPO administration
had no influence on the lipid peroxidation occurred during hemodialysis.
These data indicate that rHuEPO administration or lipid peroxidation
occurred during hemodialysis has some intradialytic biologic effects inde-
pendently. Moreover, the above results may be related to the dialysis.
induced MBP changes, rHuEPO induced hypertension, or other uremie
symptoms.
Basal serum biochemical markers as a predictor of survival in patients
undergoing hemodialysis (HD). KS. Song, S. W. Lee, J.B. Jean, S.K Bae,
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M.J. Kim, Division of Nephrology, Department of Internal Medicine, Inha
University, Incheon, Korea. To investigate the influence of first six-month
mean for serum biochemical markers, albumin (SA), cholesterol (CHOL),
triglyceride (TG), inorganic phosphate (P), BUN, creatinine (CR), on
survival in HD, we retrospectively analyzed the 57 patients who were
monitored from the start of HD between Jan. 1988 and Dec. 1995.
Exclusion criteria were as follows: transfer to CAPD, transplantation or
another dialysis center, HD for less than 3 months, non-compliance, death
due to malignant disease, accident and self-withdrawal. The patients were
divided into two groups according to the demographic characteristics and
the median value of first six-month mean for serum biochemical markers.
The mean age was 46.7 11.7 years, male-to-female ratio was 1.6:1,
diabetics were 12 (21.1%), and mean follow-up duration was 39.0 26.4
months. Among them, 30 (52.6%) were dead: cardiovascular disease 22,
infection 5, and unknown 3. Diabetics had a significantly lower 1 (63.6 vs
88.8%, P < 0.05) and 3 (19.1 vs. 62.2%, P < 0.05) year survival rate than
non-diabetics. Compared to patients of 55 years, those of <55 years
tended to have higher 1 (84.8 vs. 81.3%, P = 0.09) and 3 (59.1 vs. 46.6%P = 0.09) year survival rate without statistical significance. Low SA (<3.5
g/dl), CHOL (<130 mg/dl) and P (<5.5 mg/dl) groups had a significantly
lower I and 3 year survival rate than high SA (63.6 vs. 97.0%; 25.5 vs.
74.6%, P < 0.05), CHOL (71.4 vs. 88.0%; 38.1 vs. 60.8%, P < 0.05) and P
(71.9 vs. 96.3%; 47.1 vs. 62.9%, P < 0.05) groups, respectively. There were
no differences in the survival rate according to sex, BUN, TG, and CR. SA
was correlated with BUN (r = 0.26), CR (r = 0.26) and P (r = 0.45),
CHOL with TG (r = 0.50), and CR with BUN (r = 0.58) and P (r = 0.49).
By the Cox proportional harzard model, low SA (odds ratio 1.98), CHOL
(odds ratio 1.60), and P (odds ratio 2.09) groups were independent risk
factors for death. In conclusion, basal serum biochemical markers associ-
ated with visceral protein depletion seem to be early predictors in
mortality in HD patients.
The acute therapy of hyperkalemia with the combined regimen of
bicarbonate and beta2 agonist (salbutamol) to ESRD patients. H.J. Kim,
S.C. Yang, J.H. Lee, S.K. Kim, J.H. Lee, Hi. Kim, Department of Internal
Medicine, Hanyang University Kuri Hospital, Kuri, Korea. This study was
aimed to evaluate the efficacy of concurrent therapy of bicarbonate and
salbutamol for hyperkalemia in nine hemodialysis patients. Simultaneous
administration of 8.4% sodium bicarbonate (iv., 2 mEq/min) for one hour
and salbutamol (15 mg) in nebulized form for 10 minutes was compared
with treatment modality of either bicarbonate or salbutamol alone.
Infusion of sodium bicarbonate induced a significant rise in blood
bicarbonate from 17.3 1.1 to 22.1 0.8 mEq/liter (P < 0.01), but was
ineffective in lowering plasma potassium (—0.13 0.06 mEq/liter). As
expected, salbutamol significantly lowered plasma potassium (—0.57
0.03 mEq/liter, P < 0.02 vs. basal value) in all except 2 patients. The
combined regimen of bicarbonate and salbutamol to total 9 patients
including 2 patients without hypokalemic effect to salbutamol alone
revealed a substantially greater fall in plasma potassium (—0.96 0.08
mEq/liter, P = 0.000 vs. either drug alone) accompanied with significant
increase in plasma bicarbonate (18.8 0.8 to 23.0 0.8 mEq/liter, P <
0.01) and blood pH (7.30 0.01 to 7.38 0.01, P < 0.01). Treatment with
salbutamol or the combined drug regimen produced slight increases in the
heart rate, but not in blood pressure. However, hormonal levels involved
in potassium homeostasis including epinephrine, norepinephrine, aldoste-
ronc, and insulin as well as blood glucose before and after each treatment
modalities did not show any significant differences among each different
regimens. It is concluded that the combined regimen of bicarbonate and
bcta2-agonist (salbutamol) could be recommended as an cffieient alterna-
tive for severe hyperkalemia in uremic patients among other treatment
modalities. The data suggest that the enhanced transcellular hypokalemic
effects of salbutamol in this combined regimen with bicarbonate would be
related to increased sensitivity of beta2 receptors to beta2-agonist with
acute correction of underlying metabolic acidosis.
A comparison of CAPD outcome between older and younger patients.
M.Y flack, CD. Kim, 5.1. Kim, .1.11. Kim, S. Cho, Til. Kwon, YL. Kim and
D.K Cho, Department of Internal Medicine, Kyungpook University Hospital,
Taegu, Korea. Rapid growth in the number of dialysis patients over age 65
is occurring coincident with overall aging of the general population. Older
patients are often poor and physically incapacitated and may need family
or social support and may be susceptible to malnutrition and have multiple
complicating medical disorders in addition to end-stage renal disease.
Thus the choice of a dialysis modality is particularly critical in the older
patients. Continuous ambulatory peritoneal dialysis (CAPD) offers many
advantages to the older patients, including hemodynamic stability, steady
state chemistries, and a lack of need for vascular access. However, few
data are available in the literature documenting the use of CAPD in this
setting. Therefore, to evaluate the efficacy of CAPD in older patients, we
retrospectively reviewed the clinical outcome of 23 patients 65 years of age
or older at the start of CAPD (Older group). Then, for each of these
patients, 23 comparison subjects younger than 65 were chosen from
CAPD patients of our hospital (Control group). The Control group was
matched for sex, CAPD duration, cause of ESRD, and initial connection
device. In the older group, 23 patients (12 male/lI female) with a mean
age of 70 4 were treated with CAPD for 15 17 months. In the control
group, 23 patients (12 male/Il female) with a mean age of 41 11 were
treated with CAPD for 16 17 months. Diabetic nephropathy was the
cause of ESRD in 35% of patients. The negative CAPD selection of
patients was higher in the older group (61% vs. 17%, P = 0.0025) as well
as a need for helper (61% vs. 17%, P = 0.0025). The exit-site infection and
peritonitis rates were similar between the two groups (0.43 vs. 0.9 1/
patient-year and 1.46 vs. 2.03/patient-year). The dialysate leakage and
bleeding rates were comparable (13% vs. 22% and 9% vs. 9%). The
one-year catheter survival was similar in the older and younger patients
(87.5% vs. 84.0%). Although the negative CAPD selection of patients was
higher in the older group, outcomes were similar to those seen in younger
patients. Therefore, CAPD is an acceptable form of therapy for the older
ESRD patients, particularly if a helper participates.
Gastric emptying time (GET) in patients on continuous ambulatory
peritoneal dialysis (CAPD). J.Y. Kang, H.S. Lee, iS. Ryu, SB. Kim, 5K.
Lee, J.S. Park, CD. Hong. Department of Internal Medicine and Nuclear
Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea. This study
was performed to evaluate the prevalence of gastroparesis and the
relationship between GET and nutritional status in CAPD patients. GET
using 99Tc-DTPA labeled egg and nutritional markers were measured in
51 consecutive CAPD patients (33 M, 16 F, age 28-- 76 years, median 57)
and 13 healthy volunteers. In control group, GET was 57 9 minutes. In
diabetic patients, gastric emptying was more delayed than non-diabetic
patients. Low serum albumin and prealbumin were more prevalent in
patients with delayed GET than in those with normal GET.
GET
Normal GET > mean + 2 SD
No. of patients 24 9
DM/non-DM 11/13 4/5
Albumin 19/5 4/5
3.0/<3.0 g/dl
Prealbumin 16/8 2/7
29/<29 mg/dl
—
GET
>mean+4sD P
No. of patients
DM/non-DM
Albumin
3.0/<3.0 g/dl
Prealbumin
29/<29 mg/dl
There was no difference in insulin-like growth factor-I, cholesterol,
transferrin levels among these three groups. This results show that gastric
emptying is delayed in more than half of the patients on CAPD and
delayed gastric emptying may contribute to malnutrition.
Malfunctioning Tenckhofl' catheters: Repositioning with fluoroscopic
technique. II. Rim and KS. Jung, Department of Internal Medicine and
Department of Radiology, Kosin University, Gospel Hospital, Pusan, Korea.
Peritoncal dialysis catheter (PDC, dual-cuff, straight) malfunction due to
catheter tip malposition is a relatively common complication of peritoneal
dialysis, occurring up to 20% in implanted catheters and often requiring
revision or removal of PDC. Stiff- or flexible-wire manipulations of
18
15/3
8/10
4/it)
<0.05
<0.05
<0.05
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malpositioned PDC under the fluoroscopic guidance have been reported
as the methods of repositioning. From November 1994 to February 1996,
we performed 10 trials of repositioning in 9 patients who presented a
delayed drainage of dialysate. To reposition the PDC, a guide wire
(Amplatz Super Stiff 0.035 inch) was advanced through the PDC and Out
its end hole. The guide wire eventually met resistance and it coiled against
an abdominal wall, a solid organ or the diaphragm. Further pressure on
the guide wire caused the PDC and guide wire to buckle and migrate
deeper into the pelvis. With the catheter repositioned in the pelvis, the
stiffener from biliary drainage catheter was bent to resemble the curvature
of the newly positioned PDC. The stiffener was then placed over the guide
wire and the guide wire was removed from the stiffener. Finally, the
stiffener was removed from the PDC. Seven of the ten manipulations were
anatomically repositioned. Among the repositioned cases, two had no
functional benefit and one showed recurrence. Repositioning failed in
three cases, but one of them had a functional improvement. Complications
were abdominal pain (N = 8) and peritonitis (N = 1). Therefore, this
technique may be an effective alternative procedure to PDC revision or
removal.
The effect of albumin infusion on serum lipoprotein (A) concentration
in patients on continuous ambulatory peritoneal dialysis. W.S. Yang, S.B.
Kim, W.K Mm, and J.S. Park, Department of Internal Medicine and Clinical
Pathology, Asan Medical Center, College of Medicine, University of Ulsan,
Seoul, Korea. Lipoprotein(a) [lp(a)], an independent risk factor for
atherosclerotic cardiovascular disease, is known to be elevated in patients
with renal disease accompanied by hypoalbuminemia such as in nephrotic
syndrome and end-stage renal disease in patients on hemodialysis or
continuous ambulatory peritoneal dialysis (CAPD). To evaluate the role
of hypoalbuminemia in the elevation of serum lp(a), we measured fasting
serum lp(a) and albumin before and after infusion of 20% albumin, 100 cc
three times per week for two weeks and 4 weeks after withdrawl of
albumin infusion in 9 CAPD patients (group 1). Serum albumin and lp(a)
was measured similarly without albumin infusion in another 9 CAPD
patients (group II). C-reactive protein was followed in both groups as an
indicator of acute phase reactant. Serum lp(a) was also measured in 18
age- and sex-matched normal subjects, and lp(a) phenotype was deter-
mined for both normal subjects and CAPD patients. CAPD patients as a
whole [N = 18, median 73.6 mgldl (interquartile range; 47.0—87.5)] had
higher serum lp(a) than normal subjects [N = 18, 9.9 mg/dl (2.9—22.6)(P < 0.0001)1 though the distribution of apo(a) phenotype was similar.
Serum albumin in group I increased from 2.7 0.5 g/dl to 3.6 0.7 gldl
(P < 0.001) at the end of repeated infusion of albumin, whereas serum
lp(a) decreased from 74.0 mgldl (46.1—102.3) to 34.8 mgldl (13.1—76.4)
(P < 0.01). Four weeks after withdrawal of albumin infusion, serum
albumin decreased again to 3.0 0.5 g/dl (P < 0.005), whereas serum
lp(a) increased to 67.8 mgldl (48.9—106.8) (P < 0.05). Serum albumin in
group II was 2.8 0.6 gIdl, 3.0 0.5 g/dl, and 2.8 0.7 g/dl, respectively.
The change of serum lp(a) was not significant [67.0 mgldl (51.3—85.5) 70.8
mg/dl (48.6—83.6), and 72.8 mgldl (50.8—77.3)]. C-reactive protein was
stable during the study period in both groups. These findings indicate that
hypoalbuminemia is an important trigger factor in the elevation of serum
lp(a) in CAPD patients.
Comparison of serum lipoprotein(A) concentration based on apoli-
poprotein(A) phenotype between patients on continuous ambulatory
peritoneal dialysis and hemodialysis. J. W. Seo, KS. Yoo, K]. Kim, ES.
Kang, W.K Mm, S. B. Kim, and iS. Park, Department of Internal Medicine
and Clinical Pathology, Asan Medical Genter, College of Medicine, University
of Ulsan, Seoul, Korea. Cardiovascular disease is one of the most important
causes of death in patients on renal replacement therapy. The serum level
of lipoprotein(a)[lp(a)], an independant risk factor for atherosclerotic
cardiovascular disease, is determined mainly by the gene locus in the
general population, but is known to be elevated in patients with end-stage
renal disease. To evaluate the effect of dialysis modality on serum lp(a)
concentration, we measured fasting serum lp(a) and apolipoprotein-
(a)[apo(a)] phenotype in 82 continuOus ambulatory peritoneal dialysis
(CAPD) patients, 99 hemodialysis (}TD) patients and 153 normal subjects.
CAPD patients [median 62.7 mgldl, interquartile range; 28.2—90.3 mgldl]
had higher serum lp(a) than lID patients [18.7 mg/dl, 9.5—35.4 mg/dl] or
normal subjects [5.3 mgldl, 1.0—18.7 mgldl (P < 0.0001)]. The apo(a)
phenotype of the whole subjects consisted mainly of S5 group (S5, S5S5;
50%), S4 group (S4, S4S4, S4S5; 33%) and S3 group (S3, S3S3, 53S4,
S3S5; 13%). For the S5 group, serum lp(a) of CAPD patients (N = 51;
51.0 mg/dl, 16.3—84.4 mg/dl) was significantly higher than that of HD
patients (N = 44; 12.5 mg/dl, 3.2—22.0 mgldl) or normal subjects (N = 79;
4.1 mg/dl, 1.0—10.9 mg/dl (P < 0.0001)]. For the S4 group, serum lp(a) of
CAPD patients (N = 23; 86.8 mg/dl, 54.5—104.7 mgldl) was significantly
higher than that of HD patients (N 38; 19.8 mg/dl, 12.6—37.3 mgldl) or
normal subjects [N = 50; 5.8 mg/dl, 2.4—19.5 mg/dl (P < 0.0001)]. For the
S3 group, serum lp(a) of CAPD patients (N = 12; 81.7 mg/dl, 49.8—96.2
mgldl) was significantly higher than that of HD patients (N = 16; 43.9
mgldl, 26.2—52.1 mg/dl) or normal subjects [N = 14; 25.4 mg/dl, 3.0—56.9
mgldl (P < 0.005)]. These findings indicate that serum lp(a) is elevated in
CAPD patients as compared with HD patients for all common apo(a)
phenotypes, suggesting that CAPD modality is associated with greater
elevation of serum lp(a) which may contribute to their frequent cardio-
vascular mortality in CAPD patients.
Lipoprotein(a) and atherosclerotic cardiovascular disease in patients
on continuous ambulatory peritoneal dialysis. J.S. Lee, J.S. Ryou, T W.
Kweon, SB. Kim, W.K Mm, and J.S. Park, Departments of Intemal
Medicine, Clinical Pathology, Nuclear Medicine and General Sutgeiy, Col-
lege of Medicine, University of Ulsan, Seoul, Korea. Lipoprotein(a) [Lp(a)]
has been reported as an independent risk factor for atherosclerotic
vascular disease. In this study, the relationship between Lp(a) and
atherosclerotic cardiovascular disease was evaluated in patients on con-
tinuous ambulatory peritoneal dialysis (CAPD). Serum Lp(a) concentra-
tion and apo(a) phenotype were measured in 69 CAPD patients as well as
in 70 age- and sex-matched normal subjects, serving as control. Dipyrid-
amole thallium 201 myocardial scintigraphy with single photon emission
computed tomography (SPECT) and ankle-arm blood pressure index
(AABI) were performed in all the CAPD patients. The patients who had
positive finding in at least one of the two tests were considered to have
atherosclerotic cardiovascular disease. Serum Lp(a) (median; interquar-
tile range) was significantly higher in CAPD patients (62.8 mgldl; 36.8—
90.1) than in normal subjects (4.0 mg/dl; 1.0—11.9, P < 0.001). The
distribution of apo(a) phenotype of CAPD patients did not differ from
that of the control group (S2; 4.5 vs. 2.9%, S3; 13.4 vs. 7.2%, S4; 82.1
vs. 89.9%, P> 0.1). In the CAPD group, 9 patients (27.5%; group I) had
a positive finding of cardiovascular disease, whereas 50 patients (72.5%;
group H) had a negative finding. Serum Lp(a) concentration of group I
(65.0 mg/dl; 47.0—90.4) was not different from that of group 11(61.0 mg/dl;
32.3—90.9). No difference was present in the distribution of apo(a)
phenotype between the two groups (S2; 5.6 vs. 4.1%, S3; 11.1 vs. 14.3%,
S4 83.3 vs. 81.6%, P> 0.1). However, in the analysis of the patients who
had been on CAPD for more than 12 months, serum Lp(a) was signifi-
cantly higher in group I (N = 9, 67.8 mgldl; 62.8—127.5) than in group II(N = 16, 45.5 mgldl; 24.0—62.0) (P < 0.05). These findings suggest that
elevated serum Lp(a) can be a risk factor for cardiovascular disease in
patients who received CAPD for a prolonged period.
The effect of peritoneal membrane transport characteristics on the
nutritional status in long.term continuous ambulatory peritoneal dialysis
(CAPD) patients. I.H. Lee, KH. Ksvon, Hf. Noh, H. C. Park, S. W. Kang,
KH. Choi, H. Y Lee, D.S. Han, M.J. Shin, and J.H. Lee, Department of
Internal Medicine, College of Medicine, Institute of Kidney Disease, and
Department of Food and Nutrition, College of Human Ecology, Yonsei
University, Seoul, Korea. Protein-calorie malnutrition is common in CAPD
patients and is associated with increased morbidity and mortality. There
are many causes of malnutrition in CAPI) patients, and it is well-known
that a large amount of protein loss through the peritoneal membrane is
one of them. To investigate the effect of the peritoneal membrane
transport characteristics on the nutritional status in long-term CAPD
patients, we conducted a cross-sectional study on 110 clinically stable
patients who performed CAPD for more than 2 years, using I'ET and
measuring nutritional status by subjective global assessment (SGA),
biochemical, anthropometric, and urea kinetic parameters. The patients
were divided into 4 groups according to the PET results: group I (high
transport, P = 17, 15.5%), group II (high average transport, N 32,
29.1%), group III (low average transport, N 52, 47.3%) and group IV
(low transport, N 9, 8.1%). Malnourished patients assessed by SGA
were more prevalent in group 1 (6/17, 35.3%) than in group IV (1/9,
11.1%) (P < 0.05). Serum albumin levels (g/dl) in group I, group II, group
HI and group IV were 3.50 0.42, 3.83 0.49, 4.11 0.43, and 4.36
0.36, respectively, and there was a significant difference between group I
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and group IV (P < 0.05). Group I had a significantly lower serum
creatinine level (11.51 1.88 mgldl) than in group IV (16.32 5.09) (P <
0.05), but there were no significant differences in Hct, BUN, serum
protein, and cholesterol among the 4 groups. Albumin loss through
dialysate (glday) was significantly more in group I (5.36 1.44) than in
group III (4.17 1.09) and group IV (3.88 1.35) (P < 0.05) and Sr
(liters/week/1.73 m2) was higher in group I (67.08 10.60) than in the
others (group II, 63.75 17.72; group III, 54.92 14.54; group IV,
49.03 8.93) (P < 0.05). However, there were no statistically significant
differences in NPCR, weekly KT/Vura, and anthropometric parameters
among the 4 groups. In conclusion, in view of the results that patients in
the high transport group are malnourished, despite adequate dialysis
comparable to those in the other groups, peritoneal membrane character-
istics may be a risk factor for malnutrition in CAPD patients.
Comparison of different measurements of lean body mass (LBM) in
continuous ambulatory peritoneal dialysis (CAPD) patients. H. C. Park
KH. Kwon, H.J. Noh, I.H. Lee, SW. Kang, KH. Choi, H.Y Lee, D.S. Han,
M.J. Shin, J. Y Yoon, and J.H. Lee, Department of Internal Medicine, College
of Medicine, Institute of Kidney Disease, and Department of Food and
Nutrition, College of Human Ecology, Yonsei University, Seoul, Korea.
Protein-energy malnutrition is common in CAPD patients and is associ-
ated with increased morbidity and mortality. Malnutrition may reflect
inadequate dialysis or improper dietary intake, leading to a reduction in
LBM. Monitoring LBM, therefore, is an important measure to assess the
long-term nutritional status of the patients. At present, dual energy X-ray
absorptiometry (DEXA) is well-known to be accurate in assessing the
body compositions in normal and dialysis patients, but there are some
limitations in its routine clinical applications. To decide on a more
convenient method for estimation of LBM, we compared LBM measured
by DEXA in thirty stable CAPD patients with that by four other easily
applied techniques: anthropometric measurements (skinfolds measure-
ment; SFM), bioimpedance analysis (BIA), infrared interactance (I), and
creatinine kinetics (CK). The results were as follows:
DEXA SFM
LBM kg
LBM %
42.6 6.3
73.9 10.2
42.4 5.6
73.3 7.3
BIA I CK
LBM kg
LBM %
44.0 6.3
76.1 9.7
46.1 7.1
79.6 8.6
43.2 8.6
74.3 11.3
The correlation coefficient between LBM measured by DEXA and that by
SFM, BIA, I, and CK were 0.899, 0.861, 0.849, and 0.833, respectively (P <
0.001). The correlation coefficient between % LBM (LBM/BW) estimated
by DEXA and that by SFM, BIA, I, and CKwere 0.908, 0.829, 0.815, and
0.681, respectively (P < 0.001). LBM by SFM had the strongest correla-
tion coefficient with that by DEXA and had the smallest prediction error
(—0.241) and root mean squared prediction error (2.716). In conclusion,
SFM can be a suitable alternative to DEXA for assessment of LBM in
stable CAPD patients.
Serum albumin as a predictor of morbidity and mortality in continuous
ambulatory peritoneal dialysis (CAPD) patients. KH. Kwon, H.J. Noh,
II.C. Park, 1.11. Lee, SW. Kang, KH. Choi, H.Y. Lee, and D.S. Han,
Department of Internal Medicine, College of Medicine, Institute of Kidney
Disease, Yonsei University, Seoul, Korea. Serum albumin (SA) is a powerful
predictor of morbidity and mortality in the hemodialysis (HD) population.
In CAPD patients, SA may he more severely compromised by dialysate
protein losses and a protein intake that is lower relative to HD patients.
However, the usefulness of SA as a marker for increased morbidity and
mortality in CAPD patients remains undefined. To investigate the role of
SA and other risk factors as predictors of peritonitis, hospitalization and
death in CAPD, we conducted a study on 782 patients who were
followed-up for more than 3 months after initiation of CAPD at Severance
Hospital from January 1985 through August 1995. For each patient the
following data were collected: age, sex, duration on dialysis, presence of
diabetes or cardiovascular disease, and monthly biochemical data includ-
ing SA. Follow-up was censored on renal transplantation or transfer to
HD for survival outcome. The mean age of the patients was 45.5 13.6
years (range, 14—80) with sex ratio 1.2:1, and a mean duration on dialysis
was 30.8 25.6 months (range, 3—122). SA (P < 0.001) and duration on
dialysis (P < 0.01) were independent risk factors for peritonitis and
hospitalization. The independent predictors of mortality were age (P <
0.001), SA (P < 0.001), duration on dialysis (P < 0.001), diabetes (P <
0.001), cardiovascular disease (P < 0.001), and BUN (P = 0.005). The
patients were divided into 3 groups according to the mean SA levels
during the follow-up period (Group 1, SA < 3.5 g/dl; Group 2, 3.5 g/dl
SA < 4.0 g/dl; Group 3, SA  4.0 g/dl), and incidence of peritonitis,
hospitalization and death was compared among them. Compared to group
2 and group 3, group I experienced significantly more peritonitis (1.18 vs.
0.87, 0.66 times/patient year, P < 0.05) and hospitalization (7.93 vs. 4.70,
3.36 days/patient year, P < 0.05). The 5-year survival rates in group 1,
group 2 and group 3 were 43.4%, 60.9% and 84.1%, respectively (P <
0.05). In conclusion, low SA is an important predictor for morbidity and
mortality in CAPD patients.
Risk factors of hypercalcemia in patients with continuous ambulatory
peritoneal dialysis (CAPD). Hf. Noh, H.. Park, KH. Kwon, I.H. Lee,
S. W Kang, KH. Choi, H.Y Lee, D.S. Han, M.f. Shin, E.Y Cho, and J.H.
Lee, Department of Internal Medicine, College of Medicine, Institute of
Kidney Disease, and Department of Food and Nutrition, College of Human
Ecology, Yonsei University, Seoul, Korea. Hyperphosphatemia is a critical
problem in developing secondary hyperparathyroidism and renal Os-
teodystrophy in patients with end-stage renal failure. To control hyper-
phosphatemia, calcium carbonate (CaCO3) has been widely used, but its
use is limited by the development of hypercalcemia. We evaluated the
incidence of hypercaleemia in 144 CAPD patients on CaCO3 therapy and
compared some parameters to identify the risk factors for the develop-
ment of hypercalcemia between 22 hypercalcemic patients (more than 2
episodes of corrected serum calcium 10.5 mgJdl or elevation of serum
calcium more than 1.0 mg/dl compared to baseline serum calcium level,
group I) and 22 eucalcemic patients (group II) matched for age, sex and
duration of dialysis. Forty-four of 144 patients (30.6%) experienced more
than one episode of hypercalcemia (corrected serum calcium 10.5
mg/dl). Group I had significantly higher serum calcium level than group II
(9.75 0.34 vs. 9.07 0.37 mg/dl, P < 0.05), but the serum phosphorus
levels were similar in both groups (4.5 0.8 vs. 4.3 0.8 mg/dl). Serum
calcium level was normalized in all patients after discarding CaCO3, but
retrial of CaCO3 made 7 patients (31.8%) hypercaleemic again. Group I
had significantly lower levels of serum alkaline phosphatase (51.3 19.5
vs. 71.9 25.7 lU/liter, P < 0.05) and intact PTH (77.02 131.97 vs.
280.55 390.02, P < 0.05) compared to group II. But there was no
difference in the serum aluminum level between the groups. Other
biochemical parameters including serum bicarbonate, total protein, albu-
min and total cholesterol, peritoneal transport characteristics assessed by
PET, nutritional status by SGA, anthropometric data and dialysis ade-
quacy by urea kinetic modeling were similar in both groups. In conclusion,
it seems that hypercalcemia develops more frequently in patients with low
turnover bone disease, and dialysate with low calcium content should be
considered for use in these patients. However, further studies such as bone
biopsy following double tetracycline labelling will be needed for more
detail clarification.
Predictors of clinical outcome in CAPD. MS. Park, AS. Lim, S.H.
Chung, F.Y. Lee, M.K. Cha, .1.11. Kim, KI. Song, D.C. Han, S.D. Hwang, C.
Moon, and H.B. Lee, Hyonam Kidney Laboratory, Soon Chun Hyang
University, Seoul, Korea. To determine factors whieh may predict clinical
outcomes (death: D, transfer to HD: T, and hospital admission: HA), we
performed univariate and multivariate analysis on 13 variables and
prospectively compared these 13 variables between opposite outcomes
during 3 years of follow-up. Eighty-one patients (age 47.8 13.4 years,
32.1% diabetics, duration of CAPD before study 14.7 24.3 months) were
followed for 1 year, 59 for 2 years, and 29 for 3 years. Only those who
remained on CAPD for at least 90 days after the initial urea kinetic study
were included. Twelve patients died, 17 transferred to HD, and 63 had HA
during the follow-up of 1 year. Discriminant analysis revealed that days of
HA were a positive predictor of D and T during the follow-up of 1, 2 and
3 years (P < 0.001 each year). Age, comorbidity score (CMS) and serum
albumin (AIb) were predictors of D at 3 years of follow-up. On stepwise
variable selections, CMS (P < 0.05) and duration of CAPD (P < 0.01)
were positive predictors and serum creatinine a negative predictor (P <
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0.05) of length of HA during the first year after the initial study, while
number of peritonitis episodes (P) was the only positive predictor of the
length of HA during the follow-up of two (P < 0.05) and three (P < 0.001)
years. On stepwise variable selections, Kt/Vur,,, blood urea nitrogen level
(BUN) and NPCR were predictors of AIb. AIb decreased with time on
CAPD during follow-up of 3 years. Total ereatinine clearance decreased
during the first one year of follow-up but remained stable afterward. In
conclusion, days of HA were a predictor of D and T during 1, 2 and 3 years
of follow-up. Age, CMS and Aib also predicted D at 3 years. CMS,
duration of CAPD and P were predictors for the length of HA. Urea
kinetic indices including Kt/V,,r,,, failed to predict clinical outcomes during
the 3 years of follow-up. Alb, BUN and NPCR decreased with time on
CAPD.
Study of clinical difference between SandimmunR Soft Gelatine Capsule
and Sandimmun NeoralR in renal transplants. K.W Kahng, S.M. Kim,
CII. Park; C.M. Kang, H.C. Park, and J.Y Kwak, Departments of Internal
Medicine and Surgeiy, College of Medicine, Hanyang University, Seoul,
Korea. Cyclosporine (CsA) has improved early graft survival of renal
transplantation. Because CsA has a lipophylic nature and its absorption is
effected by diet or bile acid, there are many problems in maintaining an
optimal consistent therapeutic CsA blood level in renal transplants.
Recently, a new formulation, based on microemulsion technology, has
been developed, that is now used in Korea. This type of drug makes the
absorption of CsA be more predictable and consistent. There was a
clinical report about microcmulsion type in stable Korean renal trans-
plants. We tried to find clinical differences between soft gelatine capsule
and microemulsion type in the early post-transplantation period. This
study included 54 patients who received renal transplantation at Hanyang
University Hospital after 1995. The number in the classic group was 31(25
males and 6 females), and the average age was 34.9 years. The number of
the microemulsion group patients was 23 (14 males and 9 females), and
the average age was 37.5 years. There was no difference in HLA
mismatches between the two groups. We evaluated the number of
rejection episodes and the severity of rejection, cyclosporine level and
dosage, complete blood count, biochemistry profile, and other medical
problems. The classic group had higher CsA level/CsA dosage/body wt
than the microemulsion group (66.3 nglml/mg/kg: 47.1 ng/ml/mglkg, P <
0.05). There was no difference in the number of rejections (9/31:8/23). The
number of steroid-resistant rejections was lower in the mieroemulsion
group (4/31:1/22), but there was no significant difference. There was no
difference in other parameters. From these results, it may be suggested
that a higher dosage of Sandimmun Neoral' is needed in early post-
transplantation period than that of Sandimmun'5 soft gelatine capsule. But
the number of our patients is small and the follow-up time is short, so
study with more long-term follow-up with a larger number of patients is
needed.
Relationship between insulin-like growth factor-I (IGF-I) and nutri-
tional status in continuous ambulatory peritoneal dialysis (CAPD) pa-
tients. S.W. Lee, M.J. Kim, S.W. Kang, KH. Choi, H.Y. Lee, D.S. Han, E.Y
Cho, and J.H. Lee, Division of Nephrolagy, Department of Internal Medicine,
College of Medicine, Inha University, Incheon, Department of Internal
Medicine, College of Medicine, Department of Foodand Nutrition, College of
Human Ecology, Yonsci University, Seoul, Korea. To further ascertain the
relationship between TGF-T and other nutritional parameters in CAPD
patients, we performed a cross-sectional study in clinically stable patients
(N = 84)who were selected under the following criteria: CAPD fur more
than 6 months, free from peritonitis for at least 3 months, neither DM nor
liver diseases, serum CRY level 0.8 mg/dl, and no history of using
anaholic or catabolic hormones. Routine dietary, anthropometric, and
biochemical assessments including IGF-I were performed. Patients show-
ing evidence of kwashiorkor, marasmus, and mixed kwashiorkor maras-
mus were classified as malnourished. The patients were divided into two
groups according to the median IGF-I level: group I (N 42, TGF-1 <220
ng/ml) and group II (N = 42, IGF-I > 220 ng/ml). Malnourished patients
were more prevalent in group I than in group IT (61.9 vs. 35.7%, p < 0.05).
Serum albumin (3.8 0.5 vs. 4.1 0.5 g/dl), BUN (51.7 14.4 vs. 58.6
15.0 mg/dl), creatinine (11.2 2.6 vs. 13.2 3.7 mg/dl), urea nitrogen
appearance (4.60 1.39 vs. 5.26 1.55 g/day) were significantly lower in
group I. Mid-arm muscle circumference (MAMC) (23.9 2.1 vs. 25.7
2.3 cm), BMI (21.9 2.5 vs. 23.5 2.8 kg/rn2), lean body mass (LBM)
(40.1 8.1 vs. 46.3 11.2 kg) were also significantly lower in group 1. In
dietary assessment, animal protein intake seemed to be lower in group I
than in group II, but dietary protein intake and total caloric intake were
not different between the two groups. Patients with recombinant human
erythropoietin (rHuEPO) treatment were more prevalent in group 11(52.4
vs. 26.2%, P < 0.05) and hematocrit (27.2 5.5 vs. 23.0 4.6%,P < 0.05)
was also significantly higher in group II. But, when analysis was done only
with the patients who were not treated with rHuEPO, the difference still
remained (26.4 6.6 vs. 22.4 4.7%, P < 0.05). There were no
differences in the age, sex, duration of CAPD, serum ferritin, dialysis dose,
peritonitis rate, and residual renal function between the two groups. IGF-I
was positively correlated with hematocrit (r = 0.39, P < 0.01), serum
albumin (r = 0.36, P < 0.01), MAMC (r = 0.27, P < 0.05), BUN (r = 0.25,
P < 0.05), and LBM (r = 0.24, P < 0.05). By stepwise multiple logistic
regression analysis, hematocrit, MAMC, and BUN were independent risk
factors for low values of IGF-I. In conclusion, IGF-I seems to be a good
indicator of nutritional Status, especially skeletal muscle mass and hemat-
ocrit in CAPD patients.
A comparative study of three connector systems in continuous ambu-
latory peritoneal dialysis (CAPD) related peritonitis. I.K Jeong, H.J. Kim,
S. P. Hong, T W. Lee, C. G. Ihm, and M.J. Kim, Department of Internal
Medicine, College of Medicine, Kyung Hee University, Seoul, Korea. To
compare the general condition of peritonitis through a study of three
connector systems: The Spike-and-Pork system (SP), The Luer-Lock
system (LL), and The Double Bag system (DB), we reviewed our
experience with 111 patients from January 1989 to December 1995.
According to the kinds of connector system, we divided eases into 3
groups: The SP (1989—1991.3) was used on 37 patients (mean age 47.7,
M:F = 18:19); The LL (1991.4—1993.8) on 40 patients (mean age 56.3,
M:F = 28:12); and The DB (1993.4—1995.12) on 34 patients (mean age
49.5, M:F = 15:19) 1. Total CAPD duration was 45.7 patient year in SP,
45.9 in LL, and 32.6 in DB. The incidence of peritonitis is 1.22 episodes
per patient year in SP, 0.97 in LL, and 0.61 in DB. 2. Among the
causative organisms of peritonitis, coagulase negative Staphylococcus was
most common in the three groups (SP: 8.9%, LL: 13.3%, DB: 20%). Tn SF
and LL, S. aureus (8.9%, 13.3%), Pseudomonas (7.1%, 11.2%), andE. coli
(7.9%, 6.7%) were present in decreasing order. In DB, Pseudomonas
(15%), S. aureus (15%), and E. coli (10%) were present in decreasing
order. There were no growth of organisms in 68.3% of SP, 40% of LL, and
40% of DB. 3. The cumulative probability of experiencing the first
peritonitis at 1, 3, 6, and 12 months was 6.7%, 23.4%, 53.4%, and 86.7%
respectively in SP, 0%, 35.7%, 68.4%, and 82.6% respectively in LL, and
0%, 21.3%, 49.8%, and 85.7% respectively in DB. 4. In response to the
treatment of peritonitis, 57.3% of the peritonitis episodes in SP, 78.6% in
LL, and 80% in DB were cured with appropriate antibiotics. In 39.2% of
the peritonitis episodes in SP, 17% in LL, and 15% in DB, the catheter was
removed due to fungal, tuberculous, recurrent, or peritonitis not respond-
ing to antibiotics. 2 patients in SP, 2 patients in LL, and 1 patient in DB
died of peritonitis. 5. The cumulative probability of discontinuing CAPD
for any reason was 55% in SP, 35% in LL, and 26% in DB. Among the
patients of the discontinuation of CAPD, 71% in SP, 57% in LL, and 44%
in DB discontinued CAPD due to peritonitis. 6. The cumulative catheter
survival rate at 1, 2, 3 years was 62%, 32%, and 18% respectively in SP,
70%, 42%, and 25% respectively in LL, and 88.3%, 53%, and 28%
respectively in DB. Tn conclusion, our review suggests that there is a
relationship between the selection of connector system and the decrease
of peritonitis in CAPD.
Surgical managements of exit-site infection in CAPD patients. LI. Yun,
M.S. Park, H.B. Lee, and C. Moon, Department of General Surgery, Internal
Medicine, College of Medicine, Soon Chun Hyang University, Seoul, Korea.
Continuous ambulatory peritoneal dialysis (CAPD) is an excellent dialysis
method for maintaining the daily activities of chronic renal failure
patients, hut there have been problems with peritonitis and exit-site
infection (ESI) which eventually provoke catheter failure. In spite of every
effort to reduce the infection. ESI has not been decreased until now. ESI
is related to peritonitis and if antibiotic-resistant ESI is persistent, catheter
removal only would be the considered treatment. We treated antibiotic-
resistant ESI by surgical correction instead of removal and have reported
it. From March 1988 to February 1996 we had treated 45 ESI patients by
surgical correction methods at Soon Chun Hyang University Hospital.
Male versus female ratio was 26:19. Average age at surgical correction was
47. Median duration from catheter insertion to surgical correction was 13
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months. Twenty-nine patients experienced the peritonitis before surgical
correction (64%). Surgical methods are external cuff removal with cathe-
ter transposition (35 patients) and external cuff removal only (10 patients).
Eventually the catheter was removed in 35 patients and the remaining 10
patients still maintained the CAPD with corrected catheter. Median
duration from surgical correction to catheter removal was 5.5 months. For
catheter maintenance the group median duration was 10.5 months. Causes
of catheter removal were peritonitis (24 patients), persistent ESI (5
patients) and others. S. aureus were the most common cultured bacteria
(18 patients). Surgical correction for antibiotic-resistant ESI should be
considered before catheter removal because it could have the effect of
prolonging the catheter survival.
Comparison flow cytometry crossmatch with conventional lymphocyto-
toxic crossmatch in living donor renal transplantation—Preliminary
data. YS. Shin, C.W. Yang, S.Y Kim, E.J. Choi, YS. Chang, andB.K Bang,
Catholic University Medical College, Seoul, Korea. We compared the
sensitivity of flow cytometry crossmatch (FCXM) with conventional
lymphocytotoxic crossmatch (CXM). A total of 348 sera samples from
potential living renal transplant donors and recipients were tested with
conventional CXM and FCXM at Kangnam St. Mary's Hospital from
January 5, 1995 to April 3, 1996. Forty-five patients were followed-up for
at least 3 months after renal transplnatation. Results are as follows: of the
174 potential living donor/recipient pairs evaluated with CXM, 2 (1.1%)
had a positive warm T (TW)/CXM, 3 (1.7%) a positive warm B (BW)/
CXM, and 2 (2.9%) a positive warm T&B/CXM.
FCXM CXM TW( +)/BW( +) TW( + )/BW(—) TW( — )/BW(+)
T cell (+)
(—)
5 (100%)
0
2(100%)
0
1(33%)
2(67%)
B cell () 4(80%) 1(50%) 3 (100%)(-) 1(20%) 1(50%) 0
Of the 164 potential CXM-negative living donor/recipient pairs evaluated
with FCXM, 4 (2.4%) had a positive T/FCXM, 25 (15.2%) a positive
B/FCXM, and 6 (3.7%) a positive T&B/FCXM. Of the 45 renal trans-
planted patients who were followed-up for at least 3 months, 1 (2.2%) had
a positive BW/CXM, 11(24.4%) a positive B/FCXM, and 2 (4.4%) a
positive T/FCXM. Of the 8 patients with acute rejection episodes, 2 had a
positive B/FCXM and 1 had a positive T/FCXM. In conclusion, FCXM
was more sensitive than conventional CXM. Further follow-up study is
needed to know the effects of FCXM positivity to acute rejection.
The prognosis of the patients with renal transplantation in Alport
syndrome. H. Y. Kim, P. K Kim, M.J. Kwon, K 1. Park, and YS. Kim,
Department of Pediatrics and General Surgery, College of Medicine, Yonsei
University, Seoul, Korea. Alport syndrome is the most common chronic
progressive hereditary nephritis, with characteristic features of recurrent
or persistent microscopic hematuria, sensory-neural hearing loss and
visual disturbance. Poor prognostic factors include male sex, severe
proteinuria and a positive family history. We investigated clinical differ-
ences between 7 patients with renal transplantation (Group A) and 7
patients without renal transplantation (Group B) diagnosed at Severance
Hospital from January 1980 to August 1995. There were 10 male patients
and the male to female ratio was 6:1 in group A and 1.3:1 in group B.
Mean Onset age of ncphritis was 4.7 years in group A and 4.3 years in
group B. Average duration from onset of disease to renal transplantation
was 4.9 years. The mean elevated BUN and creatinine levels were 97.7
53.8 and 12.6 9.3 (mgldl), respectively. Group A had high frequencies of
proteinuria, hypertension, edema, sensory-neural hearing loss and visual
disturbance, and Group B had high frequencies of family histories. After
renal transplantation, the 2 year survival rates of the patient and kidney
were 100%. At present, the 7 year survival rates of the patient and kidney
are 71%, 85% respectively. Renal transplantation group had male pre-
dominance and high frequencies of proteinuria, sensory-neural hearing
loss and visual disturbances. Renal transplantation is the essential treat-
ment in Alport syndrome with chronic renal failure.
Detection of cytomegalovirus infection in renal transplant recipients by
shell vial culture and DNA detection. S.D. 1-twang, D.C. Han, MS. Park,
and H.B. Lee, Hyonam Kidney Laboratory, Soon Chun Hyang University,
Seoul, Korea. Cytomegalovirus (CMV) is a ubiquitous virus and its
infections occur frequently in immunocompromised patients. The overall
infection rate after renal transplant ranges from 60—96%. Early and
accurate laboratory diagnosis of CMV infection in renal transplant is
desirable but often difficult. For accurate diagnosis, we performed CMV
culture, amplification by polymerase chain reaction (PCR) and further
analysis of amplified products with Southern blot. The 117 specimens (89
urines, 17 blood neutrophils, 5 tissues and 6 body fluids) of 59 renal
transplant recipients were submitted to shell vial culture with centrifuga-
tion enhancement and analyzed by PCR employing primers for immediate
early (IE) gene targets (274 bp). The infectious viruses were examined
with IF staining using monoclonal antibody to the early antigen of CMV.
The amplified products were detected by gel electrophoresis and ethidium
bromide staining. When amplification was not successful, the amplified
products were transferred to the nylon membrane and hybridized with the
IE gene probe. Infectious CMV was detected in 25 specimens of 17 renal
transplant recipients by shell vial culture (28.8% of viremia). The PCR and
Southern blot disclosed CMV DNA in additional 14 and 29 specimens of
30 patients. Overall CMV infection rate was 79.7%, but PCR did not
detect CMV DNA in 10 and Southern blot in 5 samples which were
culture positive. Our data demonstrated that CMV DNA diagnosis is
more sensitive than culture but lacks consistency with culture. To increase
sensitivity and accuracy of diagnosis of CMV infection or disease, all
methods should be employed in renal transplant recipients.
Optimal indication of gancyclovir treatment during early cytomegalo-
virus (CMV) viremia in CMV seropositive recipients. A longitudinal study
of CMV pp6S antigenemia assay. C. W. Yang, SF!. Lee, SN. Yoon, H.J. An,
YO. Kim, YS. Shin, YS. Kim, E.J. Choi, and B.K Bang, Department of
Internal Medicine, Catholic University Medical College, Seoul, Korea. A
prospective study to investigate the optimal initiation of ganeyclovir
treatment during early cytomegalovirus (CMV) viremia was conducted in
60 CMV seropositive renal transplant recipients. Early CMV viremia was
diagnosed by CMV antigenemia (Ag) assay, and this assay was performed
regularly for 6 months after renal transplantation. Recipients were divided
into low (1—10) and high (>10) CMV infection according to the number
of CMV Ag positive cells. A randomized trial of gancyclovir (5 mg/kg b.i.d.
for 2 weeks) was made in recipients with high CMV infection. Early CMV
viremia was detected in 71.7% (43/60) recipients (low 55.0%; high 16.7%).
The incidences of early CMV viremia in CsA, methylprednisolone (MP)
and OKT3 groups were 68.1%, 71.5%, and 100%, respectively (P> 0.05).
Ineidences of low CMV infection in three groups were not significantly
different (CsA 59.6%; MP 42.9%; OKT3 33.3%, P> 0.05) but high CMV
infection was strongly associated with intensity of immunosuppression
(CsA 8.5%; MP 28.6%; OKT3 66.7%, P = 0.006). The recipients with low
CMV infection showed no evidence of CMV disease and CMV virenlia
was spontaneously disappeared; however, the recipients with high CMV
infection showed a diverse clinical course. In the ganeyclovir-treated group
(N = 5), CMV viremia was completely controlled, but the gancycloir-
untreated group (N = 5) showed CMV disease in 3 (60%) recipients when
CMV Ag positive cells reached peak levels. Of 3 recipients with CMV
diseases, 2 recipients received OKT3 and 1 recipient received MP. In
summary, severity of CMV infection was related to the intensity of
immunosuppression. In early CMV viremia, initiation of pre-emptive
gancyclovir treatment should he individualized, and is indicated in recip-
ients with high CMV infection with increasing CMV Ag positive cells,
especially OKT3-treated recipients.
Clinical parameters of donor and early graft function in cadaveric
kidney transplantation. S.J. Kim, K.]. I'ark, I. W. fang, 5K. Park, Di. Han,
and iS. Park, Department of Internal Medicine and General Surgery, Asan
Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
Kidney transplantation from cadaveric donor is increasing in Korea.
Knowledge of donor factors that can influence early graft function should
be an important guideline in determining the suitability of a donor kidney
for transplantation. From June 1989 to August 1995, sixty patients with
end-stage renal disease underwent kidney transplantation from thirty-two
cadaver donors in Asan Medical Center. In this study we reviewed the
clinical characteristics of the cadaver donors, including vital signs, urine
output, serum ereatinine, amounts of vasopressor needed, as well as the
cause of brain death, and we then evaluated the effect of these parameters
on the early post-transplantation graft function (up to 6 months). The data
are given as mean (range). The donors had been admitted fur 40 hours
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(12—177) before nephrectomy. During admission, the lowest systolic blood
pressure was 85 mm Hg (60—130). Platelet count was 112 x 109/liter
(11—270). Hourly urine output was 447 mI/hr (212-937). These parameters
did not significantly affect the early post-transplantation graft function of
our patients. The serum creatinine of donors was 1.5 mg/dl (0.6—3.6) at
peak and decreased to 1.2 mg/dl at the time of nephrectomy. Fifteen of
thirty-two donors had peak serum creatinine higher than 1.4 mg!dl (mean
1.9 mg/dl, range 1.5—3.6 mg/dl) with serum creatinine 1.5 mg/dl (1.5—2.0)
at the time of nephrectomy. The declining tendency and lowest level of
serum creatinine after renal transplantation in patients who received
kidneys from donor with peak serum creatinine higher than 1.4 mg/dl were
not different from those in patients who received normal functioning
kidney. In conclusion, the transient hypotension or acute reversible mild to
moderate deterioration of renal function in cadaver donor does not seem
to have significant effect on the early post-transplantation graft function if
underlying organic renal disease are ruled out by careful history taking and
clinical evaluation.
The influence of donor age and sex on outcome of graft survival rates.
J.H. Kim, CD. Kim, S.J. Kim, MY. Baek, S. Cho, TH. Kwon, YL. Kim, and
D.K Cho, Department of Internal Medicine, Kyungpook University Hospital,
Taegu, Korea. As a result of the improvement of standard surgical
techniques, the emergence of new immunosuppressants and more sensi-
tive tissue typing and crossmatching assays, renal transplant success rates
have risen steadily over the past few years. However, the long-term graft
survival rates, the ultimate goal in renal transplantation, have not in-
creased greatly. Although the loss of allografts with time has been
attributed to continued immunologic activity, it has been suggested that
nonimmunologic factors also may contribute significantly to chronic
allograft failure. Chronic hyperfilteration, particularly in association with
reduction in functioning renal mass, initiates a program of further
glomerular and tubulointerstitial injury that often progress to ESRD.
Donor age, sex, race and cold ischemic time are of particularly interest in
that they bear on the issue of possible nonimmunologic factors. To assess
the influence of donor factors (particularly age and sex) on outcome of
graft survival rates, we retrospectively reviewed the clinical outcome of all
132 consecutive kidney transplants of our hospital. The 132 recipients (85
male/47 female) with a mean age of 32 11.5 (7—62) years received
kidneys from donors (67 male/65 female) with a mean age of 41 14.1
(7—73) years. The 1-year and 3-year graft survival rates for all 132 patients
were 89.4% and 75.8%, respectively. The 1-year and 3-year graft survival
rates for kidneys from males and females were not significantly different
(90.3%188.8% and 80.4%/72.4%, respectively). The 1-year and 3-year
graft survival rates for kidneys from male to female and female to male
transplants were not significantly different (84.6%/87.8%) and 67.7%!
69.3%, respectively). The 1-year and 3-year graft survival rates for kidneys
from younger donors (less than 55 years) and older donors (aged 55 and
greater) were not significantly different (90.2%/86.5% and 79.7%/64.9%,
respectively). The 1-year and 3-year graft survival rates for kidneys from
younger male donors and older female donors were not significantly
different (89.4%/81.4% and 82.3%/56.9%, respectively). The 1-year and
3-year graft survival rates for kidneys from younger male to female and
older female to male transplants were not significantly different (82.6%!
8 1.8% and 68.9%/51.1%, respectively). Although the sample size in this
study limited definite conclusions, our data show that donor age and sex
have an insignificant influence on graft funcion.
Chronic renal dysfunction in renal transplant recipients. K. W. Kahng,
S.M Kim, C.H. Park, CM. Kong, Ji.C. Park, and J.Y. Kwak, Department of
Internal Medicine, Department of 5uiey, College of Medicine, Hanyang
University, Seoul, Korea. Cyclosporine has improved one-year graft survival
in renal transplantation but has not improved after-one-year graft survival.
We studied the rate of the decline of renal function in Korean renal
transplants. This study included 114 patients, 87 males and 27 females,
who received renal transplantation at Hanyang University Hospital and
had stable graft function at one year after rcnal transplantation. We
retrospectively collected their medical records, including blood pressure,
blood urea nitrogen, serum creatinine, complete blood count, biochemis-
try profile, and routine urinalysis, and also tried to make a linear
regression with time and renal function. There was no significant linear
model for blood nitrogen and creatinine, with time, but the average rate of
Increase in creatinine level was 0.50 mg/dl during the 2nd year, 0.413 mg/dl
during the 3rd year, 0.435 mg/dl during the 4th year, and 0.045 mg/dl
during the 5th year after transplantation. The level of hemoglobin was
decreased linearly by 0.821 (g/dl)/year. The degree of proteinuria was
increased linearly by 0.097/year. Ther was no difference in the rate of the
decline of renal function between cyclosporine group and non-cyclospo-
rine group. These results suggest that the hemoglobin level and the degree
of proteinuria change linearly with time. Because the number of patients
who had functioning grafts over 5 years was relatively small in our study,
more long term and more extensive study is needed.
The role of apoptosis in acute kidney transplantation rejection (clini-
copathologic study). J. W. Yoon, 5K. Jo, Y. S. Kim, DR. Cha, YJ. Kwon,
WY Cho, Hi Pyo, H.K Kim, and N.H Won, Department of Internal
Medicine and Pathology, College of Medicine, Korea University, Seoul,
Korea. Apoptosis is an active form of cell death and mediates the deletion
of unwanted cells with little inflammation and tissue injury. The influence
of apoptosis and abnormalities of this process on various renal disease,
including renal inflammation and autoimmunity to renal tissue, are now
being investigated; however, the relationship of rejection after kidney
transplantation (KT) and apoptosis is unknown. To evaluate the degree of
apoptosis and the relationship with the clinical parameters in acute
transplant rejection, in situ end labelling (ISEL) technique was used to
identify the apoptotic process in kidney tissues which was pathologically
confirmed as acute rejection. For quantitation of apoptotic cell number,
200 randomly selected tubular epithelial cells were counted. We defined
the high group if the percentage of apoptotic cells was more than 23%
(N = 7) and the low group if that was less than 25% (N = 5). The
relationships of apoptosis and clinical data, including the degree of HLA
mismatching, underlying disease, mean serum cylosporine level, and peak
creatinine level, were also analyzed. The results were as follows: (1) The
mean age and male:female ratio of the patients were 39.4 (range 19—65)
and 7:5, respectively. (2) Seven of 12 patients showed high staining pattern
and 5 of them were low staining pattern. The mean percentage of
apoptotic cells was 33.75 24.23%. (3) In the high group, there was
significant increase in the mean serum cyclosporine A level and lower
prednisolone dose (cyclosporine A level: 320.96 147.49 ng!ml vs.
176.70 51.33 ng/ml, p = 0.027; prednisolone dose: 2.112 0.706 vs.
3.015 0.831 mg/kg/day, P = 0.074 in the high and low groups,
respectively). (4) There were no significant differences between the 2
groups in age, sex, degree of HLA mismatching, ischemic time, peak BUN
and creatinine concentration. These results suggest that apoptosis may
occur in acute transplant rejection and the apoptotic rate seems to be
related to serum cyclosporine A level, but further studies are required to
reveal the role of apoptosis in kidney transplantation rejection.
Histopathologic findings and its clinical significance in early routine
biopsies of renal allograft recipients. YJ. Chol, C. W. Yang, D.C. Jin, BK.
Kim, B.K Bang, SM Kim, and SI. Shim, Department of Clinical Pathology
and Internal Medicine, Catholic University Medical College, Seoul, Korea. To
know the pathologic findings of early routine biopsies and their clinical
significance, we studied renal biopsies performed 2 weeks after renal
transplantation from 40 renal allograft recipients without any clinical
evidence of rejection. The pathologic diagnosis was made according to the
Banif schema. Early routine biopsies were obtained from 26 recipients
with normal renal function (Scr <1.3mg/dl) and 14 recipients with delayed
renal function (S  1.3 mg!dl and changed <30% for previous 2 weeks).
Of 40 recipients, 11(42%) and 7 (50%) recipients had very mild acute
rejection (VMAR) in stable renal function and delayed renal function,
respectively. During the follow-up period (3—24 months, mean 14.5
months), 6 recipients had developed elevation of serum creatinine (Sr)
more than 30% with a clinical impression of AR. Their routine biopsy
diagnosis was unremarkable in 3 recipients, and VMAR in another 3
recipients. All 3 recipients without additional immunosuppression showed
relatively well-maintained renal function. Glomerular immunoglobulin
and/or complement deposits were found in 36 out of 40 recipients (90%).
None of them (91.7%), except 3 recipients who have developed glomer-
ulonephritis, revealed a clinical evidence of glomerulonephritis during the
follow-up period. Conclusions: (1) The pathologic diagnosis of early
routine biopsy doesn't predict the possible occurrence of allograft rejec-
tion. (2) It may not be necessary for additional immunosuppression,
although the pathologic diagnosis is VMAR. (3) Most glomerular immu-
nologic deposits detected in routine biopsy may he clinically insignificant
nonspecific deposits.
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Nonimmunologic factors influencing long-term outcome of renal trans-
plantation. J. Y. Do, Sf1. Bae, S. W. Lim, J. W. Park, K W. Yoon, B. V. Suh,
and D.C. Park, Departments of Internal Medicine, General Surgery and
Urology, College of Medicine, Yeungnam University, Taegu, Korea. There are
two factors which influence long-term Outcome of renal transplantation.
One is immunologic factor (such as HLA matching) and the other is
nonimmunologic factor (physiological "fit" of the donor kidney to the
recipient). We know the fit of the kidney to the recipient is best measured
by the discharge of serum creatinine. So, we studied the effect of nephron
dosing, donor age and sex on the discharged serum creatinine. One
hundred fourteen renal transplanted patients in our hospital within 3 years
were included (rejection episodes during initial hospitalization were not
included). We statistically analyzed the correlation between the dis-
charged serum creatinine and several factor. (indices representing relative
kidney size, donor age, sex, first urine volume and renal scan). The results
were as follows: (1) The indices representing nephron dosing were
significantly correlated with the discharged serum creatinine (KWIR.BSA;
r =
—0.30, KW/R.BW; r = —0.35, KW/R.BMI; r = —0.41, D.BSAIR.BSA;
r =
—0.47, D.BW/R.BW; r = —0.44. Abbreviations are: KW, kidney
weight; R, recipient; D, donor; BSA, body surface area; BMI, body mass
index; BW, body weight). (2) Male donor kidneys transplanted into female
recipients had significantly tower discharged serum creatinine than female
donors into male recipients (0.89 vs. 1.22 mg%, P < 0.05). (3) The age of
the donor had a significant effect on the discharged serum creatinine (r =
0.28). In conclusion, nephron dosing, donor age, and sex were long-term
nonimmunologic prognostic factors, but further study for the correct
method of measuring for kidney size is needed.
Clinical significance of isolated pyuria after renal transplantation. MS.
Park, YS. Park, D.S. Han, J.H. Sohn, MJ. Ahn, H.J. Kim, Department of
Internal Medicine, Hanyang University Kuri Hospita4 Kuri, Korea. The
isolated pyuria (IP) found late after perioperative period in 41 renal
transplant recipients has been evaluated for its incidence, predisposing
factors, and the clinical significance including its possible evolution of
urinary tract infection (UTI) during a 2 year follow-up average. IP
occurred 103 times in total and ranged from one to 10 episodes in
individual recipients averaged 2.5 0.4 (± SE) per recipient. Beyond 2
months after renal transplantation the incidence of IP decreased progres-
sively from 42 to 0%, but none of the recipients remained free of IP
throughout the period of observation. Chronic pyelonephritis in underly-
ing renal diseases was the leading cause for the incidence of IP per
recipient (4.0), followed by diabetes (2.7), chronic glomerulonephritis(2.5), unknown (2.4), and hypertension (2.0). Incidence in females was
more than twice that in male (4.3 vs. 2.1). The kinds of medications
including furosemide and antihypertensives did not affect its incidence.
None of 103 episodes of IP was associated with symptoms of upper or
lower UTI. Furthermore, the subsequent urine cultures for ordinary
bacteria and acid fast bacilli (AFB), and smears for AFB or eosinophils
were all negative. Mean serum creatinine averaged 1.5 mgldl in recipients
(N = 9) with no IP and 1.4 mg/dl in those (N = 7) with more than 5
episodes of IP. Our results showed that the frequent episodes of IP after
renal transplantation were associated with female recipients and chronic
pyelonephritis among original renal diseases. Fortunately, its occurrence
was associated neither with graft dysfunction nor with UTI, suggesting
relatively benign nature.
Hypertension after kidney transplantation. J. Suk, YK. Seong, SB.
Park, H. C. Kim, Department of Internal Medicine, Keimyung University,
School of Medicine, Taegu, Korea. Hypertension is an important risk factor
for cardiovascular morbidity of renal transplant recipients. There arc
multiple mechanisms for the development of transplant hypertension. We
reviewed the records of 3119 renal transplant patients (male:female =
23 1:88, mean age 32.9 10.4) who had a functioning graft kidney for at
least 6 months. The patients were divided into two groups: hypertensives
(N = 229) and normotensives (N 90). We evaluated the causes of
persistant hypertension in 229 patients (72%) and of newly developed
hypertension in previously normotensive patients. The incidence of hyper-
tension was decreased 68%, 65% and 61% at 1, 3 and 5 years after
transplantation. The numbers of antihypertensive medication at the time
of operation was 1.35 1.09, which decreased significantly to 0.98 0.76
at 12 months (P < 0.05). Body weights significantly increased in the
hypertensive group in comparison with normotcnsive group (P < 0.05).
However, the serum creatinine level was not significantly different in both
groups. Causes of newly developed or aggravated hypertension were:
rejection or recurrent renal disease in 52 patients (49%), immunosuppres-
sive agents in 31(29%), renal artery stenosis in 2 (2%) and unknown in 21
(20%) patients. In our study, the 5-year graft survival was not significantly
different between the hypertensive and normotensive groups (61% vs.
64%). We conclude that a gradual reduction in the incidence and severity
of hypertension is potentially beneficial for kidney transplantation. Rejec-
tion and recurrent renal disease are major causes of post-transplant
hypertension. Future study is needed to elucidate the association between
hypertension and renal graft survival.
Post-renal transplant diabetes mellitus—A retrospective study. S.P.
Hong, T JV. Lee, C. G. ihm, and M.J. Kim, Department of Internal Medicine,
College of Medicine, Kyung Hee University, Seoul, Korea. To investigate the
prevalence and predisposing factors for post-renal transplant diabetes
mellitus (PTDM) in Korea, the records of all renal allograft recipients
from 1985 through 1994 were reviewed. One hundred seventy-nine
nondiabetic recipients, whose allografts functioned longer than 6 months,
were analyzed for the development of PTDM. Twenty-two (12.3%)
patients developed diabetes mellitus one week to 7 months after trans-
plantation; sixteen of whom were diagnosed within the first 2 months of
transplantation. Post-transplant diabetic patients were older (41 8.5 vs.
34.8 10.8 P = 0.01). The prevalence of PTDM was significantly higher
in patients who received grafts from unrelated donors (P = 0.02). The
mean fasting glucose level was higher than that of nondiabetic group, but
both of which were within the normal range (103.2 16.8 vs. 95.4 12.3,P = 0.01). We reviewed HLA phenotypes in 148 renal transplant
recipients. Among HLA-A, -B, -C, and -DR antigens, HLA-Aw33, -Bw58,
-DR7, and -DQw2 were higher in PTDM group, compared to the
non-diabetic group. Family history of diabetes mellitus, the prevalence of
post-transplant hypertension, the male to female ratio, type of immune
suppression, and 5-year graft survival rate were similar in both groups. To
identify predisposing factors 44 nondiabetic patients matched for age, sex,
time of transplant were used as case controls. Comparing PTDM and case
controls, there were no differences in cumulative steroid or cyclosporine
doses, weight gain after transplant, and graft function at the onset of
diabetes. Our data show that the incidence of PTDM is 12.3% and most
of them develop within the first 2 months of transplantation. The risk of
PTDM is higher in older patients and those with unrelated donor, higher
fasting glucose levels, and those with HLA-Aw33, -Bw58, -DR7, -DQw2
antigens. It appears to be independent of the amount of prednisone and/or
cyclosporine employed.
Development of the differential diagnostic method using recombinant
nucleocapsid proteins of Hantavirus isolated from HFRS patients in
Korea.J.H. Park, KH. Oh, H.J. Yun, C.Ahn, J.S. Han, S. Kim, J.S. Lee, IS.
Kim. Department of Internal Medicine, Microbiology. The current serologic
method for the diagnosis of Hemorrhagic fever with renal syndrome
(HFRS) utilizes the virus itself as diagnostic antigen, which is risky for its
high virulence and bears some difficulty of standardizing the amount of
antigen. In our research, we tried to develop a new diagnostic method
using recombinant nucleocapsid DNA products of Hantaan virus and
Seoul virus. Vero-E6 cell infected with Hantaan virus and Seoul virus was
the antigen for indirect immunofluorescence (IF) antibody method. The
viral RNAs were purified from the infected cells and went through
polymerase chain reaction (PCR) with a primer located on the S segment.
Then, the purified DNA was transfected into E. coli with pIH82 I plasm Id
for producing the S segment. Enzyme: linked Immunoabsorbent assay
(ELISA) and passive hemagglutination (PHA) tests using the S-segment
recombinant protein as the diagnostic antigen were implemented for the
positive and negative control serum. The PCR products for the Hantaan
virus and Seoul virus RNA were the S segment DNA of 1.3 kb. This DNA
sequence was linked to the pIH82l vector and transfected into E. coli, and
finally we produced nueleocapsid antigens of 89.5 kDa for each virus. We
tested the sensitivity and specificity of of ELISA and PHA method using
60 positive serum samples and 48 negative serum samples. The positive
criteria for ELISA were the absorption of more than 0.04 and 0.12 for
Flantaan virus 1gM and IgG antibody and 0.04 and 0.09 for Seoul virus
1gM and IgG antibody. The sensitivity and specificity of 1gM ELISA for
Hantaan virus were 93.3% and 95.8% and those for IgG ELISA were
91.7% and 95.8%, respectively. The sensitivity and specificity of 1gM
ELISA for Seoul virus were 90% and 95.8% and those for IgG ELISA
were 98.3% and 93.8%, respectively, in the P1-IA test, 0.5 ml suspension of
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2.5%-diluted sheep RBC was sensitized with 60 jg of nucleocapsid
antigen by 0.0002% tannic aeid, and positive criteria was a titer higher
than 1:320. Our P1-IA test with Hantaan virus recombinant nucleocapsid
antigen showed the sensitivity and specificity of 100%. Those for the Seoul
virus were also 100%. Positive control serum proved positive for both
Hantaan virus and Seoul virus recombinant nucleocapsid antigens. In
conclusion, we developed ELISA and PHA tests using recombinant S
segment nucleocapsid proteins for the diagnosis of HFRS. The methods
are expected to be useful for the diagnosis of Hantavirus infection because
they are easy and readily standardizable.
A study on the genetic diversity of Hantavirus isolated from HFRS
patients in Korea. K.H. Oh, YK. Oh, Hf. Yun, C. Ahn, J.S. Han, S. Kim,
J.S. Lee, and IS. Kim, Department of Internal Medicine, Microbiology.
Background: Hantavirus research so far has been mainly focused on the
virus isolated from rodent hosts. It bears some possibility that there exists
some discrepancy from the actual virus isolated from Korean Hemor-
rhagic Fever (KHF) patients. In our study, on the basis of Hantavirus
isolated from KHF patients, we made an analysis of some base sequences
from their M segment and compared them with those of Hantaan virus,
Seoul virus, Puumala virus and Prospect Hill virus. Patients and Methods:
A total of 13 samples of Hantavirus or its viral RNA isolated from KHF
patients were diagnosed clinically and by indirect immunofluorescence
(IF) method from 1990 to 1992 were included in our study. Hantavirus
RNAs from those samples were transcribed into eDNA by common
Hantavirus primer and reverse transcriptase and were amplified by
polymerase chain reaction (PCR). The amplified DNA sequences were
then analyzed by direct sequencing method. Results: The ten samples
which proved positive for Hantaan virus infection by Panel Reactive
Neutralization Test (PRNT) had a base sequence homology of about 90%
and amino acid homology of 80% with Hantaan virus Strain 76-118. Two
samples which proved positive for Hantaan virus infection by indirect IF
showed base sequence homology of 93.7% and 90.3% with Hantaan virus
strain 76-118 and amino acid sequence homology of 94.7% and 86.7%.
One sample which proved positive for Seoul virus infection by PRNT
showed base sequence homology of 63.0% and 83.7% with Hantaan virus
strain 76-118 and Seoul virus B-I strain and amino acid sequence
homology of 66.3% and 75.3%. Among the 13 samples, the frequency of
biased hypermutation were between 23.1 and 86.7% (mean SD: 57.7
21.3%). Phylogenetic analysis by Clustal V program and Mega program
enabled the classification into three viral groups. The standard strain
group includes HANM and LEEM and 21 other samples. SVO7,
HANG1G2 and SRVAGSM make another group. HANG1G2 and
SRVAGSM had the sequence homology of 97.5% between them. SVO7
had an equal homology (81.4%) to each of HANG1G2 and SRVAGSM.
Conclusion: We made an analysis of 13 viral strains isolated from KHF
patients. We found considerable genetic diversity among the strains and
they were classified through phylogenetic analysis into three groups.
The role of apoptosis in acute tubulointerstitial nephritis. S.K. Jo, J. W.
Yoon, YS. Kim, D.R. Cha, YJ. Kwon, WY Cho, H.J. Fyo, H.K Kim, and
N.H. Won, Department od Internal Medicine and Pathology, College of
Medicine, Korea University, Seoul, Korea. Apoptosis is a form of active cell
death, frequently observed in various physiologic and pathologic statuses,
controlled by extrinsic and intrinsic factors, and has characteristic features
different from those of necrosis. Although abnormalities in this process
are known to induce developmental renal disease such as polycystic kidney
disease and many other autoimnsune diseases, there are few reports about
apoptosis in acute tubulointerstitial nephritis (ATIN). To investigate the
role of apoptosis in ATTN and its relationship with clinical parameters, we
analyzed the renal tissues of the 13 patients who were histologically
confirmed as ATTN and compared the various clinical data. For identifi-
cation of apoptosis, we used in situ end-labelling (ISEL) technique which
is considered as the most sensitive method for detection of apoptosis. Two
hundred randomly selected tubular epithelial cells were counted for
quantitation of apoptosis, and we defined the degree of apoptosis as high
grade if the percentage of apoptotic cells was more than 25%, and low
grade if the percentage of apoptotic cells was less than 25%. The results
were as follows: (1) The male to female ratio was 6:7 and their mean age
was 43.5 years. (2) Seven of 13 (54%) patients were caused by drugs, 2
(15%) were infection and 4 (31%) were unknown causes. (3) Six patients
(46%) showed otiguria and the mean duration of oliguria was 9.8 days and
the mean of peak ereatinine concentration was 7.57 mg/dl. (4) Five
patients (38%) were treated with hemodialysis and four patients (31%)
were treated with corticosteroids. (5) Three of 13 patients showed a high
staining pattern, 10 of them were low staining pattern, and the mean
percentage of apoptotic cells was 14.5%. (6) In the high group, there was
a significant increase in female patients and a decrease in duration of
oliguria (P < 0.05); and there were no significant differences between the
2 groups in the degree of proteinuria, steroid administration, peak serum
creatinine concentration, and creatinine clearance. From these results,
apoptosis seems to occur in acute tubulointerstitial nephritis and the
degree of apoptosis is related with oliguric time, but further studies are
needed to reveal the role of apoptosis in ATTN.
Effects of glomerular endothelial cell transfection with antisense (AS)
procollagen (PC) al(IV) on type IV collagen synthesis and endothelial
cell proliferation. DR. Cha, YS. Kim, W. Y. Cho, and H.K. Kim, Depart-
ment of Internal Medicine, College of Medicine, Korea University, Seoul,
Korea. Collagen type IV is known as a major component of extracellular
matrix in glomerular mesangium. Collagen plays an important role in the
pathogenesis of glomerulosclerosis and regulates differentiation and pro-
liferation of intrinsic glomerular cells. To investigate the role of type IV
collagen in the glomerulosclerosis, we used antisense RNA directed
against a major portion of the PC csl(IV) coding sequence to inhibit PC
csl(IV) mRNA and ultimately collagen production and cell proliferation.
A mammalian expression vector pMAM neo-blue was used for construc-
tion of two recombinant plasmids in the antiscnse and sense orientations.
Glomerular endothelial cells were transfected at passage 16 by calcium
phosphate precipitation, and S and AS clones selected by growth in G418
antibiotics. Endothelial cells were stained with polyclonal antibody to type
IV collagen, and 3H-thymidine incorporation rates were quantitated after
stimulation with FCS. The results were as follows: (1) Three of 5 AS
clones revealed a marked decrease in collagen type IV production. (2)
Endothelial cell proliferation was significantly inhibited after stimulation
with 40% FCS in AS clones compared to S and P clones. (3) Tritiated
thymidine incorporation rate was markedly decreased in the AS clones.
(4) The effect of AS clones in the inhibition of the proliferation of
endothelial cells was abrogated by exogenous administration of type IV
collagen. These results mean that collagen type IV plays an important role
in the cell proliferation of glomerular endothelial cells, and these in vitro
data suggest the possibility of gene therapy utilizing antisense type IV
collagen in the prevention of renal disease progression.
Partial cloning of rat glomerular basement membrane (GMB) heparan
sulfate proteoglycan (HSPG), perlecan. C. W. Ko and B.S. Kasinath,
Department of Pediatrics, School of Medicine, Kyungpook National Univer-
sity, Taegu, South Korea, and Division of Nephrology, Department of
Medicine, The University of Texas Health Science Center at San Antonio,
Texas, USA. Although full length eDNA sequences of murine and human
basement membrane HSPG are known, rat basement membrane HSPG
has not been cloned. Oligonucleotide primers were synthesized from the
published sequences of domain-I of mouse and human basement mem-
brane HSPG, perlecan, where the homology was 99%. The primers were
employed in RT-PCR using polyA+ RNA from rat glomerular epithelial
cells (GEC) in culture to obtain a 497 bp product, rat perlecan domain-I
(RPD-I). RPD-l was sequenced by dideoxy chain termination method
using either the M-l3 primers or the perlecan domain-I specific primers.
The deduced amino acid sequence of the rat product showed 85% and
88% homology to the published sequences of domain-I, the three sites for
heparan sulfate glycosaminoglyean attachment with the consensus se-
quence SGD and the sequence NFT for N-linked oligosneeharide attach-
ment are fully conserved, similar to mouse and human species. By
Northern analysis, employing total and polyA+ RNA of rat GEC, RPD-I
detected a single large (--12 kb) transcript, similar in size to rat glurnerular
perlecan reported previously. Our data demonstrate that GBM HSPG
synthesized by rat GEC shares similarity with rnurine and human perlecan
basement membrane HSPG.
Inhibition of calcium-induced mitochondrial swelling in kidney of acute
cyclosporine A nephrotoxicity rat. S.A. Voon, C. W Yang, BK. Bang, YJ.
Cho,, and f. Kim, Department of Internal Medicine, Clinical Pathology and
Anatomy, Catholic University Medical College, Seoul, Korea. Mitochondria
possess an elaborate system for facilitating the transport of calcium ion
across its inner membrane. It has been reported that calcium increase
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inner membrane permeability and this phenomenon (permeability transi-
tion) is characterized by mitochondrial swelling. Recently, cyclosporine A(CsA) was identified as the first highly potent transition inhibitor; how-
ever, its biologic role was not determined. Therefore, we performed this
study to evaluate the association of inhibition on calcium-induced mito-
chondrial swelling by CsA with the acute CsA nephrotoxicity. The results
were as follows: (1.) in vitro, mitochondrial swelling of rat kidney was
increased with time progress and calcium concentration (P = 0.0001) and
this effect was maximal at 30 rM of calcium. (2.) CsA inhibited calcium-
induced mitochondrial swelling in vitro, and this effect was dose-depen-
dent (P = 0.0001). (3.) In acute CsA nephrotoxicity kidney, calcium-
induced mitochondrial swelling was inhibited with control group, and this
effect was more potent in higher dose CsA-treated group (P = 0.0001).
(4.) EM finding of acute CsA nephrotoxicity kidney showed irregular
shaped giant mitochondria and this finding was more prominent in the
higher dose CsA-treated group. In conclusion, CsA dose dependently
inhibited calcium-induced mitochondrial swelling both in vitro and in vivo,
and this suggested that inhibition of calcium-induced mitochondrial
swelling by CsA was associated with acute CsA nephrotoxicity.
Morphologic effect of calcium channel blocker (verapamil) on cyclo-
sporine A nephrotoxicity. H.K Chang, H.S. Kim, and M.H. Huh, Depart-
ment of Pathology, Kosin University Medical Center, Pusan, Korea. Effect of
calcium channel blocker (CB) on cyclosporine A toxicity (C5A) was
investigated in the male Wister rat in a 4-week experiment at the light and
electron microscopical level. To accomplish the aim of this study, 25-week-
old male Wister rats were divided into 3 experimental groups: (1.) CsA (50
mg/kg/day) alone daily per Os; (2.) CsA (50 mg/kg/day) concomitant
administration of CB verapamil (20 mg/kg/day) daily per os; (3.) CsA (50
mg/kg/day) concomitant administration of verapamil (10 mg/kg/day) daily
per Os. Morphologically, CsA ncphrotoxicity was characterized by the
following features: (I) tubular inclusion bodies corresponding to predom-
inate polymorphous autolysosomes and a small number of markedly
enlarged mitochondria; (2) tubular vacuolization due to dilation of the
rough and smooth endoplasmic reticulum; (3) tubular mierocaleification.
These morphologic features were limited to the proximal tubules. Simul-
taneous administration of CB verapamil with CsA reduced CsA-induced
morphologic damage of the proximal tubules of the kidney being charac-
terized by a significant reduction of tubular inclusion bodies irrespective of
the dosage of the verapamil. These results morphologically support the
idea that calcium channel blocker, verapamil, has a ameliorating effect on
CsA nephrotoxieity.
Inhibition of cellular proliferation by cyclosporine A during compen-
satory renal growth in uninephrectomized rats: Flow cytometric analysis.
C.W Yang, SN. Yoon, YS. Kim, S.Y Kim, E.J. Choi, and B.K Bang,
Catholic University Medical College, Seoul, Korea. Cell cycle analysis using
flow cytometer (FCMX) was performed to evaluate the influence of
cyclosporine A (C5A) on cellular proliferation during compensatory renal
growth (CRG) in uninephrectomized rats. Sprague-Dawley rats weighing
250—300 grams were divided into CsA and vehicle groups. They were
pair-fed during the study period. CsA (50 mg/kg/day) was administered
subcutaneously just after unilateral nephrectomy (Ux) and continued for
7 days. Animals were sacrificed 0, 12, 24, 48, 72, 120 and 168 hour after Ux,
and the percent change of contralateral kidney of S (DNA synthesis) and
G2M (DNA replication) phases were analysed. At each point, 6 kidneys
were utilized. Following Ux, cortical cells entering S and G,M phases
showed significant differences between two groups (P = 0.001, respective-
ly). CsA group showed significant decrease in S (at 12, 72 and 120 hours)
and (i,M phases (at 24, 72 and 120 hours) compared to the vehicle group
(P < 0.05, respectively). In contrast, medullary cells entering S and G2M
phases showed no significant differences between two groups (P 1.000,
respectively). S and G2M phases in each point showed no significant
differences between two groups during the entire experimental period. In
conclusion, CsA suppresses cellular proliferation during CR0, and main
site of action for CsA is the cortical cells.
Protein C and S in patients with chronic renal failure and various
pathologic types of nephrotic syndrome. S.H. Park, Cli. Park, J.K Seo,
S. W. Kang, K.H. C'hoi, S.K Ha, H. Y Lee, D.S. Han, and KS. Song, The
Institute of Kidney Disease Yonsei University, Department of Internal Medi-
cine and Department of Clinical Pathology, College of Medicine, Yonsei
University, Seoul, Korea. In patients with various renal diseases, a complex
association between bleeding tendency and hypercoagulability have been
described. The reason for this is not clear and even conflicting, but some
of the consistent findings as elevated factor V and VIII and the impaired,
fibrinolysis could indicate a central role for protein C (PC), protein S (PS)
and antithrombin-III (AT-Ill) in the pathogenesis of thrombotic tendency
in renal diseases. Therefore, we undertook this study to evaluate the role
of PC, PS and AT-Ill in patients with chronic renal failure (CRF) and
various pathologic types of nephrotic syndrome (NS). Plasma PC activity,
AT-Ill activity and free PS concentration were determined in three
groups: 36 adults in the control group, 48 patients with NS (MCNS 15,
FSGS 8, MGN 8, MPGN 5, IgA 4, and DM nephropathy 8), and 33
patients with CRF. Plasma PC activity in NS group (130.6 37.8%) was
significantly higher than control group (96.2 9.8%, P < 0.05) and the
CRF group (79.2 17.5%, P < 0.05), and PC activity in CRF group was
significantly lower than controls (P < 0.05). Plasma AT-Ill activity in the
NS group (85.7 22.5%) was significantly lower than control group
(95.5 10.4%, P < 0.05). However, there was no significant difference in
the plasma-free PS concentration between three groups. There was a
significant inverse correlation between plasma PC activity with serum
creatinine and creatinine clearance (P < 0.001). In patients with MCNS
among the NS group, plasma PC activity was significantly higher than
patients with other pathologic types of NS (P < 0.05). In conclusion, these
observations suggest that low plasma levels of AT-Ill activity may be the
cause of the thromboembolic tendency in patients with NS, and increased
plasma PC activity in nephrotic patients may afford some protection
against the thrombotic diathesis associated with AT-Ill deficiency. As
renal function declines, plasma PC activity would decrease progressively,
and this may explain the high thrombotie tendency in patients with uremia.
As we previously reported in patients with MCNS, plasma PC activity was
significantly higher than in patients with other pathologic types of NS.
Further studies would be needed to clarify its clinical significance.
Effect of 1-a(OH)D3 on steroid-induced osteoporosis in frequently
relapsing childhood minimal change nephrotic syndrome. H.S. Yoon, B.S.
Cho, C.G. Jhm, S.H. Cha, and D.Y Kim, Department of Pediatrics and
internal Medicine, College of Medicine, Kyung Hee University, Seoul, Korea.
Steroid induced osteoporosis (SlO) is a serious problem in frequently
relapsing nephrotic syndrome especially in growing children. To evaluate
whether 1-cs(OH)D3 (IL Sung Pharma. Co.) is effective in preventing Sb,
we gave 1-cr(OH)D3 for 1 year in 40 patients with frequently relapsing
nephrotic syndrome who were taking long-term prednisolone therapy(mean duration 50.12 29.40 months). We checked the following markers
before and after giving 1-cs(OH)D1: bone mineral density (BMD) using
dual energy X-ray absorptiometry (DEXA) at the 2nd to 4th lumbar spine,
serum calcium, serum phosphorus, parathyroid hormone (PTH), osteo-
calcin and urine pyridinoline (U-PYD). Biochemical data, endoerinolog-
ical data and BMD, before and after 1-a(OH)D3 treatment are as follows:
Pretreatment Posttreatment
Calcium mg/dl
Phosphorus mgldl
PTH pmol/liter
Osteocalcin ng/ml
U-PYD nmol/mmol Cr.
BMD g/cm2 (P < 0.05)
Data are means so.
In conclusion, lumbar spine BMD is the best marker for SlO than other
markers such as PTH, osteocalein and U-PYD. l-a(OH)D3 appears to he
effective in treating SIO especially in patients with frequently relapsing
nephrotic syndrome who are taking long-term prednisolonc therapy.
Clinical characteristics of prerenal azotemia in the elderly. YO. Kim,
C.W. Yang, D.C. fin, S.f. Ahn, S.Y Kim, E.J. Cho4 YS. Chang, and BK.
Bang, Internal Medicine, Catholic University Medical College, Seoul, Korea.
Elderly patients are susceptable to prerenal azotemia because of inade-
quate fluid intake and decreased renal functional reserve. however, the
clinical characteristics of prerenal azotemia is not clearly reported. We
retrospectively reviewed 20 patients over the age of sixty who were
admitted due to prerenal azotemia from January 1991 to December 1995.
Seven men and thirteen women (age 73.6 8.7, range 60—89) were
9.13 1.25
4.23 1.14
51.18 58.39
7.75 3.34
417.26 250.9
0.71 0.016
9.01 0.08
4.13 0.08
43.37 37.09
9.38 5.06
462.59 265.15
0.73 0.015
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included in this study. Mean body mass index was 20.9 2.3. The major
causes of prerenal azotemia were poor oral intake (12 cases, 60%) and
congestive heart failure (5 cases, 25%). In addition, diarrhea (1 case, 5%),
diuretics (1 case, 5%), and cardiogenic shock due to acute myocardial
infarction (1 case, 5%) were minor causes. Six of twenty patients (30%)
had fever over 37.5°C at admission. The mean arterial pressure below 90
mm Hg was observed 5 out 20 (25%), tachycardia over 100/mm 5 (25%),
tachypnea over 25/mm 6 (30%). Anemia (hematocrit < 30) was observed
6 out of 20 (30%) and hemoconcentration (hematocrit > 50%) was none.
The serum BUN and Cr levels were 90.1 36.1 mg/dl and 2.92 0.85
mg/dl, respectively. BUN/Cr ratio was 32.07 12.73. The plasma sodium
and potassium levels were 152.75 11.14 mEq/liter and 5.23 1.15 mEq/l
respectively. The serum albumin and total calcium levels were 3.1 0.4
g/dl and 8.0 0.6 mg/dl. Twenty-four hour urinary creatinine excretion
was 18.6 9.6 mg/kg. The duration of oliguric phase was 33.9 25.2
hours (range 5—96) and that of complete recovery of renal function (serum
Cr < 1.5 mg/dl) was 8.5 3.3 days (range 3—15). Prerenal azotemia in the
elderly is mainly related to poor oral intake and poor nutrition. Duration
of oliguric phase is short, but that of complete recovery of renal function
is longer than expected.
Acute renal failure (ARF) with the collapse of the Sam-Poong Depart-
ment in Seoul. S.!. Kim, YO. Kim, YS. Shin, C.W. Park, N.S. Yoon, C.W.
Yang, YS. Chang, and B.K. Bang, Internal Medicine, Catholic University
Medical College, Seoul, Korea. With the Sam-Poong Department's collapse
in 1995, five patients with ARF were transferred to our Hospital. Case 1
(a 21-year-old man) had been closed for 11 days in the collapsed building.
He had been able to drink rainwater. He showed mild dehydration at
admission. Case 2 (an 18-year-old woman) and case 3 (a 19-year-old
woman) had been closed for 13 and 17 days without oral fluid intake. They
showed severe dehydration and hypotension, and ARF with hypernatre-
mia at admission. Case 4 (a 39-year-old man) and case 5 (a 21-year-old
woman) had been crushed by concrete materials. Case 4 was rescued 24
hours later, and case 5 immediately. They were diagnosed with ARF due
to traumatic rhabdomyolysis. Cases 1, 2 and 3 improved immediately after
fluid therapy. Acute tubular necrosis (ATN) was not observed. In spite of
intensive prophylaxis of ATN, cases 4 and 5 progressed to ATN. Case 4
required intensive hemodialysis for 18 days and eventually recovered.
Case 5 expired due to sepsis on the 23th hospital day, in spite of intensive
hemodialysis, antibiotics, and fluid therapy. In conclusion, acute renal
failure due to starvation for a long duration (at least 17 days) completely
recovered with adequate fluid therapy. However, the prophylaxis of ARF
due to crush syndrome will be necessary.
Case 1 Case 2 Case 3 Case 4 Case 5
Preventive elfects of allopurinol on the ischemia-reperfusion renal
injury in rats. S.J. Lee, and YS. Hong, Department of Pediatrics, Biochem
ist,y, College of Medicine, Ewha Womans University, Seoul, Korea. Oxygen
free radicals have been reported to he the critical cellular mediators of
experimental ischcmia-rcperfusion renal injury. We examined the protec-
tive effect of allopurinol (an xanthine oxidase inhibitor and oxygen free
radical scavenger) on the damage by reperfusion in the ischcmic rat
kidney. For renal ischemia, the Spraguc-Dawley rats (weight 70—80 g)
were placed in a scaled 5000 ml jar with 8% 02—92% N2 gas mixture for
3.75 hours to the point of gasping, the first sign of asphyxia. Before
returning to their metabolic cage, rats were treated with a single s.c.
injection of allopurinol 135 mg/kg or an equal volume of saline. Renal
function, renal microsomal malondealdehyde (MDA), and renal phospho-
lipase A2 activity were measured at baseline, post-ischemia, and post-
reperfusion at 15 mm, 24 hr and 48 hr. Reperfusion after renal isehemia
in control rats resulted in a significant increase of lipid peroxidation
without significant change of renal function at post-reperfusion 15 minutes
compared to post-ischemia values (renal MDA, 8.5 1.92 vs. 11.4 1.71
nmol/mg protein, P < 0.05; phospholipase A2 activity, 0.67 0.04 vs.
0.82 0.05pmol/mg protein/mm, P < 0.05). Allopurinol treatment before
reperfusion prevented the reperfusion induced an increase of lipid per-
oxidation compared to saline-treated control rats (renal MDA, 11.4 1.71
vs. 8.5 0.65 nmol/mg protein, P < 0.01; PLA2 activity: 0.82 0.05 vs.
0.52 0.13pmol/mg protein/mm, P < 0.01). Allopurinol treatment before
reperfusion of ischemic rats reduced reperfusion-induced lipid peroxida-
tion.
Clinical characteristics of acute pyelonephritis associated with acute
renal failure as an initial presentation. SW. Nam, S.C. Song, S.C. Yang,
[H. Lee, S.K Kim, J.H. Lee, H.J. Kim, Department of Internal Medicine,
Hanyang university Kuri hospital, Kuri, Korea. Acute renal failure (ARF)
due to acute pyelonephritis (APN) in patients in the absence of obstruc-
tive uropathy, diabetes, or chronic renal failure was rarely reported (12
cases in the last 25 years in Clin Infect Dis, 14: 243—6, 1992 by SR Jones).
However, we observed 6 patients who were diagnosed with APN associ-
ated with ARF as an initial manifestation on admission in the past 6
months. The analysis of clinical features of these 6 patients (APN+)
compared to 7 patients of APN without ARF (APN—) revealed following
data. All were female in both groups. The mean age was 33 1.7 years in
APN+ and 48 6 years in APN—, respectively (P, NS). All in both APN—
and APN+ were caused byE. coli. However, none in both groups except
1 in APN— had bacteremia. The previous history of UT! was present in 5
in APN—, but none in APN+. Duration of clinical symptoms before
admission (8.4 0.5 vs. 4.4 1.0 days, P < 0.05) and admission days
(24.2 1.8 vs. 11.1 1.5 days, P = 0.000) were significantly longer in
APN+. On admission, BUN and serum creatinine was 45 2.7 mg/dl and
3.5 0.2 mg/dl in APN+, respectively. No one in APN+ required dialysis,
and subsequently all recovered renal function with prompt antibiotic
therapy, resulting in no significant difference compared to that of APN—
on discharge (serum creatinine, 1.0 0.1 vs. 0.9 0.1 mgldl). No
differences in leukocytosis and serum electrolyte levels on admission were
present. However, significant anemia was noted in APN+ (hemoglobin,
9.0 0.7 vs. 11.9 0.2 gldl). The days of fever and leukocytosis before
disappearance were not different in both groups, but those of flank pain
(12.8 1.5 vs. 5.7 0.7 days, P = 0.001) and pyuria (16 1.9 vs. 6.4
0.6 days, P 0.000) significantly longer in APN+. Upon ultrasonography,
all in the APN+ group showed enhanced echogenicity, but I in APN—.
Upon analysis of these data, we conclude that ARF associated with APN
as an initial manifestation was accompanied by several distinct clinical
characteristics, which could be used for the early recognition of its unusual
occurrence and subsequent appropriate management, including antibiot-
ics leading to a favorable outcome.
Na mEq/liter
K mEq/liter
Cl mEq/liter
BUN mg/dl
Cr mg/dl
LDH U/liter
CPK U/liter
FID
133 167 163 125
6.3 4.3 4.1 4.7
108 148 113 101
25.1 134 103 56.5
0.81 2.3 1.82 4.85
— — — 6824
— — — 117794
Results Improve Improve Improve Improve Expire
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6.5 Clinical characteristics and prognostic factors of paraquat poisoning.
115 H. Y Kim, and J.H. Eami, Department of Internal Medicine, College of
26.5 Medicine, Chungbuk National University, Cheongju, Korea. To evaluate the
2.0 clinical characteristics and prognostic factors in paraquat poisoning, we
1550 performed a clinical study in 29 patients with paraquat poisoning, and
1000 measured their initial plasma paraquat concentrations using scanning
— — — + spectrophotometer. (1) The mean age was 37.8 15.8 (15—75) years. 19
were male, and 10 were female patients. (2) Twenty-three cases were
suicide attempts, and 6 cases were accidents. (3) The ingested amount was
less than a mouthful in 2 patients, more than 2 mouthful in 19 patients,
and unknown in 3 patients. Five patients didn't swallow. The ingested
paraquat was 24.5% solution in all cases. (4) Oral ulcer, throat pain and
swallowing difficulty were observed in 22 patients, hypotension in 10
patients, and dyspnea in 4 patients on admission. (5) Liver function test
abnormalities were observed in 16 patients, and renal failure and/or
abnormal urinalysis were observed in 24 patients. (6) Treatments were as
follows: gastric lavage in 25 patients, Fuller's earth in 20 patients,
hemoperfusion in 12 patients, and CAVH in 3 patients. (7) Eleven
patients survived, and 18 patients expired. The causes of death were
circulatory collapse in 3 patients, multi-organ failure in 7 patients, and
pulmonary fibrosis in 5 patients. (8) The plasma concentrations were
distributed from 40 ng,ImI to 300 gIml. The plasma concentration
according to time elapsed definitely differentiated the patient's survival;
however, the ingested amount insisted by patient could not. (9) After 24
hours of poisoning, the patients whose maximal plasma creatinine con-
centration were higher than 4.7 mg/dl expired irrespective of recovery of
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renal failure. In summary, the initial plasma paraquat concentration was
the most important prognostic factor. The ingested amount was not
correlated with plasma paraquat concentration. Maximal plasma creati-
nine concentration after 24 hours of poisoning could predict the death due
to pulmonary fibrosis.
Increased urinary calcium excretion in children with urinary tract
infection caused by Eschesichia coli. H.J. Hoe, S. Y. Kim, C. W. Ko, J.H. Koo,
Department of Pediatrics, School of Medicine, Kyungpook National Univer-
sity. Taegu, South Korea. A prospective study was conducted to evaluate
the relationship between urinary tract infection by E. coli, a non-urease
producing microorganism, and formation of urinary calcium stone in
children. Study patients were composed of 22 children (1 month to 5.3
years old) with UTIs who were admitted to the department of Pediatrics,
Kyungpook National University Hospital from April to October 1995, and
a control group consisted of 14 children with minor illness. Spot urine
Ca/Cr ratios were measured before and 1 week after treatment with
appropriate antibiotics, and 24 hour urine was collected in some study
patients and controls for 24-hour urinary calcium excretion. The following
results were obtained: UTI group, spot urine Ca/Cr ratio (mg/mg) before
treatment, 0.33 0.25, was significantly higher than values of I week after
treatment and controls, 0.13 0.12, 0.13 0.06, respectively (P < 0.05).
The spot urine calcium proportion [Ca/(Ca + Cr), mg/mg] before
treatment in the UTI group was 0.23 0.13, which was significantly higher
compared to those of after treatment, 0.10 0.08 and controls, 0.11
0.05 (P < 0.05), and the spot urine creatinine proportion [Cr/(Ca + Cr),
mg/mg] before treatment in UTI group was 0.78 0.13, which was
significantly lower than those of 1 week after treatment, 0.90 0.08, and
controls, 0.89 0.13 (P < 0.05). In summary, UTI by E. coli, a non-urea
splitting microorganism, has been associated with increased urinary
calcium and decreased urinary creatinine excretion. This may be due to
impared tubular calcium resorption, and this may lead to the formation of
calcium-containing urinary stones.
Role of oxidative stress in high glucose-induced transforming growth
factor-Il and fibronectin mRNAS and proteins in mesangial cells. H. Ha,
5.11. Lee, and K.H. Kim, Department of Pharmacology, Yonsei University
College of Medicine, Seoul, Korea. Mesangial cells (MC) cultured in high
glucose (HG) concentration show increased expression of TGF-/3 mRNA
and mRNAs of extracellular matrix proteins, including fibronectin (FN) as
well as proteins. However, the cellular mechanisms underlying this are still
not completely understood. Our previous study demonstrated HG per se
caused oxidative stress in the isolated rat glomeruli. We therefore
examined whether oxidative stress is involved in this HG-induced expres-
sion of TGF-jS and FN in MC. SV-40 transformed murine MC obtained
from ATCC were grown in DMEM containing 5% FBS. MC (80%
confluent) were incubated in DMEM in the presence of different concen-
trations of glucose after arresting the growth using serum-free media. The
levels of lipid peroxide (LPO), an index of oxidative stress, were quanti-
tated by malondialdehyde-thiobarbituric acid adduct formation using
tetraethoxypropane as a standard. Glucose produced dose-dependent
increase LPO in MC. Twenty-five m glucose (HG) significantly increased
the levels of LPO after 48 hours and at the same time TGF-13 and FN
mRNAs and proteins (30 to 50%) estimated by Northern and Western
blot analysis. Osmotic control media containing either L-glucosc or
mannitol did not increase LPO in MC. In addition, 20 mM dimethylthio-
urea, a hydroxyl radical scavenger, effectively inhibited HG-induced LPO,
TGF-J3 and FN mRNAs and proteins in MC. These data suggest that
HG-induced TGF-j3 and FN production in MC arc mediated in part by
oxidative stress associated with HG.
Concurrent expression of platelet-derived growth factor fJ and trans-
forming growth factor-1 mRNA in murine anti-THY-i nephritisl.S. Ha,
H. U'. Park, HI. Cheong, and Y Choi, Department of Pediatrics, Seoul
National University College of Medicine, Seoul City Boramae Hospital,
Seoul, Korea. In anti-Thy-I nephritis induced in rats, augmented expres-
sions of platelet-derived growth factor (PDGF) and transforming
growth factor-/31 (TGF-131) have been reported, and the critical roles of
these factors in the pathogenesis of the disease have been made clear. Yet,
because the two growth factors have been analyzed separately in two
experiments, the exact order of the expressions of the factors is not clear.
This study was performed to elucidate the chronological sequence of
mRNA expression of the two growth factors in one nephritis model.
Anti-Thy-i nephritis was induced in Sprague-Dawley rats by intravenous
injection of rabbit polyclonal anti-thymocyte serum (ATS). Renal cortical
tissues obtained from nephritic rats 1, 4, 7, and 14 days after ATS injection
as well as control rats were subjected to the following studies; immuno-
fluorescent studies for rabbit IgG, light microscopic observations for
changes in glomerular cellularities and extent of mesangial matrix, mea-
surement of quantitative changes in glomerular mRNA for PDGFI3 and
TGF-pi by Northern blot analyses. Induction of nephritis was confirmed
by identification of rabbit IgG deposition on mesangial cells on day 1,
followed by the increase in cellularity and mesangial matrix on day 14. For
PDGF/3, 3 transcripts of different sizes (3.5 kb, 2.6 kb, 1.6 kb) appeared,
and the 2.6 kb transcript was the predominant one with a remarkable
increase (4.8 times of control) on day 7. TGF-j31 mRNA showed a more
striking increase (9.3 times of control) also on the day 7. PDGFI3 2.6
transcript and TGF-/31 mRNA increased concurrently with their peaks on
day 7 in murine anti-Thy-I nephritis, and the change was more marked in
TGF-pl mRNA.
Effects of hydrocortisone on leukocyte adhesion molecule expression.
C.G. Ihm, S.P. Hong, J.K Park, J.H. Ahn, TW. Lee, and M.J. Kim, College
of Medicine, Kyung-Hee University, Seoul, Korea. We preliminarily reported
that mixed leukocyte reaction (MLR) supernatant induces production of
VCAM-1 on human endothelial (EnC) and mesangial cells (MC), perhaps
by mediation of cytokines. Because cytokine release can be inhibited by
glucocorticoids, we investigated effects of hydrocortisone (HC) on their
expression induced by MLR on MC and EnC by using flow cytometry.
Interferon y, interleukin-1, or tumor necrosis factor o stimulated expres-
sion of VCAM-1 or ICAM-1 on MC or EnC by 27—138% after 24 hours
(N = 4, P < 0.05). MLR supernatant enhanced the mean fluorescence of
(by 235—835%) and percent of cells highly expressing ICAM-1 and
VCAM-I (by 202—840%) on MC or EnC (P < 0.001). HC treatment
during MLR inhibited MLR-induced up-regulation of VCAM-1 and
ICAM-1 by 24—49% on both cells (P < 0.005). However, HC had no
inhibitory effect when added with MLR supernatant to both cells. Cyclo-
sporine A treatment during MLR caused a modest decrease in MLR-
induced up-regulation of VCAM-i on EnC, without effect on that of
ICAM-i. In conclusion, alloreactive lymphocytes and monocytes up-
regulate expression of VCAM-1 and ICAM-l on EnC and MC by
mediation of cytokines. This facilitates attachment of leukocytes to renal
cells during inflammatory reaction. HC effectively prevent up-regulation
of VCAM-i and ICAM-1 by inhibiting cytokine release during MLR.
Effects of LDL and oxidized LDL on mesangial cell proliferation and
ICAM-1 expression. T W. Lee, J.K Park, S.P. Hong, J.H. Ahn, W. Park,
C. G. Ihm, and M.J. Kim, Department of Internal Medicine, College of
Medicine, Kyung Hee University, and Inje University, Sanggye Paik Hospital,
Seoul, Korea. As one of the studies for the contribution of hyperlipidemia
to the pathogenesis of glomeruloselerosis, this study was performed to
evaluate the effects of low density lipoprotein (LDL) and oxidized LDL on
mesangial cell proliferation and intercellular adhesion molecule•.l
(ICAM-I) expression. Oxidized-LDL and cell-treated LDL were prepared
from LDL by incubation with copper sulfate and mesangial cells, respec-
tively. They were each co-incubated with human mesangial cells. The
effects of LDL, oxidized-LDL and cell-treated LDL on mesangial cell
proliferation were estimated by measuring the uptake of [3H]-thymidiric
and counting the cell numbers under phase contrast microscopy. The
expression of ICAM-1 on mesangial cells was examined by indirect
immunofluorescence method. LDL increased the uptake of [3Hj-thymi-
dinc by mesangial cells at 10 sg/ml returning to control levels at 50 .rg/ml,
and decreased [3H]-thymidine uptake at 100 g/ml of LDL concentration.
Also, mesangial cell numbers decreased at 100 sg/ml of LDL concentra-
tion. In contrast, oxidized LDL decreased [HI-thymidine uptake starting
at 1 sg/ml, and decreased mesangial cell numbers starting at 10 rg/ml of
oxidized LDL concentration, in a concentration-dependent manner. Cell-
treated LDL above the concentration of 10 jsg/ml caused a concentration-
dependent increase in [3H1-thymidine uptake. LDL at certain concentra-
tions increased mesangial ccli IAM-1 expression. In conclusion, these
results that low concentration of LDL stimulate, and high concentration of
LDL and oxidized LDL inhibit human mesangial cell proliferation, may be
the in vitro evidence of lipid-mediated glomeruloselerotic injury.
Apoptosis in the developing renal corpuscles in the prenatal rat kidney.
S.1I. Lee, B.K. Bang, and J. Kim, Department of Internal Medicine and
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Department of Anatomy, Catholic University Medical College, Seoul, Korea.
The purpose of this study was to establish the role of apoptosis in the
developing renal corpuscles in the prenatal rat kidney. Kidneys from 14-,
16-, 18-, and 20-day-old fetuses of Sprague-Dawley rats were preserved by
immersion or heart perfusion fixation using Baum's fixative for immuno-
histochemistry or 3% glutaraldehyde for electron microscopy. Apoptosis
was identified by in Situ nick end labeling method using ApopTag kit,
Toluidine blue staining on 1 j.m thick plastic sections, and transmission
electron microscopy. In 14-day-old fetal kidneys, apoptotic cells and
apoptotic bodies were found only in the mesenchymal tissue surrounding
the developing nephrons. No cells undergoing apoptosis were found in the
ureteric buds and surrounding mesenchymal tissue cap. In 16-, 18-, and
20-day-old fetal kidneys, apoptotic cells and apoptotic bodies were located
mainly in the distal epithelium of the renal vesicle and in the parietal
epithelium of the renal corpuscles of S-shaped tubule, stages III and IV
nephron. This was associated with transformation from columnar cells of
the distal epithelium of the renal vesicles to squamous cells of parietal
epithelium of mature renal corpuscles, whereas in the mesenchymal tissue
in these ages, there are few apoptotic cells and apoptotic bodies. These
results demonstrate that apoptosis has an important role in transformation
of a columnar epithelium to a squamous epithelium of parietal layer of
renal corpuscle during development.
Efl'ect of calcium channel blocker (verapamil) on apoptosis in cyclo.
sporine nephrotoxicity. JR. Koo, YH. Lee, YS. Kim, YJ. Kwon, AR. Kim,
N.H. Won, and H.K. Kim, Departments of Internal Medicine and Pathology,
College of Medicine, Korea University and Hallym Univerty, Seoul, Korea.
Background: Apoptosis mediates the deletion of "unwanted cells" with
little inflammation. But it is a "double-edged sword" engaged in low grade
tissue injury, and the role of apoptosis in cyclosporine nephrotoxicity is
uncertain. Calcium channel blocker has been widely used to prevent
cyclosporine nephrotoxicity. Considering the major role of calcium in
apoptosis, it is also important to know the effect of calcium channel
blocker (verapamil) on apoptosis. Methods: Thirty Sprague-Dawley rats
were divided into 6 groups as follows: (1) Group C: Cremophor (cyclo-
sporin vehicle) 650 mg/kg/day/subcutaneously (s.c.) for 7 days; (2) Group
S4: cyclosporine 50 mg/kg/day/s.c. for 4 days; (3) Group S7: cyclosporine
50 mg/kg/day/s.c. for 7 days; (4) Group VS4: cyclosporine 50 mg/kg/day/s.c.
and verapamil 0.1 mg/kg/12 hour/s.c. for 4 days; (5) Group VS7: cyclo-
sporine 50 mg/kg/day/s.c. and verapamil 0.1 mg/kg/12 hour/s.c. for 7 days;
(6) Group R: Recovery 4 days after cyclosporine 50 mg/kg/day/s.c. for 7
days. Then the number and pattern of apoptosis in kidney were evaluated
by in situ end-labelling method and hematoxylin-eosin stain. Results: (1)
The systolic blood pressure and serum creatinine concentrations were
increased and creatinine clearance was decreased in S4, S7 and VS4, VS7
groups as compared with C and R groups. Fractional sodium excretion was
all less than 1% without a significant difference between groups. (2) In
hematoxylin-eosin stain, tubular vacuolization was increased in the S4 and
S7 groups and verapamil had no effect on the degree of tubular vaculol-
ization. (3) The number and pattern of apoptosis were as follows: (1)
Tubular cell apoptosis was maximal in S7 group and decreased in R and
VS7 groups. (2) Interstitial cell apoptosis was minimal in the S7 group and
increased in the R group. Verapamil had no effect on interstitial cell
apoptosis. (3) Cortical apoptosis was maximal in the S7 group and
decreased in the R and VS7 groups. (4) Medullary apoptosis was maximal
in the S4 group and maintained in the S7 and R groups. Verapamil had no
effect on medullary apoptosis. (5) The total number of apoptosis was
increased in S4 and S7 groups and decreased in R and VS7 groups. There
were few apoptotic cells in glomeruli and vessels, (4) The number of
tubular cell apoptosis was weakly correlated with systolic blood pressure.
Conclusion: Apoptosis probably has some role in cyclosporine-induced
tubular damage, but in interstitial cells apoptosis was rather inhibited by
cyclosporine, and vcrapamil inhibited apoptosis of cortical tubule. So
inhibition of apoptosis may be a possible preventive mechanism of calcium
channel blocker in cyclosporine nephrotoxicity.
Mesangial cell apoptosis induced by ionizing radiation and cytotoxic
drugs. DR. (ha, YS. Kim, WY Cho, and H.K Kim, Department of Internal
Medicine, College of Medicine, Korea University, Seoul, Korea. Mesangial
cell (MC) proliferation is the main histologic change in various glomerular
diseases, and it is known that MC proliferation is related with clinical
course in the proliferative glomerulonephritis. Apoptosis is now consid-
ered as an important physiologic process in cell biology, and recently many
studies have been investigated in various glomerular diseases. To evaluate
the role of apoptosis on the pharmacologic effects of cytotoxic drugs and
ionizing radiation, we studied their effects on cultured rat MC, whose
apoptotic response to these drugs is unknown. MCs were cultured in
RPMI 1640 medium with 15% FCS, cultured with or without stimuli to
induce apoptosis and were harvested at 24 and 48 hours. Identification of
apoptosis was examined by three different methods: light microscopy,
DNA electrophoresis, and in situ end labelling (ISEL) technique. For
quantitation of the percentage of apoptotic cells, MCs were fixed with
10% formalin and 200 randomly selected cells were examined on each
slide (N = 5). The results were as follows: (1) Dexamethasone induced a
significant increase in apoptotic rate after 24 and 48 hours, 13.5% and
13.2%, respectively. (2) Apoptotic rates were also increased after treat-
ment with cyclophosphamide, 7.8% (24 hours) and 13% (48 hours). (3)
Melphalan and cyclosporine A showed similarly increased apoptotic rates
(13.3% and 42.3%; melphalan, 11.7% and 14.3%; cyclosporine A). (4)
Irradiated cells also revealed a marked increased in apoptotic rate (17.7%
& 25.5%). (5) DNA extracted from these cells also showed the charac-
teristic ladder pattern of internucleosomal chromatin cleavage of l8Obp
fragments and agarose gel electrophoresis. (6) Apoptotic rates examined
by ISEL were higher than those by LM. (7) There was no significant
difference in the tritiated thymidine incorporation rate in the cyclophos-
phamide treated cells compared to control cells. These results suggest that
cytotoxic drugs used to treat glomerular disease can induce apoptotic MC
death and may operate in part via this mechanism, and further in vivo
studies are required.
Mechanism of LPS induced IL-6 expression in the growth arrested
human mesangial cells. D.K fin, P.S. Oh, HZ. Whang, H. W. Roh, S.J. Kim,
N.S. Beck, YG. Kim, and H.Y Oh, Department of Pediatrics, Department of
Nephrology, Samsung Medical Center, Center for Clinical Research, Sam-
sung Biomedical Research Institute, Seoul, Korea. Mesangial cell (MCs)
derived interleukin 6 (IL-6) is an autocrine signal leading to mesangial cell
proliferation. However, in many of the studies on the MCs proliferation,
they used the MCs in actively proliferating state in which MCs were
stimulated to secrete many cytokines. In the current study, we tried to
demonstrate the MCs IL-6 stimulation process by observing serial changes
in expression of IL-6 as well as IL-I/I and NF IL-6 (nuclear factor for IL-6)
using the lipopolysaccharide (LPS) stimulation in serum free medium.
Our results showed that MCs could be made quiescent by changing the
growth medium to serum free medium, which was confirmed by direct cell
counting and modified MTT assay. Compared with the MCs incubated in
growth medium, MCs in resting state showed decreased expression of IL-6
mRNA in Northern blotting. Cytokines which were present in the growth
medium, were not amplified (IL-In, PDFG-A, PDGF-B) or amplified in
less intensity (IL-113) by RT-PCR in serum free medium. When MCs
incubated in serum free medium were stimulated by LPS for 0, 2, 4 and 18
hours, there was steady increase of IL-I /3 mRNA while the peak expres-
sion of IL-6 mRNA was around 4 hours after stimulation. In addition, NF
IL-6 showed the same trend as IL-6. These findings demonstrate that
maximal expression of IL-6 is related to NF IL-6, and that there is a
discrepancy of peak expression between IL-i/I and IL-6 in response to
LPS stimulation in growth arrested MCs. These results support that IL-6
can be recruited to the MCs inflammatory process and may be mediated
by NF 1I.-6.
A prospective comparative study between manual and automated renal
biopsy by randomized sampling. ..H. Ku, YJ. Oh, 5K. Shin, I-IS. Kim, H.
Ci, HI-I. Lim, D.H. Kim, Department of Nephrology, Department of
Radiology, Department of Pathology, School of Medicine, Ajou University,
Suwon, Korea. Percutaneous renal biopsy may be carried Out in several
ways. Recently, the use of a spring-loaded biopsy gun has become
popularized. There have been many controversies on the tissue adequacy
and the incidence of complications when compared to the manual biopsy.
Most of studies comparing these two methods have been retrospective in
nature. Therefore, we have studied 93 patients in whom the method of
renal biopsy was assigned to one of the two methods [l4G Tru-cut needle
manual bx (group I) and l8G automated gun biopsy (group H)] according
to their national resident's identification number in a randomized and
prospective manner. There were 45 patients in group I and 48 patients in
group II. The mean age of the patients was 36.1 15.3 years. There was
no difference in PT, PTr, diastolic and systolic BP prebiopsy in groups I
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and II. Indications for biopsies were protcinuria accompanied by hema-
tuna (36.5%), proteinuria (35.5%), ARF (8.6%), SLE (7.5%), CRF(6.5%), and hematuria only (5.4%). In Group I the number of passes was
2.5 0.9 and the glomeruli obtained were 24.6 14.7, and in Group II
3.2 1.2 and 19.7 12.4, respectively. Although the total number of
glomeruli showed no statistically significant difference, the number of
glomeruli per pass (10.9 6.1 in group I, and 7.8 4.0 in group II)
showed a significant difference (P < 0.05). In all cases pathological
diagnosis were possible. The histology showed IgA nephropathy in 22
(23.9%), MCNS in 17 (18.3%), MGN in 10 (10.7%), lupus nephritis in 10
(10.7%), MPGN in 7 (7.5%), and others. The incidence of perinephric
hematoma demonstrated on ultrasound 24 hours post-biopsy was in-
creased in group 1(22.2% compared to 10.4% in group II), although no
statistically significant difference existed. There was no significant differ-
ence in gender, age, PT, PIT, systolic and diastolic BP between the group
with and without hematomas. Hct levels before biopsy did not show a
significant difference (34.1 8.1 in group I, 34.5 6.7 in group II), but
post-biopsy Hct showed a significant difference (32.4 8.9 in group I,
34.8 6.6 in group II; P < 0.05). In conclusion, both techniques rendered
adequate tissue sampling, hut the extent of bleeding seems to be more
severe with 14G Tru-cut needle.
Evaluation of complications after percutaneous renal biopsy with color
Doppler sonography. YK Seong, J. Suk, S.B. Park, H.C. Kim, C.H. Sohn,
Department of Internal Medicine, Diagnostic Radiology, Keimyung Univer-
sity, School of Medicine, Taegu, Korea. Between August 1995 and March
1996, we prospectively studied 90 consecutive ultrasound-guided percuta-
neous renal biopsies to evaluate the incidence of complications and its
evolution. All biopsied patients were monitored through a routine fol-
low-up color Doppler sonography at post-biopsy 1, 7, 14, and 30 days. The
tissue specimen was adequate for histologic evaluation in 93.3% of the
cases. Perirenal hematoma was the most frequent complication (51%) in
our series. However, most of perirenal bleeding was clinically silent;
whereas a large hematoma, with a fall of the hematocrit of 7%, was a rare
complication (2.2%). The incidence of serious post-biopsy complications
including large hematoma and arteriovenous (AV) fistula, was 14.6%. A
large hematoma (thickness above 2 cm) was observed in 5.6% and AV
fistula in 9 (10%) cases. In seven patients the AV fistula healed sponta-
neously. In two other patients needed therapeutic arterial embolization.
We conclude that color Doppler sonographic post-biopsy evaluation is
indicated only for symptomatic bleeding, large hematoma larger than 2cm
thickness by ultrasound, and the presence of AV fistula. Post-biopsy
monitoring with ultrasound will prevent serious complications after per-
cutaneous renal biopsy.
Endothelin-1 immunoreactivity in glomerular diseases. SE. Kim, KH.
Kim, S.H. Rha, S.H. Hong, Department of Internal Medicine and Depart-
ment of Anatomical Pathology, College of Medicine, Donga University,
Pusan, Korea. Endothelin-1 recently has been found to induce mitogenesis
of mesangial cell and to stimulate the production of eicosanoids as well as
to be involved in vasoconstriction and control of sodium balance. We
committed a retrospective, double-blind study to analyze endothelin-i
immunoreactivity in 76 biopsies of patients with various glomerular
diseases by immunoperoxidase staining utilizing anti-endothelin-1 serum.
The clinical factors such as age, sex, BUN, serum creatinine, creatinine
clearance, serum albumin, and 24-hr urine protein did not show any
correlation with endothelin- I immunoreactivity in glomerular endothe-
hum, vascular cndothelium, and tubular epithelium. On the other hand, a
group of IgA ncphrupathy with glomerular proliferative change (8 focal
glomerulonephritis and 7 diffuse mesangial proliferative glemerulonephri-
tis) and a group of other proliferative glomerulonephritis (II membrano-
proliferative glomerulonephritis type 1, 5 poststreptococcal glomerulone-
phritis, 8 focal or diffuse proliferative lupus nephritis) have more
prominent immunoreactivity in glomerular endothelium, vascular endo-
thelium, and tubular epithehium than the non-proliferative glomerular
disease group (24 minimal change diseases, 7 membranous nephropathies,
6 TgA nephropathies with minor glomerular abnormality). These results
can provide another clue that endothelin-1 has a potential role in the
pathophysiologic mechanism of proliferative glomerular diseases.
Thin basement membrane disease without glomerular IgA deposition
in children. If. Sohn, YH. Park, YH. Ahn, Yf. Kim, and W.V. Chung,
Department of Pediatrics, College of Medicine, Yeungnam University, Dc-
partment of Pediatrics and Pathology, Catholic University Taegu-Hyosung,
Taegu, and Inje University Pusan Paik Hospital, Pusan, Korea. Thin
glomerular basement membrane (TGBM) disease is now recognized as
one of the leading causes of isolated microscopic hematuria, regarded as
a benign condition and characterized by the presence of familial benign
hematuria. However, there are few studies of TGBM in Korea. Kidney
biopsies were taken in 88 patients for evaluation of recurrent benign
hematuria with or without intermittent gross hematuria. Among them,
clinical and pathological findings were assessed in 18 patients whose main
abnormality was an essentially TGBM. The subjects were aged 9.1 3.2
(2 to 12) years, and 8 males and 10 females; most were referred because
of recurrent microscopic hematuria for 18.3 (3 to 60) months. A family
history of benign hematuria was found in 10 first degree relatives (10/52)
of 6 patients (33.3%). There were no significant differences in serum
creatinine, BUN, creatinine clearance, 24-hour urine protein and base-
ment membrane thickness whether or not patients had a family history of
hematuria. The presence of family history of hematuria did not influence
the progression of the disease. Kidney biopsy showed few changes by light
microscopy. C1 and fibrinogen deposit in mesangium were found in only 3
patients. Electron microscopic findings revealed that thinning of the GBM
varied from 146 to 225 nm without splitting and layering of the GBM. In
conclusion, TGBM might be a common cause of recurrent benign
hematuria with the familial microscopic hematuria in Korea.
Long-term benefits of aspirin plus dipyridamol and angiotensin-con-
verting enzyme inhibitor therapy in patients with immunoglobulin A
nephropathy. C. W. Park, Y. 0. Kim, Y. S. Shin, H. C. Song, D.C. Jin, S. V.
Kim, E.J. Choi, YS. Chang, and B.K Bang, Division of Nephrology, Catholic
University Medical College, Seoul, Korea. Of 189 cases of immunoglobulin
A nephropathy (IgAN) in the Catholic University Medical College
Registry, 132 were enrolled by retrospective analysis. These patients have
been followed a minimum of 6 months (range, 6 to 107 months).
Monitering of these patients included routine blood pressure (BP) esti-
mates, renal function status by serum creatinine (Pcr) and creatinine
clearance (Cr), and 24 hr proteinuria (Uprot) at renal biopsy, 2, 6, 12
months after renal biopsy and last follow-up (mean SD, 31 15 months,
median 36 months). These patients were grouped into four categories: (1)
no treatment (NT, N 13); (2) aspirin + dipyridamol (AD, N 57); (3)
angiotensin-converting enzyme inhibitors (ACEi, N = 18); (4) AD
ACEi (AA, N = 44). Despite lower in NT than AD, ACEi and AA
(0.80 0.50 vs. 1.82 2.00 vs. 1.89 1.64 vs. 2.34 2.14 glday, P < 0.01)
and higher mean blood pressure in ACE1 and AA than NT and AD at the
baseline (P = 0.02), there were no statistically significant differences in the
WHO pathologic score, age, sex, Cr and Car. During the follow-up
period, there were no differences between and within (pre- vs. post-
treatment) the group in renal function status by Cr and CCr (P > 0.05).
Mean BP decreased significantly in ACEi and AA, the angiotensin-
converting enzyme inhibitor treated groups, compared to basal level in 2
months after initiation of therapy and then maintained the level over the
study period (P < 0.001). In NT proteinuria increased significantly in the
last follow-up period than baseline level (1.37 0.62 g/day, P = 0.02), but
in all treated groups proteinuria decreased significantly over the entire
study periods (P < 0.001) and no difference between AD, ACEi and AA
(P = 0.24) was found. More than 50% of proteinuria decreased to the
basal level was statistically associated with basal heavy proteinuria (P
0.006) and AD + ACEi, not the WHO pathologic score, age, sex, basal BP,
Cr and Ct-, (P > 0.1). In conclusion, this long-term retrospective review
suggests that ACEi is effective in stabilizing BP and AD, and ACEi, and
AD + ACEi therapies arc effective in rapid decreasing (not synergistic) and
maintaining proteinuria, and preserving renal function. Aspirin plus dipyrid-
amole combined with ACEi might he more effective than ACEi for decreas-
ing protcinuria in IgA nephropathy patients with heavy proteinuria.
Adult minimal change nephrotic syndrome (MCNS): Treatment and a
long-term follow-up. H.C. Song, Hf. Song, YO. Kim, S.Y. Shin, CI!. Park,
D.C. Jin, S. Y Kim, E.J. Choi, YS. fang, B.K. Bang, Department of Internal
Medicine Catholic University, Seoul, Korea. MCNS is a common type of
nephrotie syndrome in the adult. 60—70% of them respond to corticoste-
roids and renal prognosis is excellent. To interpret the clinical factors
which influence the responses to treatment, we analyzed 101 patients with
MCNS retrospectively. There are no significant differences in serum
albumin, serum ereatinine, hypertension, microscopic hematuria, creati-
nine clearance and proteinuria compared with age group ( 30 years,
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31—50 years,  51 years). After the eighth course of prednisolone, 74 of
the 101 patients were in complete remission. Among the patients who
were in complete remission, 45 patients relapsed and the mean duration of
remission was 25 weeks (range 2—155 weeks). On multivariate analysis
microscopic hematuria (P = 0.0014) was independent risk factor of partial
and non-response to prednisolone. Cyelophosphamide was used in 28
patients, usually in a course of four to twelve weeks (frequent relapse 10,
corticosteroids resistance 17, steroid dependent 1). Twenty-three patients(82%) showed complete remission within 12 weeks and duration of
remission was longer after treatment with cyclophosphamide than with
prednisolone (60.4 39.3 weeks vs. 26.4 30.2 weeks, P = 0.004). For
follow-up of renal function in 44 patients (median 46 months, 24—84
months), only I patient's serum creatinine level was double that of the
initial serum creatinine level and only 1 ease of death was observed. In
conclusion, in adult MCNS, microscopic hematuria at the initial presen-
tation was an independent risk factor of partial or non-response to
corticosteroids therapy. Renal function deterioration and death associated
with complications of nephrotic syndrome and treatment are very rare.
Clinicopathological characteristics of thin glomerular basement mem-
brane nephropathy. SM Oh, IH. Kim, P.J. Hwang, KR. Na, iS. Kim, K T
Bin, S.S. Kim, K W Lee, KS. Suh, and Y T Shin, Department of Internal
Medicine and Pathology, Chungnam University, Taejeon, Korea. Thin gb-
merular basement membrane nephropathy, also called benign recurrent
hematuria, was characterized by diffuse thinning of the glomerular base-
ment membrane and by hematuria. Eight cases of the adult thin glomer-
ular basement membrane nephropathy were studied to clarify the clinico-
pathological characteristics of the disease. The present study was based on
retrospective review of 283 native kidney biopsys performed at the
Chungnam National University from January 1993 to January 1996. Of
283 cases, eight satisfied the criteria of thin glomerular basement mem-
brane nephropathy, pacing the incidence of the disease at 2.83%. The
inclusion criteria of the disease was normal finding by light microscopy and
no deposit by immunofluorescence microscopy but diffuse thinning of the
glomerular basement membrane by electron microscopy. These patients
had a mean age of 33.3 years (range from 16 to 50) and included 6 females
and 2 males. The associated symptoms were upper respiratory tract
infection (1 case), abdominal discomfort (1 case), and flank pain (2 cases).
All the patients who was normotensive and had hematuria (one case
showed gross hematuria). Among them three patients had mild protein-
uria but never pyuria nor urinary cast. Serum urea nitrogen, creatinine,
total protein, and albumin concentration were all within normal limits.
Abnormalities were not observed in immunoglobulins, complement com-
ponents, serologic tests (RA, ASO), and HBSAg. Renal biopsy findings by
light and immunofluorescence microscopy did not indicate any abnormal-
ities, but showed diffuse thinning of the glomerular basement membrane
(range 170 to 277 nm). In conclusion, among patients with idiopathic renal
hematuria with normal renal function and blood pressure, thin glomerular
basement membrane nephropathy should be considered.
Response to therapy and outcome in focal segmental glomerulosclero-
sis in adults. Hi. Hong, Ti. Choi, SB. Lee, S.P. Hong, T. W Lee, C.G. Ihm,
M.J. Kim, College of Medicine, Hyung-Hee University, Seoul, Korea. The
response to therapy in adult patients with ncphrotic syndrome caused by
primary focal segmental glomerulosclerosis (FSGS) was discouraging, but
recent reports have shown high remission rate. Of these patients in
remission, few progressed to endstage renal disease. Therefore, we
analyzed author's experiences in 42 Korean adults with primary FSGS
between January 1986 and December 1994 in an attempt to know the
response to therapy and outcome. Results arc: (1)26 of 42 patients (62%)
had nephrotic range proteinuria, and renal insufficiency (serum creati-
nine > 1.4 mgldl) was present in 14 patients (34%). Nephrotic patients
had a higher serum level of creatininc than that of nonnephrotic patients,
and there was no difference between the two groups in blood pressure,
age, and hcmaturia; (2) 21 patients with nephrotic range proteinuria
received a combined treatment with prednisolonc and cyclnphosphamide.
Complete remission (proteinuria < 300 mg/day) was observed in 10 cases
(48%), and partial remission (< 2.50 g/day) in 6 cases (28%), with mean
remission duration of 4.1 3.6 months. They had remission within 8
months of therapy except one. (3) The responder group had relatively slow
progression of azotemia than non-responders (0.0176 0.028 dl/mg/
month vs. —0.0029 0.020 dl/mg/month, slope of inverse creatinine), but
there was no significant difference. Two of 5 non-responders progressed to
ESRD (P = 0.11). (4) The degree of proteinuria, initial serum creatinine,
age, and sex did not affect the patient's response to therapy. In conclusion,
nephrotic patients with primary FSGS may benefit from a more prolonged
course of therapy with prednisolone and cycbophosphamide.
Clinical studies of children with membranous glomerulonephritis. G.H.
Lee, J.H. Park, P.K Kim, Ii. Kim, Department of Pediatrics & Pathology,
College of Medicine, The Institude of Kidney Disease, Yonsei University,
Seoul, Korea. Membranous glomerulonephritis is the most common cause
of nephrotic syndrome in adults, but it is uncommon in childhood. The
disease usually presents as nephrotic syndrome but occasionally as asymp-
tomatic proteinuria or asymptomatic hematuria. Membranous gbomerulo-
nephritis may be seen in association with hepatitis B, syphilis, SLE, cancer,
Gold and penicillamine. Thus, we investigated seventeen patients who
were confirmed by renal biopsies at pediatric department, Yonsei Univer-
sity from Jan. 1986 to Dec. 1995 to have membranous gbomerulonephritis.
Fifteen were male and five female. The age at the time of manifestation of
renal disease was between 3.6 and 16 years, the mean age was 9.5 years.
The first presenting symptoms were severe proteinuria with generalized
edema in 16 patients, asymptomatic proteinuria in 4, asymptomatic
microscopic hematuria in 18 and gross hematuria in 4. In viral marker studies,
14 patients were positive in HBs Ag and 11 out of 14 patients revealed HBe
Ag(+). Four patients were in Stage I, 14 in Stage II and 2 in Stage III. We
treated all patients with prednisolone and 10 patients with cyclosporine A and
prednisolone. There were remissions in 17 patients during average fol-
low-up period of 3.2 years, but persistent asymptomatic proteinuria in 3.
Factors contributing to the outcome in patients with idiopathic mem-
branous glomerulonephritis—Single center study in Korea. TH Lee, Yl.
Park, J.K Kwon, YK Seong, J. Suk, SB. Park; and HG. Kim, Department
of Internal Medicine, School of Medicine, Keimyung University, Taegu,
Korea. Seventy-four adult patients with idiopathic membranous glomeru-
lonephritis (IMGN), in whom renal biopsy has been performed at
Keimyung University Dongsna Hospital, were studied for the clinical
evolution of the disease and factors which might be involved in the
development of chronic renal failure. The period of follow-up ranged from
6 to 160 months (mean 43.6 33.3 months). There were 46 males and 28
females with a mean age of 41 years. Mean time from the onset to the
renal biopsy was 13 months. The clinical presentation at the time of
diagnosis were nephrotic syndrome (57%), asymptomatic urinary abnor-
mality (25%), acute nephritic syndrome (15%), and recurrent gross
hematuria (3%). Fourteen of the patients had chronic renal failure or
end-stage renal disease with mean follow-up period of 44 51 months.
Three and 5 year renal survival rates were 86% and 73%, respectively.
Using Student's t-test of the SPSS package, four parameters were found as
predictive factors for prognosis at the time of biopsy: serum creatinine
concentration  1.7 mg/dl at the time of biopsy (P < 0.01), proteinuria
 3.0 g/day (P = 0.04), remission of proteinuria less than 2.0 g/24 hr (P <
0.01), and RBC  5/HPF (P < 0.01). No effect on prognosis was observed
in the age, sex, steroid and/or immunosuppressive therapy, serum albumin
concentration, and serum total cholesterol concentration.
Clinicopathologic characteristics of idiopathic membranoproliferative
glomerulonephritis (MPGN) in adults. Yl. Park, T.H. Lee, YK Seong, J.
Suk, S. B. Park, and H. C'. Kim, Department of Internal Medicine, School of
Medicine, Keimyung University, Taegu, Korea. A retrospective analysis of 59
patients with adult onset idiopathic membranoproliferative gbomerubone-
phritis (MPGN) seen between Jan. 1980 and Feb. 1996 is reported.
Among the total 1048 cases with primary gbomerubonephritis seen during
the same period, idiopathic MPGN accounted for 5.6% of it. All patients
had type I MPGN. No case of dense deposit variant was seen. Male-to-
female ratio of the patients was 1.7:1 with a slight male preponderance
with a mean age of 33.5 15.5 years (16 — 71 years). The clinical
presentations at the diagnosis were nephrotic syndrome (62.6%), acute
nephritic syndrome (15.3%), proteinuria (10.2%), recurrent hematuria(10.2%), and chronic renal failure (1.7%). On physical examination,
edema (64.4%), hypertension (44.1%), and gross hematuria (18.6%) were
frequently noticed. As laboratory features, microscopic hematuria
(57.6%), anemia (47.5%), azotenlia (45.8%), and decreased serum C3 and
C4 were observed in 36% and 15%, respectively. During a me-an follow-up
of 38.5 months (3 -- 122 months), 17 patients (28.8%) developed
end-stage renal failure. Steroid/immunosuppresive therapy did not influ-
ence the rate of progression of renal failure. Cumulative renal survival at
3 and 5 years after diagnosis were 85% and 74%, respectively.
